ALLY FINANCIAL INC., 10-Q filed on 5/5/2026
Quarterly Report
v3.26.1
Cover Page - shares
 3 Months Ended
Mar. 31, 2026
May 01, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2026  
Document Transition Report false  
Entity File Number 1-3754  
Entity Registrant Name Ally Financial Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 38-0572512  
Entity Address, Address Description Ally Detroit Center  
Entity Address, Address Line One 500 Woodward Avenue  
Entity Address, Address Line Two Floor 10  
Entity Address, City or Town Detroit  
Entity Address, State or Province MI  
Entity Address, Postal Zip Code 48226  
City Area Code 866  
Local Phone Number 710-4623  
Title of 12(b) Security Common Stock, par value $0.01 per share  
Trading Symbol ALLY  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   306,523,062
Entity Central Index Key 0000040729  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Amendment Flag false  
v3.26.1
Condensed Consolidated Statement of Comprehensive Income (unaudited) - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Financing revenue and other interest income    
Interest and fees on finance receivables and loans $ 2,658 $ 2,709
Interest on loans held-for-sale 9 5
Interest and dividends on investment securities and other earning assets 234 230
Interest on cash and cash equivalents 81 98
Operating leases 392 351
Total financing revenue and other interest income 3,374 3,393
Interest expense    
Interest on deposits 1,233 1,403
Interest on short-term borrowings 19 1
Interest on long-term debt 265 271
Total interest expense 1,517 1,675
Net depreciation expense on operating lease assets 268 240
Net financing revenue and other interest income 1,589 1,478
Other revenue    
Insurance premiums and service revenue earned 360 364
(Loss) gain on mortgage and automotive loans, net (3) 1
Other loss on investments, net (21) (499)
Other income, net of losses 177 197
Total other revenue 513 63
Total net revenue 2,102 1,541
Provision for credit losses 467 191
Noninterest expense    
Compensation and benefits expense 491 505
Insurance losses and loss adjustment expenses 121 161
Goodwill impairment 0 305
Other operating expenses 623 663
Total noninterest expense 1,235 1,634
Income (loss) from continuing operations before income tax expense (benefit) 400 (284)
Income tax expense (benefit) from continuing operations 81 (59)
Net income (loss) from continuing operations 319 (225)
Net income (loss) 319 (225)
Other comprehensive income, net of tax 13 662
Comprehensive income 332 437
Net income (loss) from continuing operations attributable to common shareholders [1] 291 (253)
Net income (loss) attributable to common shareholders [1] $ 291 $ (253)
Basic weighted-average common shares outstanding (in shares) [1],[2] 310,992 309,006
Diluted weighted-average common shares outstanding (in shares) [1],[2],[3] 313,219 309,006
Basic earnings per common share    
Net income (loss) from continuing operations (in dollars per share) [1] $ 0.94 $ (0.82)
Net income (loss) (in dollars per share) [1] 0.94 (0.82)
Diluted earnings per common share    
Net income (loss) from continuing operations (in dollars per share) [1] 0.93 (0.82)
Net income (loss) (in dollars per share) [1] 0.93 (0.82)
Cash dividends declared per common share (in dollars per share) [1] $ 0.30 $ 0.30
[1] Figures in the table may not recalculate exactly due to rounding. Earnings per share is calculated based on unrounded numbers.
[2]
(b)Includes shares related to share-based compensation that vested but were not yet issued.
[3]
(c)Due to the antidilutive effect of the net loss from continuing operations for the three months ended March 31, 2025, basic weighted-average common shares outstanding was used to calculate basic and diluted earnings per share. During the three months ended March 31, 2025, there were 2.7 million in share-based awards excluded because their inclusion would have been antidilutive.
v3.26.1
Condensed Consolidated Statement of Comprehensive Income (unaudited) (Parenthetical)
shares in Millions
 3 Months Ended
Mar. 31, 2025
shares
Income Statement [Abstract]  
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 2.7
v3.26.1
Condensed Consolidated Balance Sheet (unaudited) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Cash and cash equivalents    
Noninterest-bearing $ 380 $ 405
Interest-bearing 9,138 9,625
Total cash and cash equivalents 9,518 10,030
Equity securities 863 876
Available-for-sale securities (amortized cost basis of $25,974 and $25,825) 23,038 22,973
Held-to-maturity securities (fair value of $4,387 and $4,451) 4,337 4,371
Loans held-for-sale, net 337 549
Finance receivables and loans, net    
Finance receivables and loans, net of unearned income 139,890 137,454
Allowance for loan losses (3,540) (3,490)
Total finance receivables and loans, net 136,350 133,964
Investment in operating leases, net 8,699 8,772
Premiums receivable and other insurance assets 2,817 2,844
Other assets 11,310 11,623
Total assets 197,269 196,002
Deposit liabilities    
Noninterest-bearing 137 125
Interest-bearing 153,015 151,524
Total deposit liabilities 153,152 151,649
Short-term borrowings 4,126 4,695
Long-term debt 17,349 17,070
Interest payable 852 729
Unearned insurance premiums and service revenue 3,665 3,656
Accrued expenses and other liabilities 2,516 2,705
Total liabilities 181,660 180,504
Contingencies (refer to Note 23)
Equity    
Common stock and paid-in capital ($0.01 par value, shares authorized 1,100,000,000; issued 522,896,204 and 520,355,804; and outstanding 307,407,671 and 308,492,929) 22,346 22,295
Preferred stock 2,324 2,324
Retained earnings 827 633
Accumulated other comprehensive loss (2,773) (2,786)
Treasury stock, at cost (215,488,533 and 211,862,875 shares) (7,115) (6,968)
Total equity 15,609 15,498
Total liabilities and equity $ 197,269 $ 196,002
v3.26.1
Condensed Consolidated Balance Sheet (unaudited) (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Statement of Financial Position [Abstract]    
Available-for-sale securities, amortized cost $ 25,974 $ 25,825
Held-to-maturity securities, fair value $ 4,387 $ 4,451
Common stock, par value per share (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 1,100,000,000 1,100,000,000
Common stock, shares issued (in shares) 522,896,204 520,355,804
Common stock, shares outstanding (in shares) 307,407,671 308,492,929
Treasury stock, common, shares (in shares) 215,488,533 211,862,875
v3.26.1
Condensed Consolidated Balance Sheet (unaudited) (VIEs) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Finance receivables and loans, net $ 139,890 $ 137,454
Allowance for loan losses (3,540) (3,490)
Total finance receivables and loans, net 136,350 133,964
Other assets 11,310 11,623
Total assets 197,269 196,002
Long-term debt 17,349 17,070
Accrued expenses and other liabilities 2,516 2,705
Total liabilities 181,660 180,504
Consumer    
Finance receivables and loans, net 101,973 101,140
Consumer | Consumer automotive    
Finance receivables and loans, net 86,662 85,568
Allowance for loan losses (3,250) (3,208)
On‑balance sheet variable interest entities    
Allowance for loan losses (133) (116)
Total finance receivables and loans, net 3,409 2,980
Other assets 344 260
Total assets 3,753 3,240
Long-term debt 2,056 1,479
Accrued expenses and other liabilities 4 3
Total liabilities 2,060 1,482
On‑balance sheet variable interest entities | Consumer | Consumer automotive    
Finance receivables and loans, net 3,542 3,096
Total assets 12,625 12,149
Total liabilities $ 2,191 $ 1,619
v3.26.1
Condensed Consolidated Statement of Changes in Equity (unaudited) - USD ($)
$ in Millions
Total
Preferred stock dividends — Series B
Preferred stock dividends — Series C
Common stock and paid-in capital
Preferred stock
Retained earnings (accumulated deficit)
Retained earnings (accumulated deficit)
Preferred stock dividends — Series B
Retained earnings (accumulated deficit)
Preferred stock dividends — Series C
Accumulated other comprehensive loss
Treasury stock
Beginning balance at Dec. 31, 2024 $ 13,903     $ 22,142 $ 2,324 $ 270     $ (3,924) $ (6,909)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net (loss) income (225)         (225)        
Preferred stock dividends   $ (16) $ (12)       $ (16) $ (12)    
Share-based compensation 49     49            
Other comprehensive income 662               662  
Common stock repurchases (34)                 (34)
Common stock dividends (95)         (95)        
Ending balance at Mar. 31, 2025 14,232     22,191 2,324 (78)     (3,262) (6,943)
Beginning balance at Dec. 31, 2025 15,498     22,295 2,324 633     (2,786) (6,968)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net (loss) income 319         319        
Preferred stock dividends   $ (16) $ (12)       $ (16) $ (12)    
Share-based compensation 51     51            
Other comprehensive income 13               13  
Common stock repurchases (147)                 (147)
Common stock dividends (97)         (97)        
Ending balance at Mar. 31, 2026 $ 15,609     $ 22,346 $ 2,324 $ 827     $ (2,773) $ (7,115)
v3.26.1
Condensed Consolidated Statement of Changes in Equity (unaudited) (Parenthetical) - $ / shares
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Statement of Stockholders' Equity [Abstract]    
Cash dividends declared per common share (in dollars per share) [1] $ 0.30 $ 0.30
[1] Figures in the table may not recalculate exactly due to rounding. Earnings per share is calculated based on unrounded numbers.
v3.26.1
Condensed Consolidated Statement of Cash Flows (unaudited) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Operating activities      
Net income (loss) $ 319 $ (225)  
Reconciliation of net income (loss) to net cash provided by operating activities      
Depreciation and amortization 378 361  
Goodwill impairment 0 305 $ 305
Provision for credit losses 467 191  
Loss (gain) on mortgage and automotive loans, net 3 (1)  
Other loss on investments, net 21 499  
Originations and purchases of loans held-for-sale (626) (490)  
Proceeds from sales and repayments of loans held-for-sale 585 543  
Net change in      
Deferred income taxes 22 (178)  
Interest payable 123 64  
Other assets 71 (128)  
Other liabilities (80) (137)  
Other, net 88 136  
Net cash provided by operating activities 1,371 940  
Investing activities      
Purchases of equity securities (331) (196)  
Proceeds from sales of equity securities 333 122  
Purchases of available-for-sale securities (781) (3,649)  
Proceeds from sales of available-for-sale securities 125 2,669  
Proceeds from repayments of available-for-sale securities 506 440  
Purchases of held-to-maturity securities (44) (248)  
Proceeds from repayments of held-to-maturity securities 117 109  
Purchases of finance receivables and loans held-for-investment (1,754) (843)  
Proceeds from sales of finance receivables and loans initially held-for-investment 254 5  
Originations and repayments of finance receivables and loans initially held-for-investment and other, net (1,137) 537  
Purchases of operating lease assets (705) (819)  
Disposals of operating lease assets 474 681  
Net change in nonmarketable equity investments 26 2  
Other, net (126) (151)  
Net cash used in investing activities (3,043) (1,341)  
Financing activities      
Net change in short-term borrowings (569) 1,714  
Net increase (decrease) in deposits 1,684 (64)  
Proceeds from issuance of long-term debt 1,081 24  
Repayments of long-term debt (824) (1,074)  
Repurchases of common stock (147) (34)  
Common stock dividends paid (102) (100)  
Preferred stock dividends paid (28) (28)  
Net cash provided by financing activities 1,095 438  
Effect of exchange-rate changes on cash and cash equivalents and restricted cash (3) 0  
Net (decrease) increase in cash and cash equivalents and restricted cash (580) 37  
Cash and cash equivalents and restricted cash at beginning of year 11,809 11,380 11,380
Cash and cash equivalents and restricted cash at March 31, 11,229 11,417 11,809
Cash paid for      
Interest 1,370 1,587  
Income taxes 12 13  
Noncash items      
Finance receivables and loans held-for-investment transferred to loans held-for-sale 7 2,321  
Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]      
Cash and cash equivalents on the Condensed Consolidated Balance Sheet 9,518 10,409 10,030
Restricted cash and cash equivalents and restricted cash held for securitization trusts included in other assets on the Condensed Consolidated Balance Sheet [1] 1,711 1,008  
Total cash and cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows $ 11,229 $ 11,417 $ 11,809
[1] Refer to Note 10 for additional details describing the nature of restricted cash and cash equivalent balances.
v3.26.1
Description of Business, Basis of Presentation, and Changes in Significant Accounting Policies
 3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business, Basis of Presentation, and Changes in Significant Accounting Policies Description of Business, Basis of Presentation, and Changes in Significant Accounting Policies
Ally Financial Inc. (together with its consolidated subsidiaries unless the context otherwise requires, Ally, the Company, we, us, or our) is a financial-services company with the nation’s largest all-digital bank and an industry-leading automotive financing and insurance business, driven by a mission to “Do It Right” and be a relentless ally for all stakeholders. The Company serves customers with deposits and securities brokerage and investment advisory services as well as automotive financing and insurance offerings. The Company also includes a seasoned corporate finance business that offers capital for equity sponsors and middle-market companies. Ally is a Delaware corporation and is registered as a BHC under the BHC Act and an FHC under the GLB Act.
Our accounting and reporting policies conform to U.S. GAAP. Additionally, where applicable, the policies conform to the accounting and reporting guidelines prescribed by bank regulatory authorities. Certain reclassifications may have been made to the prior periods’ financial statements and notes to conform to the current period’s presentation, which did not have a material impact on our Condensed Consolidated Financial Statements. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure, including those of contingent assets and liabilities at the date of the financial statements. It also includes estimates related to the income and expenses during the reporting period and the related disclosures. In developing the estimates and assumptions, management uses all available evidence; however, actual results could differ because of uncertainties associated with estimating the amounts, timing, and likelihood of possible outcomes. Our most significant estimates pertain to the allowance for loan losses, the valuations of automotive operating lease assets and residuals, the fair value of financial instruments, and the determination of the provision for income taxes.
The Condensed Consolidated Financial Statements at March 31, 2026, and for the three months ended March 31, 2026, and 2025, are unaudited but reflect all adjustments that are, in management’s opinion, necessary for the fair presentation of the results for the interim periods presented. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements (and the related Notes) included in our Annual Report on Form 10-K for the year ended December 31, 2025, as filed on February 25, 2026, with the SEC.
Significant Accounting Policies
Income Taxes
In calculating the provision for interim income taxes, in accordance with ASC 740, Income Taxes, we apply an estimated annual effective tax rate to year-to-date ordinary income. At the end of each interim period, we estimate the effective tax rate expected to be applicable for the full fiscal year. This method differs from that described in Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K, which describes our annual significant income tax accounting policy and related methodology.
Refer to Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K regarding additional significant accounting policies.
Recently Issued Accounting Standards
Expense Disaggregation Disclosures (ASU 2024-03)
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income (Subtopic 220-40): Expense Disaggregation Disclosures. The purpose of this ASU is to provide additional disclosure that will allow investors to better understand an entity’s performance, better assess an entity’s prospects for future cash flows, and more easily compare an entity’s performance over time and in relation to other similar entities. This ASU will require that an entity disclose, on an interim and annual basis, a disaggregation in the notes to the financial statements of certain income statement line items if the line item includes any of the five required expense categories, which are defined as (1) purchases of inventory, (2) employee compensation, (3) depreciation (including amortization of a finance ROU asset and leasehold improvements), (4) intangible asset amortization, and (5) depletion expense. For the “employee compensation” category, banking entities may continue to present compensation expense on the face of the income statement in accordance with Regulation S-X Rule 210.9-04. The disclosure should include a qualitative description of other expenses included within the income statement line item that are otherwise not disaggregated. This ASU will also require entities to disclose their total selling expenses for each reporting period. Selling expenses are not defined within the ASU, which will require entities to determine and disclose how they define selling expenses on an annual basis. The amendments are effective on January 1, 2027, for annual reporting, and for interim reporting thereafter, with early adoption permitted. The amendments must be applied using either a prospective or retrospective approach. We do not expect the impact of these amendments to be material.
Targeted Improvements to the Accounting for Internal-Use Software (ASU 2025-06)
In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The purpose of this ASU is to improve the accounting for internal-use software costs by aligning the accounting with modern software development processes. This ASU removes all references to sequential software development project stages from U.S. GAAP, but does not change the types of costs that are eligible to be capitalized. Under the updated guidance, entities will be required to begin capitalizing software project costs when (1) management has authorized and committed to funding the software project and (2) it is probable that the project will be completed, and the software will be used to perform the function intended (called the “probable-to-complete” threshold). When evaluating whether the probable-to-complete threshold is met, entities must consider whether there is significant development uncertainty associated with the software, including determining whether the software project contains technological innovations or novel, unique, or unproven functions or features. Entities should also consider if there are significant performance requirements (e.g., functions or features) of the software project that have not yet been identified or continue to be substantially revised. The amendments do not define what is considered “significant” and instead will require management judgment. The amendments are effective January 1, 2028, with early adoption permitted. The amendments can be applied using a prospective approach, a retrospective approach, or a modified approach that bases the adoption of the amendments on the completion status of the software project as of the adoption date. We are currently evaluating the impact of these amendments.
Purchased Loans (ASU 2025-08)
In November 2025, the FASB issued ASU 2025-08, Financial Instruments—Credit Losses (Topic 326): Purchased Loans. This ASU expands the gross-up approach applied to PCD financial assets to loans that are purchased and considered seasoned, excluding credit card loans, debt securities, and trade receivables accounted for under the revenue recognition guidance. Under the expanded gross-up approach, the amortized cost basis for a seasoned loan receivable will be the purchase price plus the initial measurement of the allowance for loan losses, on the acquisition date. Any remaining discount embedded in the purchase price will be amortized into interest income over the term of the loan. The purchased seasoned loan designation would be evaluated on a loan-by-loan basis. The resulting accounting will reflect no day-one provision expense on qualifying seasoned loans and a lower yield over time than what is currently presented under the non-PCD model. Loans acquired in a business combination would be considered seasoned. For a loan acquired through an asset transfer or by consolidating a VIE, the acquisition must be at least 90 days after loan origination and the acquirer must not have been involved in originating the loan for the loan to be considered seasoned. The amendments are effective January 1, 2027, with early adoption permitted and must be adopted on a prospective basis. We are currently evaluating the impact of these amendments.
v3.26.1
Revenue from Contracts with Customers
 3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Revenue from Contracts with Customers Revenue from Contracts with Customers
Our primary revenue sources, which include financing revenue and other interest income, are addressed by other U.S. GAAP topics and are not in the scope of ASC Topic 606, Revenue from Contracts with Customers. As part of our Insurance operations, we recognize revenue from insurance contracts, which are addressed by other U.S. GAAP topics and are not included in the scope of this standard. Certain noninsurance contracts within our Insurance operations, including VSCs, GAP contracts, and VMCs, are included in the scope of this standard. All revenue associated with noninsurance contracts is recognized over the contract term on a basis proportionate to the anticipated cost emergence. Further, commissions and sales expense incurred to obtain these contracts are amortized over the terms of the related policies and service contracts on the same basis as premiums and service revenue are earned, and all advertising costs are recognized as expense when incurred.
The following table presents a disaggregated view of our revenue from contracts with customers. For further information regarding our revenue recognition policies and details about the nature of our respective revenue streams, refer to Note 1 and Note 3 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K.
Three months ended March 31, ($ in millions)
Automotive Finance operationsInsurance operationsCorporate Finance operationsCorporate and OtherConsolidated
2026
Revenue from contracts with customers
Noninsurance contracts (a) (b) (c)$— $242 $— $— $242 
Remarketing fee income32 — — — 32 
Brokerage commissions and other revenue— — — 19 19 
Banking fees and interchange income— — — 5 5 
Brokered/agent commissions— 2 — — 2 
Other6 — — 1 7 
Total revenue from contracts with customers38 244 — 25 307 
All other revenue67 98 35 6 206 
Total other revenue (d)$105 $342 $35 $31 $513 
2025
Revenue from contracts with customers
Noninsurance contracts (a) (b) (c)$— $241 $— $— $241 
Remarketing fee income31 — — — 31 
Brokerage commissions and other revenue— — — 20 20 
Banking fees and interchange income (e)— — — 19 19 
Brokered/agent commissions— 5 — — 5 
Other5 1 — 1 7 
Total revenue from contracts with customers36 247 — 40 323 
All other revenue61 117 29 (467)(260)
Total other revenue (d)$97 $364 $29 $(427)$63 
(a)We had opening balances of $3.0 billion in unearned revenue associated with outstanding contracts at both January 1, 2026, and 2025, and $239 million and $238 million of these balances were recognized as insurance premiums and service revenue earned in our Condensed Consolidated Statement of Comprehensive Income during the three months ended March 31, 2026, and 2025, respectively.
(b)At March 31, 2026, we had unearned revenue of $3.0 billion associated with outstanding contracts, and with respect to this balance we expect to recognize revenue of $653 million during the remainder of 2026, $751 million in 2027, $599 million in 2028, $440 million in 2029, and $544 million thereafter. At March 31, 2025, we had unearned revenue of $3.0 billion associated with outstanding contracts.
(c)We had deferred insurance assets of $1.8 billion at both March 31, 2026, and December 31, 2025, and recognized $138 million of expense during the three months ended March 31, 2026. We had deferred insurance assets of $1.8 billion at both March 31, 2025, and December 31, 2024, and recognized $141 million of expense during the three months ended March 31, 2025.
(d)Represents a component of total net revenue. Refer to Note 22 for further information on our reportable operating segments.
(e)Interchange income is reported net of customer rewards related to Ally Credit Card. Customer rewards expense was $6 million for the three months ended March 31, 2025. We closed the sale of Ally Credit Card on April 1, 2025. Refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information.
In addition to the components of other revenue presented above, as part of our Automotive Finance operations, we recognized net remarketing losses on the sale of off-lease vehicles of $10 million and $19 million for the three months ended March 31, 2026, and 2025, respectively. These losses are included in depreciation expense on operating lease assets in our Condensed Consolidated Statement of Comprehensive Income. Refer to Note 8 for additional information.
v3.26.1
Other Income, Net of Losses
 3 Months Ended
Mar. 31, 2026
Other Nonoperating Income (Expense) [Abstract]  
Other Income, Net of Losses Other Income, Net of Losses
Details of other income, net of losses, were as follows.
Three months ended March 31,
($ in millions)20262025
Late charges and other administrative fees$36 $51 
Remarketing fees32 31 
Income from equity-method investments (a)17 26 
Other, net92 89 
Total other income, net of losses (b)$177 $197 
(a)Refer to Note 10 for further information on our equity-method investments.
(b)Includes the activity of Ally Credit Card prior to the sale on April 1, 2025.
v3.26.1
Reserves for Insurance Losses and Loss Adjustment Expenses
 3 Months Ended
Mar. 31, 2026
Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net [Abstract]  
Reserves for Insurance Losses and Loss Adjustment Expenses Reserves for Insurance Losses and Loss Adjustment Expenses
The following table shows a rollforward of our reserves for insurance losses and loss adjustment expenses.
($ in millions)20262025
Total gross reserves for insurance losses and loss adjustment expenses at January 1,$233 $189 
Less: Reinsurance recoverable69 60 
Net reserves for insurance losses and loss adjustment expenses at January 1,164 129 
Net insurance losses and loss adjustment expenses incurred related to:
Current year122 161 
Prior years (a)(1)— 
Total net insurance losses and loss adjustment expenses incurred121 161 
Net insurance losses and loss adjustment expenses paid or payable related to:
Current year(50)(44)
Prior years(55)(54)
Total net insurance losses and loss adjustment expenses paid or payable(105)(98)
Net reserves for insurance losses and loss adjustment expenses at March 31,180 192 
Plus: Reinsurance recoverable (b)71 76 
Total gross reserves for insurance losses and loss adjustment expenses at March 31, (c)$251 $268 
(a)There have been no material adverse changes to the reserve for prior years.
(b)Included in premiums receivable and other insurance assets on our Condensed Consolidated Balance Sheet.
(c)Included in accrued expenses and other liabilities on our Condensed Consolidated Balance Sheet.
v3.26.1
Other Operating Expenses
 3 Months Ended
Mar. 31, 2026
Operating Expenses [Abstract]  
Other Operating Expenses Other Operating Expenses
Details of other operating expenses were as follows.
Three months ended March 31,
($ in millions)20262025
Insurance commissions$152 $161 
Technology and communications101 103 
Advertising and marketing60 61 
Property and equipment depreciation59 63 
Lease and loan administration45 46 
Regulatory and licensing fees36 44 
Professional services35 31 
Vehicle remarketing and repossession34 33 
Amortization of intangible assets— 3 
Other101 118 
Total other operating expenses (a)$623 $663 
(a)Includes the activity of Ally Credit Card prior to the sale on April 1, 2025. Refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information.
v3.26.1
Investment Securities
 3 Months Ended
Mar. 31, 2026
Investments, Debt and Equity Securities [Abstract]  
Investment Securities Investment Securities
Our investment portfolio includes various debt and equity securities. Our debt securities, which are classified as available-for-sale or held-to-maturity, include government securities, corporate bonds, asset-backed securities, and mortgage-backed securities. The amortized cost basis, fair value, and gross unrealized gains and losses on available-for-sale and held-to-maturity securities were as follows.
March 31, 2026December 31, 2025
Amortized cost basisGross unrealized
Fair value
Amortized cost basisGross unrealized
Fair value
($ in millions)gainslossesgainslosses
Available-for-sale securities
Debt securities
U.S. Treasury and federal agencies$2,444 $8 $(55)$2,397 $2,308 $22 $(51)$2,279 
U.S. States and political subdivisions593 — (76)517 624 1 (74)551 
Foreign government202 1 (4)199 191 1 (4)188 
Agency mortgage-backed residential (a)14,787 16 (2,108)12,695 14,966 19 (2,084)12,901 
Mortgage-backed residential226 — (33)193 230 — (32)198 
Agency mortgage-backed commercial (a)5,729 8 (630)5,107 5,540 14 (622)4,932 
Asset-backed2 — — 2 12 — — 12 
Corporate debt1,991 8 (71)1,928 1,954 19 (61)1,912 
Total available-for-sale securities (b) (c) (d) (e) (f)$25,974 $41 $(2,977)$23,038 $25,825 $76 $(2,928)$22,973 
Held-to-maturity securities
Debt securities
Agency mortgage-backed residential$1,337 $3 $(157)$1,183 $1,303 $8 $(157)$1,154 
Mortgage-backed residential2,957 203 — 3,160 3,018 228 — 3,246 
Asset-backed retained notes43 1 — 44 50 1 — 51 
Total held-to-maturity securities (d) (f) (g)$4,337 $207 $(157)$4,387 $4,371 $237 $(157)$4,451 
(a)Fair value includes basis adjustments for securities in closed portfolios with active hedges under the portfolio layer method. This includes a $31 million liability and a $13 million asset for agency mortgage-backed residential securities at March 31, 2026, and December 31, 2025, respectively, and a $10 million asset and a $33 million asset for agency mortgage-backed commercial securities at March 31, 2026, and December 31, 2025, respectively. These basis adjustments would be allocated to the amortized cost basis of specific securities within the pool if the hedge was dedesignated. Refer to Note 18 for additional information.
(b)Certain available-for-sale securities are included in fair value hedging relationships. Refer to Note 18 for additional information.
(c)Certain entities related to our Insurance operations are required to deposit securities with state regulatory authorities. These deposited securities totaled $14 million at both March 31, 2026, and December 31, 2025.
(d)Investment securities with a fair value of $3.5 billion and $3.7 billion were pledged as collateral at March 31, 2026, and December 31, 2025, respectively. This primarily included $2.7 billion pledged to secure advances from the FHLB at both March 31, 2026, and December 31, 2025. This also included securities pledged for other purposes as required by contractual obligations or law, under which agreements we granted the counterparty the right to sell or pledge $866 million and $932 million of the underlying available-for-sale securities at March 31, 2026, and December 31, 2025, respectively.
(e)Totals do not include accrued interest receivable, which was $86 million and $87 million at March 31, 2026, and December 31, 2025, respectively. Accrued interest receivable is included in other assets on our Condensed Consolidated Balance Sheet.
(f)There was no allowance for credit losses recorded at both March 31, 2026, and December 31, 2025, as management determined that there were no expected credit losses in our portfolio of available-for-sale and held-to-maturity securities.
(g)Totals do not include accrued interest receivable, which was $12 million and $13 million at March 31, 2026, and December 31, 2025, respectively. Accrued interest receivable is included in other assets on our Condensed Consolidated Balance Sheet.
The maturity distribution of debt securities outstanding is summarized in the following tables based upon contractual maturities. Call or prepayment options may cause actual maturities to differ from contractual maturities.
TotalDue in one year or lessDue after one year through five yearsDue after five years through ten yearsDue after ten years
($ in millions)AmountYieldAmountYieldAmountYieldAmountYieldAmountYield
March 31, 2026
Fair value of available-for-sale securities (a)
U.S. Treasury and federal agencies$2,397 3.5 %$68 1.5 %$2,050 3.7 %$279 2.3 %$— — %
U.S. States and political subdivisions517 3.4 39 5.1 54 3.7 53 4.5 371 3.1 
Foreign government199 2.8 14 1.9 92 2.3 93 3.4 — — 
Agency mortgage-backed residential (b)12,695 2.9 — — 1 2.8 — — 12,694 2.9 
Mortgage-backed residential193 2.7 — — — — — — 193 2.7 
Agency mortgage-backed commercial (b)5,107 2.7 144 3.1 1,647 3.3 2,491 2.4 825 2.3 
Asset-backed2 1.5 1 1.5 1 1.3 — — — — 
Corporate debt1,928 3.6 214 2.6 892 2.5 700 4.9 122 5.4 
Total available-for-sale securities$23,038 3.0 $480 2.8 $4,737 3.3 $3,616 3.0 $14,205 2.9 
Amortized cost basis of available-for-sale securities$25,974 $483 $4,871 $4,046 $16,574 
Amortized cost basis of held-to-maturity securities (c)
Agency mortgage-backed residential$1,337 3.5 %$— — %$— — %$— — %$1,337 3.5 %
Mortgage-backed residential2,957 2.8 — — 4 2.9 1 5.3 2,952 2.8 
Asset-backed retained notes
43 5.4 — — 30 5.3 13 5.7 — — 
Total held-to-maturity securities
$4,337 3.0 $— — $34 5.0 $14 5.7 $4,289 3.0 
December 31, 2025
Fair value of available-for-sale securities (a)
U.S. Treasury and federal agencies$2,279 3.4 %$84 0.8 %$1,771 3.9 %$424 2.0 %$— — %
U.S. States and political subdivisions551 3.4 48 4.8 50 3.7 65 4.3 388 3.1 
Foreign government188 2.8 14 2.0 75 2.3 99 3.3 — — 
Agency mortgage-backed residential (b)12,901 2.9 — — 1 2.8 — — 12,900 2.9 
Mortgage-backed residential198 2.7 — — — — — — 198 2.7 
Agency mortgage-backed commercial (b)4,932 2.7 87 3.4 1,453 3.5 2,314 2.4 1,078 2.3 
Asset-backed12 1.5 — — 12 1.5 — — — — 
Corporate debt1,912 3.4 232 2.4 866 2.5 679 4.6 135 5.5 
Total available-for-sale securities$22,973 3.0 $465 2.5 $4,228 3.4 $3,581 2.9 $14,699 2.9 
Amortized cost basis of available-for-sale securities$25,825 $468 $4,298 $3,968 $17,091 
Amortized cost basis of held-to-maturity securities (c)
Agency mortgage-backed residential
$1,303 3.5 %$— — %$— — %$— — %$1,303 3.5 %
Mortgage-backed residential3,018 2.8 — — 5 2.9 1 5.5 3,012 2.8 
Asset-backed retained notes
50 5.4 — — 35 5.3 15 5.7 — — 
Total held-to-maturity securities
$4,371 3.0 $— — $40 5.0 $16 5.7 $4,315 3.0 
(a)Yield is calculated using the effective yield of each security at the end of the period, weighted based on the fair value by security for the securities within each maturity distribution range. The effective yield considers the contractual coupon and amortized cost basis inclusive of hedge basis adjustments for dedesignated hedges, and excludes expected capital gains and losses. Yield does not consider hedging effects for securities in active hedges.
(b)Fair value includes basis adjustments for securities in closed portfolios with active hedges under the portfolio layer method. This includes a $31 million liability and a $13 million asset for agency mortgage-backed residential securities at March 31, 2026, and December 31, 2025, respectively, and a $10 million asset and a $33 million asset for agency mortgage-backed commercial securities at March 31, 2026, and December 31, 2025, respectively. These basis adjustments would be allocated to the amortized cost basis of specific securities within the pool if the hedge was dedesignated. Refer to Note 18 for additional information.
(c)Yield is calculated using the effective yield of each security at the end of the period, weighted based on amortized cost basis by security for the securities within each maturity distribution range. The effective yield considers the contractual coupon and amortized cost basis and excludes capital gains, capital losses, and the premium or discount on securities transferred from available-for-sale to held-to-maturity.
The balances of cash equivalents were $444 million and $107 million at March 31, 2026, and December 31, 2025, respectively, and were composed primarily of money-market funds.
The following table presents interest and dividends on investment securities.
Three months ended March 31,
($ in millions)20262025
Taxable interest$214 $210 
Taxable dividends4 5 
Interest and dividends exempt from U.S. federal income tax5 6 
Interest and dividends on investment securities$223 $221 
The following table presents gross gains and losses realized upon the sales of available-for-sale securities, and net gains or losses on equity securities held during the period.
Three months ended March 31,
($ in millions)20262025
Available-for-sale securities
Gross realized gains$3 $— 
Gross realized losses (a)— (495)
Net realized gain (loss) on available-for-sale securities3 (495)
Net realized gain on equity securities35 8 
Net unrealized loss on equity securities(59)(12)
Other loss on investments, net$(21)$(499)
(a)Includes losses reclassified from accumulated other comprehensive loss related to the balance sheet repositioning of our available-for-sale securities portfolio during the three months ended March 31, 2025.
The following table presents the credit quality of our held-to-maturity securities, based on the latest available information as of March 31, 2026, and December 31, 2025. The credit ratings are sourced from nationally recognized statistical rating organizations, which include S&P, Moody’s, Fitch, and DBRS. The ratings presented are a composite of the ratings sourced from the agencies or, if the ratings cannot be sourced from the agencies, are based on the asset type of the particular security. All our held-to-maturity securities were current in their payment of principal and interest as of both March 31, 2026, and December 31, 2025. We have not recorded any interest income reversals on our held-to-maturity securities during the three months ended March 31, 2026, or March 31, 2025.
($ in millions)AAAAAABBBTotal (a)
March 31, 2026
Debt securities
Agency mortgage-backed residential$— $1,337 $— $— $1,337 
Mortgage-backed residential2,893 63 1 — 2,957 
Asset-backed retained notes38 3 1 1 43 
Total held-to-maturity securities$2,931 $1,403 $2 $1 $4,337 
December 31, 2025
Debt securities
Agency mortgage-backed residential$— $1,303 $— $— $1,303 
Mortgage-backed residential2,951 66 1 — 3,018 
Asset-backed retained notes45 2 2 1 50 
Total held-to-maturity securities$2,996 $1,371 $3 $1 $4,371 
(a)Rating agencies indicate that they base their ratings on many quantitative and qualitative factors, which may include capital adequacy, liquidity, asset quality, business mix, level and quality of earnings, and the current operating, legislative, and regulatory environment. A credit rating is not a recommendation to buy, sell, or hold securities, and the ratings are subject to revision or withdrawal at any time by the assigning rating agency.
The following table summarizes available-for-sale securities in an unrealized loss position, which we evaluated to determine if a credit loss exists requiring the recognition of an allowance for credit losses. For additional information on our methodology, refer to Note 1. As of March 31, 2026, and December 31, 2025, we did not have the intent to sell available-for-sale securities in an unrealized loss position and we do not believe it is more likely than not that we will be required to sell these securities before recovery of their amortized cost basis. We have not recorded any interest income reversals on our available-for-sale securities during the three months ended March 31, 2026, or March 31, 2025.
March 31, 2026December 31, 2025
Less than 12 months12 months or longerLess than 12 months12 months or longer
($ in millions)
Fair value
Unrealized loss
Fair value
Unrealized loss
Fair valueUnrealized lossFair valueUnrealized loss
Available-for-sale securities
Debt securities
U.S. Treasury and federal agencies$267 $(1)$572 $(54)$— $— $609 $(51)
U.S. States and political subdivisions47 (1)398 (75)24 — 429 (74)
Foreign government91 (1)67 (3)51 (1)72 (3)
Agency mortgage-backed residential (a)552 (7)9,938 (2,101)120 — 10,310 (2,084)
Mortgage-backed residential— — 193 (33)— — 198 (32)
Agency mortgage-backed commercial (a)678 (6)3,548 (624)299 (1)3,629 (621)
Asset-backed— — 2 — — — 12 — 
Corporate debt423 (7)1,030 (64)86 (1)1,123 (60)
Total available-for-sale securities
$2,058 $(23)$15,748 $(2,954)$580 $(3)$16,382 $(2,925)
(a)Includes basis adjustments for certain securities that are included in closed portfolios with active hedges under the portfolio layer method at March 31, 2026, and December 31, 2025. The basis adjustments would be allocated to the amortized cost basis of specific securities within the pool if the hedge was dedesignated. Refer to Note 18 for additional information.
During the three months ended March 31, 2026, and March 31, 2025, management determined that there were no expected credit losses for securities in an unrealized loss position. This analysis considered a variety of factors including, but not limited to, performance indicators of the issuer, default rates, industry analyst reports, credit ratings, and other relevant information, which indicated that contractual cash flows are expected to occur. As a result of this evaluation, management determined that no credit reserves were required at March 31, 2026, or December 31, 2025.
v3.26.1
Finance Receivables and Loans, Net
 3 Months Ended
Mar. 31, 2026
Receivables [Abstract]  
Finance Receivables and Loans, Net Finance Receivables and Loans, Net
The composition of finance receivables and loans reported at amortized cost basis was as follows.
($ in millions)March 31, 2026December 31, 2025
Consumer automotive (a)$86,662 $85,568 
Consumer mortgage (b)15,311 15,572 
Total consumer101,973 101,140 
Commercial
Commercial and industrial
Automotive18,972 18,339 
Other11,093 10,309 
Commercial real estate7,852 7,666 
Total commercial37,917 36,314 
Total finance receivables and loans (c) (d)$139,890 $137,454 
(a)Certain finance receivables and loans are included in fair value hedging relationships. Refer to Note 18 for additional information.
(b)Includes loans originated as interest-only mortgage loans of $2 million at both March 31, 2026, and December 31, 2025, of which all have exited the interest-only period.
(c)Totals include net unearned income, unamortized premiums and discounts, and deferred fees and costs of $2.5 billion and $2.4 billion at March 31, 2026, and December 31, 2025, respectively.
(d)Totals do not include accrued interest receivable, which was $790 million and $800 million at March 31, 2026, and December 31, 2025, respectively. Accrued interest receivable is included in other assets on our Condensed Consolidated Balance Sheet.
The following tables present an analysis of the activity in the allowance for loan losses on finance receivables and loans for the three months ended March 31, 2026, and 2025, respectively.
Three months ended March 31, 2026 ($ in millions)
Consumer automotiveConsumer mortgageCommercialTotal
Allowance at January 1, 2026$3,208 $12 $270 $3,490 
Charge-offs (a)(671)— (1)(672)
Recoveries247 8 — 255 
Net charge-offs(424)8 (1)(417)
Provision for credit losses467 (9)9 467 
Other(1)— 1 — 
Allowance at March 31, 2026
$3,250 $11 $279 $3,540 
(a)Refer to Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for information regarding our charge-off policies.
Three months ended March 31, 2025 ($ in millions)
Consumer automotiveConsumer mortgageConsumer other (a)CommercialTotal
Allowance at January 1, 2025$3,170 $19 $319 $206 $3,714 
Charge-offs (b)(676)— (68)(1)(745)
Recoveries231 1 5 1 238 
Net charge-offs(445)1 (63)— (507)
Provision for credit losses418 — (257)30 191 
Other1 (2)1 — — 
Allowance at March 31, 2025
$3,144 $18 $— $236 $3,398 
(a)Consists of Credit Card. We closed the sale of Ally Credit Card on April 1, 2025. Refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information.
(b)Refer to Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for information regarding our charge-off policies.
The following table presents sales of finance receivables and loans and transfers of finance receivables and loans from held-for-investment to held-for-sale based on net carrying value.
Three months ended March 31,
($ in millions)20262025
Consumer other (a)$— $2,248 
Commercial7 73 
Total sales and transfers$7 $2,321 
(a)Consists of credit card finance receivables and loans. We closed the sale of Ally Credit Card on April 1, 2025. Refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information.
The following table presents purchases of finance receivables and loans based on unpaid principal balance at the time of purchase.
Three months ended March 31,
($ in millions)20262025
Consumer automotive$1,622 $749 
Consumer mortgage— 8
Commercial2 — 
Total purchases of finance receivables and loans$1,624 $757 
Nonaccrual Loans
The following tables present the amortized cost basis of our finance receivables and loans on nonaccrual status. All consumer or commercial finance receivables and loans that were 90 days or more past due were on nonaccrual status as of March 31, 2026, and December 31, 2025. Refer to Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information on our accounting policy for finance receivables and loans on nonaccrual status.
March 31, 2026
($ in millions)Nonaccrual status at Jan. 1, 2026Nonaccrual statusNonaccrual with no allowance (a)
Consumer automotive$1,155 $1,128 $410 
Consumer mortgage62 62 40 
Total consumer1,217 1,190 450 
Commercial
Commercial and industrial
Automotive15 3 3 
Other124 112 3 
Commercial real estate10 1 1 
Total commercial149 116 7 
Total finance receivables and loans (b)$1,366 $1,306 $457 
(a)Represents a component of nonaccrual status at end of period.
(b)We recorded interest income from cash payments associated with finance receivables and loans on nonaccrual status of $13 million for the three months ended March 31, 2026.
December 31, 2025
($ in millions)Nonaccrual status at Jan. 1, 2025Nonaccrual statusNonaccrual with no allowance (a)
Consumer automotive$1,231 $1,155 $416 
Consumer mortgage54 62 44 
Consumer other (b)90 — — 
Total consumer1,375 1,217 460 
Commercial
Commercial and industrial
Automotive15 15 15 
Other (c)94 124 — 
Commercial real estate2 10 10 
Total commercial111 149 25 
Total finance receivables and loans (d)$1,486 $1,366 $485 
(a)Represents a component of nonaccrual status at end of period.
(b)Consists of credit card finance receivables and loans. We closed the sale of Ally Credit Card on April 1, 2025.
(c)Includes PCD loans acquired during the year ended December 31, 2025.
(d)We recorded interest income from cash payments associated with finance receivables and loans on nonaccrual status of $4 million for the three months ended March 31, 2025.
Credit Quality Indicators
We evaluate the credit quality of our consumer loan portfolio based on the aging status of the loan and by payment activity. Loan delinquency reporting is generally based upon borrower payment activity, relative to the contractual terms of the loan.
The following tables present the amortized cost basis of our consumer finance receivables and loans by credit quality indicator based on delinquency status and origination year.
Origination yearRevolving loans converted to term
March 31, 2026 ($ in millions)
202620252024202320222021 and priorRevolving loansTotal
Consumer automotive
Current$10,303 $30,792 $17,844 $11,317 $7,695 $4,750 $— $— $82,701 
30–59 days past due24 563 567 529 477 356 — — 2,516 
60–89 days past due1 200 236 236 226 153 — — 1,052 
90 or more days past due— 83 90 89 86 69 — — 417 
Total consumer automotive (a)10,328 31,638 18,737 12,171 8,484 5,328 — — 86,686 
Consumer mortgage
Current— — 12 26 1,670 13,506 — 7 15,221 
30–59 days past due— — — — 3 35 — — 38 
60–89 days past due— — — 1 1 8 — — 10 
90 or more days past due— — — 1 5 34 — 2 42 
Total consumer mortgage— — 12 28 1,679 13,583 — 9 15,311 
Total consumer$10,328 $31,638 $18,749 $12,199 $10,163 $18,911 $— $9 $101,997 
(a)Certain consumer automotive loans are included in fair value hedging relationships. The amortized cost basis excludes a liability of $24 million related to basis adjustments for loans in closed portfolios with active hedges under the portfolio layer method at March 31, 2026. These basis adjustments would be allocated to the amortized cost basis of specific loans within the pool if the hedge was dedesignated. Refer to Note 18 for additional information.
Origination yearRevolving loans converted to term
December 31, 2025 ($ in millions)
202520242023202220212020 and priorRevolving loansTotal
Consumer automotive
Current$33,588 $19,891 $12,759 $8,885 $4,253 $1,696 $— $— $81,072 
30–59 days past due483 638 632 600 339 137 — — 2,829 
60–89 days past due156 272 295 284 148 60 — — 1,215 
90 or more days past due55 99 103 101 59 29 — — 446 
Total consumer automotive (a)34,282 20,900 13,789 9,870 4,799 1,922 — — 85,562 
Consumer mortgage
Current— 15 28 1,690 9,117 4,618 — 7 15,475 
30–59 days past due— — 2 5 11 17 — — 35 
60–89 days past due— — — 1 6 7 — — 14 
90 or more days past due— — — 5 16 25 — 2 48 
Total consumer mortgage— 15 30 1,701 9,150 4,667 — 9 15,572 
Total consumer$34,282 $20,915 $13,819 $11,571 $13,949 $6,589 $— $9 $101,134 
(a)Certain consumer automotive loans are included in fair value hedging relationships. The amortized cost basis excludes an asset of $6 million related to basis adjustments for loans in closed portfolios with active hedges under the portfolio layer method at December 31, 2025. These basis adjustments would be allocated to the amortized cost basis of specific loans within the pool if the hedge was dedesignated. Refer to Note 18 for additional information.
We evaluate the credit quality of our commercial loan portfolio using regulatory risk ratings, which are based on relevant information about the borrower’s financial condition, including current financial information, historical payment experience, credit documentation, and current economic trends, among other factors. We use the following definitions for risk ratings below Pass.
•Special mention — Loans that have a potential weakness that deserves management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or the institution’s credit position at some future date.
•Substandard — Loans that are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. These loans have a well-defined weakness or weakness that jeopardize the liquidation of the debt. They are characterized by the distinct possibility that the institution will sustain some loss if the deficiencies are not corrected.
•Doubtful — Loans that have all the weaknesses inherent in those classified as substandard, with the additional characteristic that the weaknesses make collection or liquidation in full, based on the basis of currently existing facts, conditions, and values, highly questionable and improbable.
•Loss — Loans that are considered uncollectible and of such little value that their continuance as bankable assets is not warranted. This classification does not mean that the asset has absolutely no recovery or salvage value, but rather that it is not practical or desirable to defer writing off this basically worthless asset even though partial recovery may be effected in the future.
The regulatory risk classification utilized is influenced by internal credit risk ratings, which are based on a variety of factors. A borrower’s internal credit risk rating is updated at least annually, and more frequently when a borrower’s credit profile changes, including when we become aware of potential credit deterioration. The following tables present the amortized cost basis of our commercial finance receivables and loans by credit quality indicator based on risk rating and origination year.
Origination yearRevolving loans converted to term
March 31, 2026 ($ in millions)
202620252024202320222021 and priorRevolving loansTotal
Commercial
Commercial and industrial
Automotive
Pass$630 $923 $340 $243 $254 $167 $14,816 $— $17,373 
Special mention— 5 — 15 9 5 1,509 — 1,543 
Substandard— — 1 — 1 — 54 — 56 
Total automotive630 928 341 258 264 172 16,379 — 18,972 
Other
Pass256 684 596 193 235 368 7,124 228 9,684 
Special mention— 69 71 — 262 368 390 6 1,166 
Substandard— — — — — 80 51 — 131 
Doubtful— — — — — 93 19 — 112 
Total other256 753 667 193 497 909 7,584 234 11,093 
Commercial real estate
Pass389 2,079 998 754 1,032 2,166 66 69 7,553 
Special mention7 22 45 35 65 105 — — 279 
Substandard— — — 2 15 1 — — 18 
Doubtful— — — 2 — — — — 2 
Total commercial real estate396 2,101 1,043 793 1,112 2,272 66 69 7,852 
Total commercial$1,282 $3,782 $2,051 $1,244 $1,873 $3,353 $24,029 $303 $37,917 
Origination yearRevolving loans converted to term
December 31, 2025 ($ in millions)
202520242023202220212020 and priorRevolving loansTotal
Commercial
Commercial and industrial
Automotive
Pass$942 $391 $257 $266 $113 $86 $14,861 $— $16,916 
Special mention2 1 15 10 — 5 1,328 — 1,361 
Substandard1 1 — 1 — — 59 — 62 
Total automotive945 393 272 277 113 91 16,248 — 18,339 
Other
Pass757 594 173 306 215 166 6,647 191 9,049 
Special mention— 47 — 236 115 260 347 8 1,013 
Substandard— — — — 20 61 42 — 123 
Doubtful— — — — — 107 17 — 124 
Total other757 641 173 542 350 594 7,053 199 10,309 
Commercial real estate
Pass1,981 1,069 759 1,080 919 1,461 55 59 7,383 
Special mention— 45 44 67 45 61 — — 262 
Substandard— — 2 15 — 1 — — 18 
Doubtful— — 2 1 — — — — 3 
Total commercial real estate1,981 1,114 807 1,163 964 1,523 55 59 7,666 
Total commercial$3,683 $2,148 $1,252 $1,982 $1,427 $2,208 $23,356 $258 $36,314 
The following table presents an analysis of our past-due commercial finance receivables and loans recorded at amortized cost basis.
($ in millions)30–59 days past due60–89 days past due90 days or more past dueTotal past dueCurrentTotal finance receivables and loans
March 31, 2026
Commercial
Commercial and industrial
Automotive$— $— $— $— $18,972 $18,972 
Other— — 71 71 11,022 11,093 
Commercial real estate— — 2 2 7,850 7,852 
Total commercial$— $— $73 $73 $37,844 $37,917 
December 31, 2025
Commercial
Commercial and industrial
Automotive$— $— $— $— $18,339 $18,339 
Other— — 70 70 10,239 10,309 
Commercial real estate— — 3 3 7,663 7,666 
Total commercial$— $— $73 $73 $36,241 $36,314 
The following tables present gross charge-offs of our finance receivables and loans for each portfolio class by origination year during the three months ended March 31, 2026, and during the year ended December 31, 2025, respectively. Refer to Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information on our charge-off policy.
Origination yearRevolving loans converted to term
March 31, 2026 ($ in millions)
202620252024202320222021 and priorRevolving loansTotal
Consumer automotive$1 $147 $162 $158 $125 $78 $— $— $671 
Total consumer1 147 162 158 125 78 — — 671 
Commercial
Commercial and industrial
Other— — — — — 1 — — 1 
Total commercial— — — — — 1 — — 1 
Total finance receivables and loans$1 $147 $162 $158 $125 $79 $— $— $672 
Origination yearRevolving loans converted to term
December 31, 2025 ($ in millions)
202520242023202220212020 and priorRevolving loansTotal
Consumer automotive$168 $564 $747 $660 $318 $153 $— $— $2,610 
Consumer mortgage (a)— — — 1 1 1 — — 3 
Consumer other (b)— — — — — — 64 4 68 
Total consumer168 564 747 661 319 154 64 4 2,681 
Commercial
Commercial and industrial
Automotive— — — — 1 — 1 — 2 
Total commercial— — — — 1 — 1 — 2 
Total finance receivables and loans$168 $564 $747 $661 $320 $154 $65 $4 $2,683 
(a)Excludes $5 million of write-downs from transfers to held-for-sale during the year ended December 31, 2025.
(b)Consists of Credit Card. We closed the sale of Ally Credit Card on April 1, 2025.
Loan Modifications with Borrowers Experiencing Financial Difficulty
The following tables present the amortized cost basis of loans that were modified subsequent to origination during the three months ended March 31, 2026, and 2025, respectively, for each portfolio segment, by modification type. For additional information on loan modification types in scope of this disclosure, refer to Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K. The below tables exclude consumer mortgage finance receivables and loans currently enrolled in a trial modification program. Trial modifications generally represent a three-month period during which the borrower makes monthly payments under the anticipated modified payment terms. If the borrower successfully completes the trial loan modification program, the contractual terms of the loan are updated and the modification is considered permanent. As of March 31, 2026, and December 31, 2025, there were $9 million and $8 million of consumer mortgage finance receivables and loans in a trial modification program, respectively.
Payment extensions
Three months ended March 31, 2026
($ in millions)
Payment deferralsContractual maturity extensionsPrincipal forgivenessInterest rate concessionsCombinationTotal (a)
Consumer automotive$— $199 $3 $— $— $202 
Consumer mortgage— 1 — — 2 3 
Total consumer— 200 3 — 2 205 
Commercial
Commercial and industrial
Automotive7 — — — — 7 
Other— 54 — — — 54 
Total commercial7 54 — — — 61 
Total finance receivables and loans$7 $254 $3 $— $2 $266 
(a)Represents 0.2% of total finance receivables and loans outstanding as of March 31, 2026.
Payment extensions
Three months ended March 31, 2025
($ in millions)
Payment deferralsContractual maturity extensionsPrincipal forgivenessInterest rate concessionsCombinationTotal (a)
Consumer automotive$— $105 $1 $— $— $106 
Consumer mortgage— — — — 1 1 
Total consumer— 105 1 — 1 107 
Commercial
Commercial and industrial
Automotive2 — — — — 2 
Other4 22 — — — 26 
Total commercial6 22 — — — 28 
Total finance receivables and loans$6 $127 $1 $— $1 $135 
(a)Represents 0.1% of total finance receivables and loans outstanding as of March 31, 2025.
The following tables present the financial effect of loan modifications that occurred during the three months ended March 31, 2026, and 2025, respectively.
Payment extensions (a)Principal forgivenessInterest rate concessions (a)Combination (a) (b) (c)
Three months ended
March 31, 2026
($ in millions)
Number of months extended/deferredAmount forgivenInitial rateRevised rateRemaining termRevised remaining termInitial rateRevised rate
Consumer automotive36$1 — %— %— — — %— %
Consumer mortgage204— — — 2914023.8 2.0 
Commercial
Commercial and industrial
Automotive7$— — %— %— — — %— %
Other20— — — — — — — 
Total commercial18$— — — — — — — 
(a)Calculated using a weighted-average balance for each portfolio class.
(b)Term is presented in number of months.
(c)Some consumer mortgage combination loan modifications include deferrals of principal. The weighted average number of months deferred for these loans was 159 months.
Payment extensions (a)Principal forgivenessInterest rate concessions (a)Combination (a) (b)
Three months ended
March 31, 2025
($ in millions)
Number of months extended/deferredAmount forgivenInitial rateRevised rateRemaining termRevised remaining termInitial rateRevised rate
Consumer automotive29$— — %— %— — — %— %
Consumer mortgage— — — — 2914804.5 2.8 
Commercial
Commercial and industrial
Automotive7$— — %— %——— %— %
Other16— — — ——— — 
Total commercial15$— — — ——— — 
(a)Calculated using a weighted-average balance for each portfolio class.
(b)Term is presented in number of months.
The following tables present the subsequent performance of loans recorded at amortized cost basis, by portfolio segment and credit quality indicator, that were modified within the 12 months prior to March 31, 2026, and 2025, respectively.
March 31, 2026 ($ in millions)
Current30–59 days past due60–89 days past due90 or more days past dueTotal
Consumer automotive
Contractual maturity extensions$585 $97 $33 $9 $724 
Principal forgiveness— — 1 8 9 
Combination1 — — — 1 
Total consumer automotive586 97 34 17 734 
Consumer mortgage
Payment deferrals— 1 — — 1 
Contractual maturity extensions2 1 — — 3 
Interest rate concessions— — — 1 1 
Combination6 — — — 6 
Total consumer mortgage8 2 — 1 11 
Total consumer$594 $99 $34 $18 $745 
March 31, 2026 ($ in millions)
PassSpecial mentionSubstandardDoubtfulTotal
Commercial and industrial
Automotive
Payment deferrals$— $— $7 $— $7 
Interest rate concessions— — 13 — 13 
Total automotive— — 20 — 20 
Other
Payment deferrals35 — — — 35 
Contractual maturity extensions74 71 19 — 164 
Total other109 71 19 — 199 
Commercial real estate
Payment deferrals— 3 — — 3 
Interest rate concessions— — 7 — 7 
Total commercial real estate— 3 7 — 10 
Total commercial$109 $74 $46 $— $229 
March 31, 2025 ($ in millions)
Current30–59 days past due60–89 days past due90 or more days past dueTotal
Consumer automotive
Contractual maturity extensions$328 $62 $23 $7 $420 
Principal forgiveness— — — 5 5 
Combination2 — — — 2 
Total consumer automotive330 62 23 12 427 
Consumer mortgage
Contractual maturity extensions1 — — 1 2 
Combination1 — — — 1 
Total consumer mortgage2 — — 1 3 
Total consumer$332 $62 $23 $13 $430 
March 31, 2025 ($ in millions)
PassSpecial mentionSubstandardDoubtfulTotal
Commercial and industrial
Automotive
Payment deferrals $— $— $4 $— $4 
Combination— — — 3 3 
Total automotive— — 4 3 7 
Other
Payment deferrals— — 4 — 4 
Contractual maturity extensions25 — 22 — 47 
Combination— — 14 — 14 
Total other25 — 40 — 65 
Commercial real estate
Payment deferrals— — — 1 1 
Total commercial real estate— — — 1 1 
Total commercial$25 $— $44 $4 $73 
As of March 31, 2026, 2,580 consumer automotive loans with a total amortized cost basis of $60 million and 1 consumer mortgage loan with a total amortized cost basis of $1 million redefaulted within 12 months of modification, whereas 1,858 consumer automotive loans with a total amortized cost basis of $46 million redefaulted within 12 months of modification as of March 31, 2025.
v3.26.1
Leasing
 3 Months Ended
Mar. 31, 2026
Leases [Abstract]  
Leasing Leasing
Ally as the Lessee
We have operating leases for certain of our corporate facilities, which have remaining lease terms of 1 month to 10 years. Most of the property leases have fixed payment terms with annual fixed-escalation clauses and include options to extend or terminate the lease. We do not include these term extensions or termination provisions in our estimates of the lease term if we do not consider it reasonably certain that the options will be exercised.
We also have operating leases for a fleet of vehicles that is used by our sales force for business purposes, with noncancelable lease terms of 367 days. Thereafter, the leases are month-to-month, up to a maximum of 48 months from inception.
During both the three months ended March 31, 2026, and March 31, 2025, we paid $9 million in cash for amounts included in the measurement of lease liabilities. These amounts are included in net cash provided by operating activities in our Condensed Consolidated Statement of Cash Flows. During the three months ended March 31, 2026, and March 31, 2025, we obtained $7 million and $5 million, respectively, of ROU assets in exchange for new lease liabilities. As of March 31, 2026, the weighted-average remaining lease term of our operating lease portfolio was 5 years, and the weighted-average discount rate was 3.68%, compared to 5 years and 3.66% as of December 31, 2025.
The following table presents future minimum rental payments we are required to make under operating leases that have commenced as of March 31, 2026, and that have noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$29 
202733 
202828 
202910 
20309 
2031 and thereafter24 
Total undiscounted cash flows133 
Difference between undiscounted cash flows and discounted cash flows(12)
Total lease liability$121 
The following table details the components of total net operating lease expense.
Three months ended March 31,
($ in millions)20262025
Operating lease expense$8 $8 
Variable lease expense2 1 
Total lease expense, net (a)$10 $9 
(a)Included in other operating expenses in our Condensed Consolidated Statement of Comprehensive Income.
Ally as the Lessor
Investment in Operating Leases
We purchase consumer operating lease contracts and the associated vehicles from automotive dealerships or manufacturers after those contracts are executed. The amount we pay for an operating lease contract is based on the negotiated price for the vehicle less vehicle trade-in, down payment from the consumer, and available automotive manufacturer incentives. Under the operating lease, the consumer is obligated to make payments in amounts equal to the amount by which the negotiated purchase price of the vehicle (less any trade-in value, down payment, tax credits, or available manufacturer incentives) exceeds the contract residual value (including residual support) of the vehicle at lease termination, plus operating lease rental charges. The customer can terminate the lease at any point after commencement, subject to additional charges and fees. The consumer, dealership, or automotive manufacturer may have the option to purchase the vehicle at the end of the lease term, which generally ranges from 24 to 60 months, at the residual value of the vehicle, however it is not reasonably certain this option will be exercised and accordingly our consumer leases are classified as operating leases. In addition to the charges described above, the consumer is generally responsible for certain charges related to excess mileage or excessive wear and tear on the vehicle. These charges are deemed variable lease payments and, as these payments are not based on a rate or index, they are recognized as net depreciation expense on operating lease assets in our Condensed Consolidated Statement of Comprehensive Income as incurred.
When we acquire a consumer operating lease, we assume ownership of the vehicle. We require that property damage, bodily injury, collision, and comprehensive insurance be obtained by the lessee on all consumer operating leases. When vehicles are not purchased by
customers, the receiving dealer, or automotive manufacturer at scheduled lease termination, the vehicle is returned to us for remarketing. We generally bear the risk of loss to the extent the value of a leased vehicle upon remarketing is below the expected residual value after adjusting for any OEM residual value guarantees. At termination, our actual sales proceeds from remarketing the vehicle may be higher or lower than the estimated residual value after adjusting for any OEM residual value guarantees resulting in a gain or loss on remarketing, which is included in net depreciation expense on operating lease assets in our Condensed Consolidated Statement of Comprehensive Income. Excessive mileage or excessive wear and tear on the vehicle during the lease may impact the sales proceeds received upon remarketing. As of both March 31, 2026, and December 31, 2025, consumer operating leases with a carrying value, net of accumulated depreciation, of $3.4 billion were covered by OEM residual value guarantees of approximately 50% of the vehicles’ contract residual value.
The following table details our investment in operating leases.
($ in millions)March 31, 2026December 31, 2025
Vehicles$10,131 $10,163 
Accumulated depreciation(1,432)(1,391)
Investment in operating leases, net$8,699 $8,772 
The following table presents future minimum rental payments we have the right to receive under operating leases with noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$1,118 
20271,041 
2028460 
202975 
20303 
Total lease payments from operating leases$2,697 
We recognized operating lease revenue of $392 million and $351 million, for the three months ended March 31, 2026, and 2025, respectively. Depreciation expense on operating lease assets includes net remarketing losses recognized on the sale of operating lease assets. The following table summarizes the components of depreciation expense on operating lease assets.
Three months ended March 31,
($ in millions)20262025
Depreciation expense on operating lease assets (excluding remarketing losses) (a)$258 $221 
Remarketing losses, net10 19 
Net depreciation expense on operating lease assets$268 $240 
(a)Includes variable lease payments related to excess mileage and excessive wear and tear on vehicles of $5 million and $6 million during the three months ended March 31, 2026, and 2025, respectively.
Finance Leases
In our Automotive Finance operations, we also hold automotive leases that require finance lease treatment as prescribed by ASC Topic 842, Leases. Our total gross investment in finance leases, which consists of lease payment receivables, and is included in finance receivables and loans, net, on our Condensed Consolidated Balance Sheet, was $375 million, and $376 million as of March 31, 2026, and December 31, 2025, respectively. Interest income on finance lease receivables was $8 million and $11 million for the three months ended March 31, 2026, and 2025, respectively, and is included in interest and fees on finance receivables and loans in our Condensed Consolidated Statement of Comprehensive Income.
The following table presents future minimum rental payments we have the right to receive under finance leases with noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$102 
2027123 
202895 
202966 
203038 
2031 and thereafter15 
Total undiscounted cash flows439 
Difference between undiscounted cash flows and discounted cash flows(64)
Present value of lease payments recorded as lease receivable$375 
Leasing Leasing
Ally as the Lessee
We have operating leases for certain of our corporate facilities, which have remaining lease terms of 1 month to 10 years. Most of the property leases have fixed payment terms with annual fixed-escalation clauses and include options to extend or terminate the lease. We do not include these term extensions or termination provisions in our estimates of the lease term if we do not consider it reasonably certain that the options will be exercised.
We also have operating leases for a fleet of vehicles that is used by our sales force for business purposes, with noncancelable lease terms of 367 days. Thereafter, the leases are month-to-month, up to a maximum of 48 months from inception.
During both the three months ended March 31, 2026, and March 31, 2025, we paid $9 million in cash for amounts included in the measurement of lease liabilities. These amounts are included in net cash provided by operating activities in our Condensed Consolidated Statement of Cash Flows. During the three months ended March 31, 2026, and March 31, 2025, we obtained $7 million and $5 million, respectively, of ROU assets in exchange for new lease liabilities. As of March 31, 2026, the weighted-average remaining lease term of our operating lease portfolio was 5 years, and the weighted-average discount rate was 3.68%, compared to 5 years and 3.66% as of December 31, 2025.
The following table presents future minimum rental payments we are required to make under operating leases that have commenced as of March 31, 2026, and that have noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$29 
202733 
202828 
202910 
20309 
2031 and thereafter24 
Total undiscounted cash flows133 
Difference between undiscounted cash flows and discounted cash flows(12)
Total lease liability$121 
The following table details the components of total net operating lease expense.
Three months ended March 31,
($ in millions)20262025
Operating lease expense$8 $8 
Variable lease expense2 1 
Total lease expense, net (a)$10 $9 
(a)Included in other operating expenses in our Condensed Consolidated Statement of Comprehensive Income.
Ally as the Lessor
Investment in Operating Leases
We purchase consumer operating lease contracts and the associated vehicles from automotive dealerships or manufacturers after those contracts are executed. The amount we pay for an operating lease contract is based on the negotiated price for the vehicle less vehicle trade-in, down payment from the consumer, and available automotive manufacturer incentives. Under the operating lease, the consumer is obligated to make payments in amounts equal to the amount by which the negotiated purchase price of the vehicle (less any trade-in value, down payment, tax credits, or available manufacturer incentives) exceeds the contract residual value (including residual support) of the vehicle at lease termination, plus operating lease rental charges. The customer can terminate the lease at any point after commencement, subject to additional charges and fees. The consumer, dealership, or automotive manufacturer may have the option to purchase the vehicle at the end of the lease term, which generally ranges from 24 to 60 months, at the residual value of the vehicle, however it is not reasonably certain this option will be exercised and accordingly our consumer leases are classified as operating leases. In addition to the charges described above, the consumer is generally responsible for certain charges related to excess mileage or excessive wear and tear on the vehicle. These charges are deemed variable lease payments and, as these payments are not based on a rate or index, they are recognized as net depreciation expense on operating lease assets in our Condensed Consolidated Statement of Comprehensive Income as incurred.
When we acquire a consumer operating lease, we assume ownership of the vehicle. We require that property damage, bodily injury, collision, and comprehensive insurance be obtained by the lessee on all consumer operating leases. When vehicles are not purchased by
customers, the receiving dealer, or automotive manufacturer at scheduled lease termination, the vehicle is returned to us for remarketing. We generally bear the risk of loss to the extent the value of a leased vehicle upon remarketing is below the expected residual value after adjusting for any OEM residual value guarantees. At termination, our actual sales proceeds from remarketing the vehicle may be higher or lower than the estimated residual value after adjusting for any OEM residual value guarantees resulting in a gain or loss on remarketing, which is included in net depreciation expense on operating lease assets in our Condensed Consolidated Statement of Comprehensive Income. Excessive mileage or excessive wear and tear on the vehicle during the lease may impact the sales proceeds received upon remarketing. As of both March 31, 2026, and December 31, 2025, consumer operating leases with a carrying value, net of accumulated depreciation, of $3.4 billion were covered by OEM residual value guarantees of approximately 50% of the vehicles’ contract residual value.
The following table details our investment in operating leases.
($ in millions)March 31, 2026December 31, 2025
Vehicles$10,131 $10,163 
Accumulated depreciation(1,432)(1,391)
Investment in operating leases, net$8,699 $8,772 
The following table presents future minimum rental payments we have the right to receive under operating leases with noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$1,118 
20271,041 
2028460 
202975 
20303 
Total lease payments from operating leases$2,697 
We recognized operating lease revenue of $392 million and $351 million, for the three months ended March 31, 2026, and 2025, respectively. Depreciation expense on operating lease assets includes net remarketing losses recognized on the sale of operating lease assets. The following table summarizes the components of depreciation expense on operating lease assets.
Three months ended March 31,
($ in millions)20262025
Depreciation expense on operating lease assets (excluding remarketing losses) (a)$258 $221 
Remarketing losses, net10 19 
Net depreciation expense on operating lease assets$268 $240 
(a)Includes variable lease payments related to excess mileage and excessive wear and tear on vehicles of $5 million and $6 million during the three months ended March 31, 2026, and 2025, respectively.
Finance Leases
In our Automotive Finance operations, we also hold automotive leases that require finance lease treatment as prescribed by ASC Topic 842, Leases. Our total gross investment in finance leases, which consists of lease payment receivables, and is included in finance receivables and loans, net, on our Condensed Consolidated Balance Sheet, was $375 million, and $376 million as of March 31, 2026, and December 31, 2025, respectively. Interest income on finance lease receivables was $8 million and $11 million for the three months ended March 31, 2026, and 2025, respectively, and is included in interest and fees on finance receivables and loans in our Condensed Consolidated Statement of Comprehensive Income.
The following table presents future minimum rental payments we have the right to receive under finance leases with noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$102 
2027123 
202895 
202966 
203038 
2031 and thereafter15 
Total undiscounted cash flows439 
Difference between undiscounted cash flows and discounted cash flows(64)
Present value of lease payments recorded as lease receivable$375 
Leasing Leasing
Ally as the Lessee
We have operating leases for certain of our corporate facilities, which have remaining lease terms of 1 month to 10 years. Most of the property leases have fixed payment terms with annual fixed-escalation clauses and include options to extend or terminate the lease. We do not include these term extensions or termination provisions in our estimates of the lease term if we do not consider it reasonably certain that the options will be exercised.
We also have operating leases for a fleet of vehicles that is used by our sales force for business purposes, with noncancelable lease terms of 367 days. Thereafter, the leases are month-to-month, up to a maximum of 48 months from inception.
During both the three months ended March 31, 2026, and March 31, 2025, we paid $9 million in cash for amounts included in the measurement of lease liabilities. These amounts are included in net cash provided by operating activities in our Condensed Consolidated Statement of Cash Flows. During the three months ended March 31, 2026, and March 31, 2025, we obtained $7 million and $5 million, respectively, of ROU assets in exchange for new lease liabilities. As of March 31, 2026, the weighted-average remaining lease term of our operating lease portfolio was 5 years, and the weighted-average discount rate was 3.68%, compared to 5 years and 3.66% as of December 31, 2025.
The following table presents future minimum rental payments we are required to make under operating leases that have commenced as of March 31, 2026, and that have noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$29 
202733 
202828 
202910 
20309 
2031 and thereafter24 
Total undiscounted cash flows133 
Difference between undiscounted cash flows and discounted cash flows(12)
Total lease liability$121 
The following table details the components of total net operating lease expense.
Three months ended March 31,
($ in millions)20262025
Operating lease expense$8 $8 
Variable lease expense2 1 
Total lease expense, net (a)$10 $9 
(a)Included in other operating expenses in our Condensed Consolidated Statement of Comprehensive Income.
Ally as the Lessor
Investment in Operating Leases
We purchase consumer operating lease contracts and the associated vehicles from automotive dealerships or manufacturers after those contracts are executed. The amount we pay for an operating lease contract is based on the negotiated price for the vehicle less vehicle trade-in, down payment from the consumer, and available automotive manufacturer incentives. Under the operating lease, the consumer is obligated to make payments in amounts equal to the amount by which the negotiated purchase price of the vehicle (less any trade-in value, down payment, tax credits, or available manufacturer incentives) exceeds the contract residual value (including residual support) of the vehicle at lease termination, plus operating lease rental charges. The customer can terminate the lease at any point after commencement, subject to additional charges and fees. The consumer, dealership, or automotive manufacturer may have the option to purchase the vehicle at the end of the lease term, which generally ranges from 24 to 60 months, at the residual value of the vehicle, however it is not reasonably certain this option will be exercised and accordingly our consumer leases are classified as operating leases. In addition to the charges described above, the consumer is generally responsible for certain charges related to excess mileage or excessive wear and tear on the vehicle. These charges are deemed variable lease payments and, as these payments are not based on a rate or index, they are recognized as net depreciation expense on operating lease assets in our Condensed Consolidated Statement of Comprehensive Income as incurred.
When we acquire a consumer operating lease, we assume ownership of the vehicle. We require that property damage, bodily injury, collision, and comprehensive insurance be obtained by the lessee on all consumer operating leases. When vehicles are not purchased by
customers, the receiving dealer, or automotive manufacturer at scheduled lease termination, the vehicle is returned to us for remarketing. We generally bear the risk of loss to the extent the value of a leased vehicle upon remarketing is below the expected residual value after adjusting for any OEM residual value guarantees. At termination, our actual sales proceeds from remarketing the vehicle may be higher or lower than the estimated residual value after adjusting for any OEM residual value guarantees resulting in a gain or loss on remarketing, which is included in net depreciation expense on operating lease assets in our Condensed Consolidated Statement of Comprehensive Income. Excessive mileage or excessive wear and tear on the vehicle during the lease may impact the sales proceeds received upon remarketing. As of both March 31, 2026, and December 31, 2025, consumer operating leases with a carrying value, net of accumulated depreciation, of $3.4 billion were covered by OEM residual value guarantees of approximately 50% of the vehicles’ contract residual value.
The following table details our investment in operating leases.
($ in millions)March 31, 2026December 31, 2025
Vehicles$10,131 $10,163 
Accumulated depreciation(1,432)(1,391)
Investment in operating leases, net$8,699 $8,772 
The following table presents future minimum rental payments we have the right to receive under operating leases with noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$1,118 
20271,041 
2028460 
202975 
20303 
Total lease payments from operating leases$2,697 
We recognized operating lease revenue of $392 million and $351 million, for the three months ended March 31, 2026, and 2025, respectively. Depreciation expense on operating lease assets includes net remarketing losses recognized on the sale of operating lease assets. The following table summarizes the components of depreciation expense on operating lease assets.
Three months ended March 31,
($ in millions)20262025
Depreciation expense on operating lease assets (excluding remarketing losses) (a)$258 $221 
Remarketing losses, net10 19 
Net depreciation expense on operating lease assets$268 $240 
(a)Includes variable lease payments related to excess mileage and excessive wear and tear on vehicles of $5 million and $6 million during the three months ended March 31, 2026, and 2025, respectively.
Finance Leases
In our Automotive Finance operations, we also hold automotive leases that require finance lease treatment as prescribed by ASC Topic 842, Leases. Our total gross investment in finance leases, which consists of lease payment receivables, and is included in finance receivables and loans, net, on our Condensed Consolidated Balance Sheet, was $375 million, and $376 million as of March 31, 2026, and December 31, 2025, respectively. Interest income on finance lease receivables was $8 million and $11 million for the three months ended March 31, 2026, and 2025, respectively, and is included in interest and fees on finance receivables and loans in our Condensed Consolidated Statement of Comprehensive Income.
The following table presents future minimum rental payments we have the right to receive under finance leases with noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$102 
2027123 
202895 
202966 
203038 
2031 and thereafter15 
Total undiscounted cash flows439 
Difference between undiscounted cash flows and discounted cash flows(64)
Present value of lease payments recorded as lease receivable$375 
Leasing Leasing
Ally as the Lessee
We have operating leases for certain of our corporate facilities, which have remaining lease terms of 1 month to 10 years. Most of the property leases have fixed payment terms with annual fixed-escalation clauses and include options to extend or terminate the lease. We do not include these term extensions or termination provisions in our estimates of the lease term if we do not consider it reasonably certain that the options will be exercised.
We also have operating leases for a fleet of vehicles that is used by our sales force for business purposes, with noncancelable lease terms of 367 days. Thereafter, the leases are month-to-month, up to a maximum of 48 months from inception.
During both the three months ended March 31, 2026, and March 31, 2025, we paid $9 million in cash for amounts included in the measurement of lease liabilities. These amounts are included in net cash provided by operating activities in our Condensed Consolidated Statement of Cash Flows. During the three months ended March 31, 2026, and March 31, 2025, we obtained $7 million and $5 million, respectively, of ROU assets in exchange for new lease liabilities. As of March 31, 2026, the weighted-average remaining lease term of our operating lease portfolio was 5 years, and the weighted-average discount rate was 3.68%, compared to 5 years and 3.66% as of December 31, 2025.
The following table presents future minimum rental payments we are required to make under operating leases that have commenced as of March 31, 2026, and that have noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$29 
202733 
202828 
202910 
20309 
2031 and thereafter24 
Total undiscounted cash flows133 
Difference between undiscounted cash flows and discounted cash flows(12)
Total lease liability$121 
The following table details the components of total net operating lease expense.
Three months ended March 31,
($ in millions)20262025
Operating lease expense$8 $8 
Variable lease expense2 1 
Total lease expense, net (a)$10 $9 
(a)Included in other operating expenses in our Condensed Consolidated Statement of Comprehensive Income.
Ally as the Lessor
Investment in Operating Leases
We purchase consumer operating lease contracts and the associated vehicles from automotive dealerships or manufacturers after those contracts are executed. The amount we pay for an operating lease contract is based on the negotiated price for the vehicle less vehicle trade-in, down payment from the consumer, and available automotive manufacturer incentives. Under the operating lease, the consumer is obligated to make payments in amounts equal to the amount by which the negotiated purchase price of the vehicle (less any trade-in value, down payment, tax credits, or available manufacturer incentives) exceeds the contract residual value (including residual support) of the vehicle at lease termination, plus operating lease rental charges. The customer can terminate the lease at any point after commencement, subject to additional charges and fees. The consumer, dealership, or automotive manufacturer may have the option to purchase the vehicle at the end of the lease term, which generally ranges from 24 to 60 months, at the residual value of the vehicle, however it is not reasonably certain this option will be exercised and accordingly our consumer leases are classified as operating leases. In addition to the charges described above, the consumer is generally responsible for certain charges related to excess mileage or excessive wear and tear on the vehicle. These charges are deemed variable lease payments and, as these payments are not based on a rate or index, they are recognized as net depreciation expense on operating lease assets in our Condensed Consolidated Statement of Comprehensive Income as incurred.
When we acquire a consumer operating lease, we assume ownership of the vehicle. We require that property damage, bodily injury, collision, and comprehensive insurance be obtained by the lessee on all consumer operating leases. When vehicles are not purchased by
customers, the receiving dealer, or automotive manufacturer at scheduled lease termination, the vehicle is returned to us for remarketing. We generally bear the risk of loss to the extent the value of a leased vehicle upon remarketing is below the expected residual value after adjusting for any OEM residual value guarantees. At termination, our actual sales proceeds from remarketing the vehicle may be higher or lower than the estimated residual value after adjusting for any OEM residual value guarantees resulting in a gain or loss on remarketing, which is included in net depreciation expense on operating lease assets in our Condensed Consolidated Statement of Comprehensive Income. Excessive mileage or excessive wear and tear on the vehicle during the lease may impact the sales proceeds received upon remarketing. As of both March 31, 2026, and December 31, 2025, consumer operating leases with a carrying value, net of accumulated depreciation, of $3.4 billion were covered by OEM residual value guarantees of approximately 50% of the vehicles’ contract residual value.
The following table details our investment in operating leases.
($ in millions)March 31, 2026December 31, 2025
Vehicles$10,131 $10,163 
Accumulated depreciation(1,432)(1,391)
Investment in operating leases, net$8,699 $8,772 
The following table presents future minimum rental payments we have the right to receive under operating leases with noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$1,118 
20271,041 
2028460 
202975 
20303 
Total lease payments from operating leases$2,697 
We recognized operating lease revenue of $392 million and $351 million, for the three months ended March 31, 2026, and 2025, respectively. Depreciation expense on operating lease assets includes net remarketing losses recognized on the sale of operating lease assets. The following table summarizes the components of depreciation expense on operating lease assets.
Three months ended March 31,
($ in millions)20262025
Depreciation expense on operating lease assets (excluding remarketing losses) (a)$258 $221 
Remarketing losses, net10 19 
Net depreciation expense on operating lease assets$268 $240 
(a)Includes variable lease payments related to excess mileage and excessive wear and tear on vehicles of $5 million and $6 million during the three months ended March 31, 2026, and 2025, respectively.
Finance Leases
In our Automotive Finance operations, we also hold automotive leases that require finance lease treatment as prescribed by ASC Topic 842, Leases. Our total gross investment in finance leases, which consists of lease payment receivables, and is included in finance receivables and loans, net, on our Condensed Consolidated Balance Sheet, was $375 million, and $376 million as of March 31, 2026, and December 31, 2025, respectively. Interest income on finance lease receivables was $8 million and $11 million for the three months ended March 31, 2026, and 2025, respectively, and is included in interest and fees on finance receivables and loans in our Condensed Consolidated Statement of Comprehensive Income.
The following table presents future minimum rental payments we have the right to receive under finance leases with noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$102 
2027123 
202895 
202966 
203038 
2031 and thereafter15 
Total undiscounted cash flows439 
Difference between undiscounted cash flows and discounted cash flows(64)
Present value of lease payments recorded as lease receivable$375 
v3.26.1
Securitizations and Variable Interest Entities
 3 Months Ended
Mar. 31, 2026
Securitizations And Variable Interest Entities [Abstract]  
Securitizations and Variable Interest Entities Securitizations and Variable Interest Entities
We securitize, transfer, and service consumer automotive loans. We often securitize these loans (also referred to as financial assets) using SPEs. An SPE is a legal entity that is designed to fulfill a specified limited need of the sponsor. Our principal use of SPEs is to obtain liquidity by securitizing certain of our financial assets. SPEs are often VIEs and may or may not be included on our Condensed Consolidated Balance Sheet. Additionally, we opportunistically sell consumer automotive whole-loans to SPEs where we have a continuing involvement.
VIEs are legal entities that either have an insufficient amount of equity at risk for the entity to finance its activities without additional subordinated financial support or, as a group, the holders of the equity investment at risk lack the ability to control the entity’s activities that most significantly impact economic performance through voting or similar rights, or do not have the obligation to absorb the expected losses or the right to receive expected residual returns of the entity.
The VIEs included on our Condensed Consolidated Balance Sheet represent SPEs where we are deemed to be the primary beneficiary, primarily due to our servicing activities and our beneficial interests in the VIE that could be potentially significant.
The nature, purpose, and activities of nonconsolidated SPEs are similar to those of our consolidated SPEs with the primary difference being the nature and extent of our continuing involvement. For nonconsolidated SPEs, the transferred financial assets are removed from our balance sheet provided the conditions for sale accounting are met. The financial assets obtained from the sale are primarily reported as cash or retained interests (if applicable). Liabilities incurred as part of these sales, are recorded at fair value at the time of sale and are reported as accrued expenses and other liabilities on our Condensed Consolidated Balance Sheet. Upon the sale of the loans, we recognize a gain or loss on sale for the difference between the assets recognized, the assets derecognized, and the liabilities recognized as part of the transaction. With respect to our ongoing right to service the assets we sell, the servicing fee we receive represents adequate compensation, and consequently, we do not recognize a servicing asset or liability.
The pretax loss on sales of financial assets into nonconsolidated VIEs was $3 million during the three months ended March 31, 2026. We had no pretax gains or losses during the three months ended March 31, 2025.
We provide long-term guarantee contracts to investors in certain nonconsolidated affordable housing entities and have extended a line of credit to provide liquidity. Since we do not have control over the entities or the power to make decisions, we do not consolidate the entities and our involvement is limited to the guarantee and the line of credit.
We are involved with various other nonconsolidated equity investments, including affordable housing entities and venture capital funds and loan funds. We do not consolidate these entities and our involvement is limited to our outstanding investment, additional capital committed to these funds plus any previously recognized LIHTCs that are subject to recapture.
Refer to Note 1 and Note 11 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for further description of our securitization activities and our involvement with VIEs.
The following table presents our involvement in consolidated and nonconsolidated VIEs in which we hold variable interests. We have excluded certain transactions with nonconsolidated entities from the balances presented in the table below, where our only continuing involvement relates to financial interests obtained through the ordinary course of business, primarily from lending and investing arrangements. For additional detail related to the assets and liabilities of consolidated variable interest entities, refer to our Condensed Consolidated Balance Sheet.
($ in millions)Carrying value of total assetsCarrying value of total liabilitiesAssets sold to nonconsolidated VIEs (a)Maximum exposure to loss in nonconsolidated VIEs
March 31, 2026
On‑balance sheet variable interest entities
Consumer automotive$12,625 (b)$2,191 (c)$— $— 
Off-balance sheet variable interest entities
Consumer automotive (d)46 (e)— 3,379 3,425 (f)
Commercial other2,778 (g)736 (h)— 3,539 (i)
Total$15,449 $2,927 $3,379 $6,964 
December 31, 2025
On-balance sheet variable interest entities
Consumer automotive$12,149 (b)$1,619 (c)$— $— 
Off-balance sheet variable interest entities
Consumer automotive (d)53 (e)— 3,192 3,245 (f)
Commercial other2,822 (g)820 (h)— 3,690 (i)
Total$15,024 $2,439 $3,192 $6,935 
(a)Represents the current unpaid principal balance of outstanding consumer automotive finance receivables and loans within the VIEs.
(b)Includes $8.9 billion of assets that were not encumbered by VIE beneficial interests held by third parties at both March 31, 2026, and December 31, 2025. Ally or consolidated affiliates hold the interests in these assets.
(c)Includes $131 million and $137 million of liabilities that were not obligations to third-party beneficial interest holders at March 31, 2026, and December 31, 2025, respectively.
(d)Includes activity where we sell loans through a pass-through program to a third party.
(e)Represents retained notes and certificated residual interests, of which $43 million and $50 million were classified as held-to-maturity securities at March 31, 2026, and December 31, 2025, respectively, and $3 million were classified as other assets at both March 31, 2026, and December 31, 2025. These assets represent our compliance with the risk retention rules under the Dodd-Frank Act, requiring us to retain at least five percent of the credit risk of the assets underlying asset-backed securitizations.
(f)Maximum exposure to loss represents the current unpaid principal balance of outstanding loans based on our customary representation and warranty provisions. This measure is based on the unlikely event that all the loans have underwriting defects or other defects that trigger a representation and warranty provision and the collateral supporting the loans are worthless. This required disclosure is not an indication of our expected loss.
(g)Amounts are classified as other assets except for $57 million and $56 million classified as equity securities at March 31, 2026, and December 31, 2025, respectively.
(h)Amounts are classified as accrued expenses and other liabilities.
(i)For certain nonconsolidated affordable housing entities, maximum exposure to loss represents the yield we guaranteed investors through long-term guarantee contracts. The amount disclosed is based on the unlikely event that the yield delivered to investors in the form of LIHTCs and other tax credits is recaptured. For nonconsolidated equity investments, maximum exposure to loss represents our outstanding investment, additional committed capital, and LIHTCs and other tax credits subject to recapture. The amount disclosed is based on the unlikely event that our committed capital is funded, our investments become worthless, and the tax credits previously delivered to us are recaptured. This required disclosure is not an indication of our expected loss.
Cash Flows with Nonconsolidated Special-Purpose Entities
The following table summarizes cash flows received and paid related to SPEs and asset-backed financings where the transfer is accounted for as a sale and we have a continuing involvement with the transferred consumer automotive and credit card assets (for example, servicing) that were outstanding during the three months ended March 31, 2026, and March 31, 2025. Additionally, this table contains information regarding cash flows received from and paid to nonconsolidated SPEs that existed during each period.
Three months ended March 31,
($ in millions)20262025
Consumer automotive
Cash proceeds from transfers completed during the period$480 $191 
Servicing fees20 14 
Cash flows received on retained interests in securitization entities8 12 
Other cash flows received2 1 
Consumer other (a)
Cash proceeds from transfers completed during the period— 8 
Servicing fees— 1 
(a)Includes activity from Ally Credit Card. We closed the sale of Ally Credit Card on April 1, 2025.
Delinquencies and Net Credit Losses
The following tables present quantitative information about off-balance sheet securitizations and whole-loan sales where we have continuing involvement.
Total amountAmount 60 days or more past due
($ in millions)March 31, 2026December 31, 2025March 31, 2026December 31, 2025
Off-balance-sheet securitization entities
Consumer automotive$858 $1,002 $16 $18 
Whole-loan sales (a)
Consumer automotive2,521 2,190 143 143 
Total$3,379 $3,192 $159 $161 
(a)Whole-loan sales are not part of a securitization transaction, but represent consumer automotive pools of loans sold to third-party investors.
Net credit losses
Three months ended March 31,
($ in millions)20262025
Off-balance-sheet securitization entities
Consumer automotive$4 $5 
Whole-loan sales (a)
Consumer automotive41 23 
Consumer other (b)— 7 
Total$45 $35 
(a)Whole-loan sales are not part of a securitization transaction, but represent consumer automotive and credit card pools of loans sold to third-party investors.
(b)Includes activity from Ally Credit Card. We closed the sale of Ally Credit Card on April 1, 2025.
v3.26.1
Other Assets
 3 Months Ended
Mar. 31, 2026
Other Assets [Abstract]  
Other Assets Other Assets
The components of other assets were as follows.
($ in millions)March 31, 2026December 31, 2025
Property and equipment at cost$2,275 $2,280 
Accumulated depreciation(1,150)(1,130)
Net property and equipment1,125 1,150 
Net deferred tax assets2,368 2,334 
Proportional amortization investments (a) (b)2,032 2,094 
Restricted cash and cash equivalents (c)1,390 1,543 
Accrued interest, fees, and rent receivables (d)930 941 
Nonmarketable equity investments901 922 
Equity-method investments (e)741 715 
Restricted cash held for securitization trusts (f)321 236 
Other accounts receivable210 403 
Goodwill190 190 
Operating lease right-of-use assets107 109 
Other assets995 986 
Total other assets (g)$11,310 $11,623 
(a)Proportional amortization investments includes qualifying LIHTC, NMTC, and HTC investments.
(b)Presented gross of the associated unfunded commitment. Refer to Note 13 for further information.
(c)Primarily represents restricted cash equivalents funded through the issuance of credit-linked notes. Additionally, includes a number of arrangements with third parties where certain restrictions are placed on balances we hold due to collateral agreements associated with operational processes with a third-party bank, partner, or letter of credit arrangements and corresponding collateral requirements. Refer to Note 17 for further information about the issuance of credit-linked notes.
(d)Primarily relates to accrued interest, fees, and rent receivables related to our consumer automotive and commercial automotive finance receivables and loans.
(e)Primarily relates to investments made in connection with our CRA program.
(f)Includes restricted cash collected from customer payments on securitized receivables, which are distributed by us to investors as payments on the related secured debt, and cash reserve deposits utilized as a form of credit enhancement for various securitization transactions.
(g)Includes gross intangible assets of $80 million at both March 31, 2026, and December 31, 2025, and accumulated amortization of $80 million at both March 31, 2026, and December 31, 2025.
The following table summarizes information about our proportional amortization investments.
 Three months ended March 31,
($ in millions)20262025
Tax credits and other tax benefits from proportional amortization investments (a) (b)$79 $56 
Investment amortization expense recognized as a component of income tax expense (a)62 45 
Net benefit from proportional amortization investments (a)$17 $11 
(a)Amounts are included within income tax expense from continuing operations on our Condensed Consolidated Statement of Comprehensive Income and as a component of operating activities within deferred income taxes, other assets, and other liabilities on our Condensed Consolidated Statement of Cash Flows.
(b)There were no impairment losses recognized during the three months ended March 31, 2026, and March 31, 2025, resulting from the forfeiture or ineligibility of tax credits or other circumstances.
Our proportional amortization investments were $2.0 billion and $2.1 billion at March 31, 2026, and December 31, 2025, respectively, and are included within other assets on our Condensed Consolidated Balance Sheet. Unfunded commitments to provide additional capital to proportional amortization investments were $735 million and $819 million at March 31, 2026, and December 31, 2025, respectively, and are included within accrued expenses and other liabilities on our Condensed Consolidated Balance Sheet. Substantially all of the unfunded commitments at March 31, 2026, are expected to be paid out within the next five years.
The total carrying value of the nonmarketable equity investments held at March 31, 2026, and December 31, 2025, including cumulative unrealized gains and losses, was as follows.
($ in millions)March 31, 2026December 31, 2025
FRB stock$454 $452 
FHLB stock335 359 
Equity investments without a readily determinable fair value
Cost basis94 94 
Adjustments
Upward adjustments56 57 
Downward adjustments (including impairment)(38)(40)
Carrying amount, equity investments without a readily determinable fair value112 111 
Nonmarketable equity investments$901 $922 
During the three months ended March 31, 2026, and March 31, 2025, unrealized gains and losses included in the carrying value of the nonmarketable equity investments still held as of March 31, 2026, and March 31, 2025, were as follows.
Three months ended March 31,
($ in millions)20262025
Upward adjustments$— $— 
Downward adjustments (including impairment) (a)$(1)$— 
(a)No impairment on FHLB and FRB stock was recognized during the three months ended March 31, 2026, and March 31, 2025.
The carrying balance of goodwill by reportable operating segment was as follows.
($ in millions)Automotive Finance operationsInsurance operationsCorporate and Other (a)Total
Goodwill at December 31, 2024
$20 $27 $504 $551 
Goodwill impairment— — (305)(305)
Transfer to assets of operations held-for-sale (b)— — (56)(56)
Goodwill at December 31, 2025
$20 $27 $143 $190 
Goodwill impairment— — — — 
Goodwill at March 31, 2026
$20 $27 $143 $190 
(a)Includes $143 million of goodwill associated with Ally Invest at both March 31, 2026, and December 31, 2025.
(b)We closed the sale of Ally Credit Card on April 1, 2025. Refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for further information on Ally Credit Card.
During the year ended December 31, 2025, we recognized a $305 million goodwill impairment charge at Corporate and Other related to the transfer of Ally Credit Card to held-for-sale on the Condensed Consolidated Balance Sheet. Subsequent to the impairment charge, the goodwill balance of $56 million was transferred to assets of operations held-for-sale on the Condensed Consolidated Balance Sheet. We closed the sale of Ally Credit Card on April 1, 2025. For additional information, refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K.
v3.26.1
Deposit Liabilities
 3 Months Ended
Mar. 31, 2026
Deposits [Abstract]  
Deposit Liabilities Deposit Liabilities
Deposit liabilities consisted of the following.
($ in millions)March 31, 2026December 31, 2025
Noninterest-bearing deposits$137 $125 
Interest-bearing deposits
Savings, money market, and spending accounts112,800 109,214 
Certificates of deposit40,215 42,310 
Total deposit liabilities$153,152 $151,649 
At March 31, 2026, and December 31, 2025, certificates of deposit included $5.9 billion and $6.2 billion, respectively, of those in denominations in excess of $250 thousand.
v3.26.1
Debt
 3 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Debt Debt
Short-Term Borrowings
The following table presents the composition of our short-term borrowings portfolio.
March 31, 2026December 31, 2025
($ in millions)
Unsecured
Secured (a)
Total
Unsecured
Secured (a)
Total
Federal Home Loan Bank
$— $3,600 $3,600 $— $4,150 $4,150 
Securities sold under agreements to repurchase
— 526 526 — 545 545 
Total short-term borrowings$— $4,126 $4,126 $— $4,695 $4,695 
(a)Refer to the section below titled Long-Term Debt for further details on assets restricted as collateral for payment of the related debt.
We periodically enter into term repurchase agreements—short-term borrowing agreements in which we sell securities to one or more investors while simultaneously committing to repurchase them at a specified future date, at the stated price plus accrued interest. As of March 31, 2026, the securities sold under agreements to repurchase consisted of $526 million in U.S. Treasury securities, of which $427 million in repurchase agreements were set to mature within 30 days, and the remaining $99 million of repurchase agreements are set to mature within 31 to 60 days.
The primary risk associated with these repurchase agreements is that the counterparty will be unable to perform under the terms of the contract. As the borrower, we are exposed to the excess fair value of the securities pledged over the amount borrowed. Daily mark-to-market collateral management is designed to limit this risk to the initial margin. However, should a counterparty declare bankruptcy or become insolvent, we may incur additional delays and costs. In some instances, we may place or receive cash collateral with counterparties under collateral arrangements associated with our repurchase agreements. As of March 31, 2026, we placed cash collateral of $10 million related to repurchase agreements. As of December 31, 2025, we placed cash collateral of $1 million related to repurchase agreements.
Long-Term Debt
The following table presents the composition of our long-term debt portfolio.
March 31, 2026December 31, 2025
($ in millions)UnsecuredSecuredTotalUnsecuredSecuredTotal
Long-term debt (a) (b)
Due within one year$(20)$2,459 $2,439 $— $2,659 $2,659 
Due after one year9,939 4,971 14,910 10,012 4,399 14,411 
Total long-term debt (c)$9,919 $7,430 $17,349 $10,012 $7,058 $17,070 
(a)Includes basis adjustments related to the application of hedge accounting. Refer to Note 18 for additional information.
(b)Includes scheduled amortization of original issue discount.
(c)Includes advances from the FHLB of Pittsburgh of $4.2 billion at both March 31, 2026, and December 31, 2025.
The following table presents the scheduled remaining maturity of long-term debt at March 31, 2026, assuming no early redemptions will occur. The amounts below include adjustments to the carrying value resulting from the application of hedge accounting. The actual payment of secured debt may vary based on the payment activity of the related pledged assets.
($ in millions)202620272028202920302031 and thereafter
Total
Unsecured
Long-term debt
$59 $1,595 $876 $1,748 $793 $5,518 $10,589 
Original issue discount
(63)(95)(107)(123)(143)(139)(670)
Total unsecured
(4)1,500 769 1,625 650 5,379 9,919 
Secured
Long-term debt
2,079 2,751 2,056 435 85 24 7,430 
Total long-term debt
$2,075 $4,251 $2,825 $2,060 $735 $5,403 $17,349 
The following table summarizes assets restricted as collateral for the payment of the related debt obligation.
($ in millions)March 31, 2026December 31, 2025
Consumer automotive finance receivables$37,151 $36,807 
Consumer mortgage finance receivables15,342 15,604 
Commercial finance receivables7,899 7,686 
Investment securities (amortized cost basis of $3,012 and $3,114) (a)
3,187 3,292 
Other assets (b)1,224 1,381 
Total assets restricted as collateral (c) (d)$64,803 $64,770 
Secured debt (e)$11,556 $11,753 
(a)A portion of the restricted investment securities at both March 31, 2026, and December 31, 2025, was restricted under repurchase agreements. Refer to the section above titled Short-Term Borrowings for information on the repurchase agreements.
(b)Includes the collateral accounts restricted for the payment of credit-linked notes recorded within restricted cash and cash equivalents. Excludes restricted cash and cash reserves for securitization trusts. Refer to Note 10 and Note 17 for additional information.
(c)All restricted assets are those of Ally Bank.
(d)Ally Bank has an advance agreement with the FHLB, and had assets pledged to secure borrowings that were restricted as collateral to the FHLB totaling $25.9 billion and $26.0 billion at March 31, 2026, and December 31, 2025, respectively. These assets were primarily composed of consumer mortgage finance receivables and loans as well as mortgage-backed securities. Ally Bank has access to the FRB Discount Window and had assets pledged and restricted as collateral to the FRB totaling $33.6 billion and $33.7 billion at March 31, 2026, and December 31, 2025, respectively. These assets were composed of consumer automotive finance receivables and loans. Availability under these programs is only for the operations of Ally Bank and cannot be used to fund the operations or liabilities of Ally or its other subsidiaries.
(e)Includes $4.1 billion and $4.7 billion of short-term borrowings at March 31, 2026, and December 31, 2025, respectively.
v3.26.1
Accrued Expenses and Other Liabilities
 3 Months Ended
Mar. 31, 2026
Accounts Payable and Accrued Liabilities [Abstract]  
Accrued Expenses and Other Liabilities Accrued Expenses and Other Liabilities
The components of accrued expenses and other liabilities were as follows.
($ in millions)
March 31, 2026December 31, 2025
Unfunded commitments for proportional amortization investments (a)$735 $819 
Accounts payable544 420 
Reserves for insurance losses and loss adjustment expenses (b)251 233 
Employee compensation and benefits242 417 
Deferred revenue135 141 
Operating lease liabilities121 124 
Other liabilities488 551 
Total accrued expenses and other liabilities$2,516 $2,705 
(a)Primarily relates to unfunded commitments for investments in qualified affordable housing projects.
(b)Refer to Note 4 for further information.
v3.26.1
Preferred Stock
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Preferred Stock Preferred Stock
The following table summarizes information about our preferred stock. For additional information regarding our preferred stock, refer to Note 17 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K.
March 31, 2026December 31, 2025
Series B preferred stock (a) (b)
Issuance dateApril 22, 2021April 22, 2021
Carrying value ($ in millions)
$1,335$1,335
Par value (per share)
$0.01$0.01
Liquidation preference (per share)
$1,000$1,000
Number of shares authorized1,350,0001,350,000
Number of shares issued and outstanding1,350,0001,350,000
Dividend/coupon
Prior to May 15, 20264.700%4.700%
On and after May 15, 2026
Five Year Treasury + 3.868%
Five Year Treasury + 3.868%
Series C preferred stock (a)
Issuance dateJune 2, 2021June 2, 2021
Carrying value ($ in millions)
$989$989
Par value (per share)
$0.01$0.01
Liquidation preference (per share)
$1,000$1,000
Number of shares authorized1,000,0001,000,000
Number of shares issued and outstanding1,000,0001,000,000
Dividend/coupon
Prior to May 15, 20284.700%4.700%
On and after May 15, 2028
Seven Year Treasury + 3.481%
Seven Year Treasury + 3.481%
(a)We may, at our option, redeem the Series B and Series C shares on any dividend payment date on or after May 15, 2026, or May 15, 2028, respectively, or at any time within 90 days following a regulatory event that precludes the instruments from being included in additional Tier 1 capital.
(b)On May 4, 2026, we announced our intent to redeem all of our issued and outstanding 4.700% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B on May 15, 2026. Refer to Note 24 for additional information.
v3.26.1
Accumulated Other Comprehensive Loss
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Accumulated Other Comprehensive Loss Accumulated Other Comprehensive Loss
The following table presents changes, net of tax, in each component of accumulated other comprehensive loss.
Investment securities
($ in millions)
Available-
for-sale securities (a)		Held-to-maturity securitiesTranslation adjustments and net investment hedges (b)Cash flow hedges (b)Accumulated other comprehensive loss
Balance at January 1, 2025$(3,307)$(616)$20 $(21)$(3,924)
Net change642 15 — 5 662 
Balance at March 31, 2025$(2,665)$(601)$20 $(16)$(3,262)
Balance at January 1, 2026$(2,260)$(551)$23 $2 $(2,786)
Net change(5)14 — 4 13 
Balance at March 31, 2026$(2,265)$(537)$23 $6 $(2,773)
(a)Represents the after-tax difference between the fair value and amortized cost basis of our available-for-sale securities portfolio. Refer to Note 6 for additional information.
(b)For additional information on derivative instruments and hedging activities, refer to Note 18.
The following tables present the before- and after-tax changes in each component of accumulated other comprehensive loss.
Three months ended March 31, 2026 ($ in millions)
Before taxTax effectAfter tax
Investment securities
Available-for-sale securities
Net unrealized losses arising during the period$(4)$1 $(3)
Less: Net realized gains reclassified to income from continuing operations3 (a)(1)(b)2 
Net change(7)2 (5)
Held-to-maturity securities
Less: Amortization of amounts previously recorded upon transfer from available-for-sale(19)(c)5 (b)(14)
Translation adjustments
Net unrealized losses arising during the period(3)1 (2)
Net investment hedges (d)
Net unrealized gains arising during the period3 (1)2 
Cash flow hedges (d)
Less: Net realized losses reclassified to income from continuing operations(5)(e)1 (b)(4)
Net change5 (1)4 
Other comprehensive income$17 $(4)$13 
(a)Includes gains reclassified to other loss on investments, net, in our Condensed Consolidated Statement of Comprehensive Income.
(b)Includes amounts reclassified to income tax expense (benefit) from continuing operations in our Condensed Consolidated Statement of Comprehensive Income.
(c)Includes amounts reclassified to interest and dividends on investment securities and other earning assets in our Condensed Consolidated Statement of Comprehensive Income.
(d)For additional information on derivative instruments and hedging activities, refer to Note 18.
(e)Includes losses reclassified to interest and fees on finance receivables and loans in our Condensed Consolidated Statement of Comprehensive Income.
Three months ended March 31, 2025 ($ in millions)
Before taxTax effectAfter tax
Investment securities
Available-for-sale securities
Net unrealized gains arising during the period$346 $(81)$265 
Less: Net realized losses reclassified to income from continuing operations(495)(a)118 (b)(377)
Net change841 (199)642 
Held-to-maturity securities
Less: Amortization of amounts previously recorded upon transfer from available-for-sale(20)(c)5 (b)(15)
Cash flow hedges (d)
Less: Net realized losses reclassified to income from continuing operations(7)(e)2 (b)(5)
Net change7 (2)5 
Other comprehensive income$868 $(206)$662 
(a)Includes losses reclassified to other loss on investments, net, in our Condensed Consolidated Statement of Comprehensive Income related to the balance sheet repositioning of our available-for-sale securities portfolio. Refer to Note 8 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information.
(b)Includes amounts reclassified to income tax expense (benefit) from continuing operations in our Condensed Consolidated Statement of Comprehensive Income.
(c)Includes amounts reclassified to interest and dividends on investment securities and other earning assets in our Condensed Consolidated Statement of Comprehensive Income.
(d)For additional information on derivative instruments and hedging activities, refer to Note 18.
(e)Includes losses reclassified to interest and fees on finance receivables and loans in our Condensed Consolidated Statement of Comprehensive Income.
v3.26.1
Earnings per Common Share
 3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Earnings per Common Share Earnings per Common Share
The following table presents the calculation of basic and diluted earnings per common share.
Three months ended March 31,
($ in millions, except per share data; shares in thousands) (a)
20262025
Net income (loss) from continuing operations$319 $(225)
Preferred stock dividends — Series B(16)(16)
Preferred stock dividends — Series C(12)(12)
Net income (loss) from continuing operations attributable to common shareholders$291 $(253)
Net income (loss) attributable to common shareholders$291 $(253)
Basic weighted-average common shares outstanding (b)310,992 309,006 
Diluted weighted-average common shares outstanding (b) (c)313,219 309,006 
Basic earnings per common share
Net income (loss) from continuing operations$0.94 $(0.82)
Net income (loss)$0.94 $(0.82)
Diluted earnings per common share
Net income (loss) from continuing operations$0.93 $(0.82)
Net income (loss)$0.93 $(0.82)
(a)Figures in the table may not recalculate exactly due to rounding. Earnings per share is calculated based on unrounded numbers.
(b)Includes shares related to share-based compensation that vested but were not yet issued.
(c)Due to the antidilutive effect of the net loss from continuing operations for the three months ended March 31, 2025, basic weighted-average common shares outstanding was used to calculate basic and diluted earnings per share. During the three months ended March 31, 2025, there were 2.7 million in share-based awards excluded because their inclusion would have been antidilutive.
v3.26.1
Regulatory Capital and Other Regulatory Matters
 3 Months Ended
Mar. 31, 2026
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]  
Regulatory Capital and Other Regulatory Matters Regulatory Capital and Other Regulatory Matters
Ally is subject to enhanced prudential standards that have been established by the FRB under the Dodd-Frank Act, as amended by the EGRRCP Act and as applied to Category IV firms under the Tailoring Rules. Refer to the discussion below, however, about rules proposed by the U.S. banking agencies in 2023 that would significantly alter the Tailoring Rules. Currently, as a Category IV firm, Ally is (1) subject to supervisory stress testing on a two-year cycle, (2) required to submit an annual capital plan to the FRB, (3) exempted from company-run capital stress testing requirements, (4) required to maintain a buffer of unencumbered highly liquid assets to meet projected net stressed cash outflows over a 30-day planning horizon, (5) exempted from the requirements of the LCR and the net stable funding ratio (provided that our average wSTWF continues to remain under $50 billion), (6) exempted from the requirements of the supplementary leverage ratio, the countercyclical capital buffer, and single-counterparty credit limits, and (7) eligible to exclude most elements of accumulated other comprehensive income from regulatory capital. Even so, we are subject to rules enabling the FRB to conduct supervisory stress testing on a more or less frequent basis based on our financial condition, size, complexity, risk profile, scope of operations, or activities or based on risks to the U.S. economy. Further, we are subject to rules requiring the resubmission of our capital plan if we determine that there has been or will be a material change in our risk profile, financial condition, or corporate structure since we last submitted the capital plan or if the FRB determines that (a) our capital plan is incomplete or our capital plan or internal capital adequacy process contains material weaknesses, (b) there has been, or will likely be, a material change in our risk profile (including a material change in our business strategy or any risk exposure), financial condition, or corporate structure, or (c) the BHC stress scenario(s) are not appropriate for our business model and portfolios, or changes in the financial markets or the macroeconomic outlook that could have a material impact on our risk profile and financial condition require the use of updated scenarios. While a resubmission is pending, without prior approval of the FRB, we would generally be prohibited from paying dividends, repurchasing our common stock, or making other capital distributions. In addition, to satisfy the FRB in its review of our capital plan, we may be required to further cease or limit these capital distributions or to issue capital instruments that could be dilutive to shareholders. The FRB also may prevent us from maintaining or expanding lending or other business activities.
Basel Capital Framework
The FRB and other U.S. banking agencies have adopted risk-based and leverage capital rules that establish minimum capital-to-asset ratios for BHCs, like Ally, and depository institutions, like Ally Bank.
The risk-based capital ratios are based on a banking organization’s RWAs, which are generally determined under the standardized approach applicable to Ally and Ally Bank by (1) assigning on-balance-sheet exposures to broad risk-weight categories according to the counterparty or, if relevant, the guarantor or collateral (with higher risk weights assigned to categories of exposures perceived as representing greater risk), and (2) multiplying off-balance-sheet exposures by specified credit conversion factors to calculate credit equivalent amounts and assigning those credit equivalent amounts to the relevant risk-weight categories. The leverage ratio, in contrast, is based on an institution’s average unweighted on-balance-sheet exposures.
Under U.S. Basel III, Ally and Ally Bank must maintain a minimum Common Equity Tier 1 risk-based capital ratio of 4.5%, a minimum Tier 1 risk-based capital ratio of 6%, and a minimum total risk-based capital ratio of 8%. On top of the minimum risk-based capital ratios, Ally and Ally Bank are subject to a capital conservation buffer requirement, which must be satisfied entirely with capital that qualifies as Common Equity Tier 1 capital. Failure to maintain more than the full amount of the capital conservation buffer requirement would result in automatic restrictions on the ability of Ally and Ally Bank to make capital distributions, including dividend payments and share repurchases and redemptions, and to pay discretionary bonuses to executive officers. U.S. Basel III also subjects Ally and Ally Bank to a minimum Tier 1 leverage ratio of 4%. While the capital conservation buffer requirement for Ally Bank is fixed at 2.5% of RWAs, the capital conservation buffer requirement for a Category IV firm, like Ally, is equal to its stress capital buffer requirement. The stress capital buffer requirement for Ally, in turn, is the greater of 2.5% and the result of the following calculation: (1) the difference between Ally’s starting and minimum projected Common Equity Tier 1 capital ratios under the severely adverse scenario in the supervisory stress test, plus (2) the sum of the dollar amount of Ally’s planned common stock dividends for each of the fourth through seventh quarters of its nine-quarter capital planning horizon, as a percentage of RWAs. As of March 31, 2026, the stress capital buffer requirement for Ally was 2.6%. Refer to the discussion below regarding a rule proposed by the FRB that would make certain changes to the methodology for determining the stress capital buffer requirement.
Ally and Ally Bank are currently subject to the U.S. Basel III standardized approach for credit risk but not to the U.S. Basel III advanced approaches for credit risk or operational risk. Ally is also not currently subject to the U.S. market-risk capital rule, which applies only to banking organizations with significant trading assets and liabilities. Since Ally and Ally Bank are currently not subject to the advanced approaches risk-based capital rules, we elected to apply a one-time option to exclude most components of accumulated other comprehensive income and loss from regulatory capital. At both March 31, 2026, and December 31, 2025, Ally had $2.8 billion of accumulated other comprehensive loss, net of applicable income taxes, that was excluded from Common Equity Tier 1 capital. Refer to the discussion below about rules proposed by the U.S. banking agencies in 2023 that would require us to recognize all components of accumulated other comprehensive income and loss in regulatory capital, except gains and losses on cash-flow hedges where the hedged items are not recognized on our balance sheet at fair value. Refer also to Note 15 for additional details about our accumulated other comprehensive loss.
Failure to satisfy regulatory-capital requirements could result in significant sanctions—such as bars or other limits on capital distributions and discretionary bonuses to executive officers, limitations on acquisitions and new activities, restrictions on our acceptance of brokered deposits, a loss of our status as an FHC, or informal or formal enforcement and other supervisory actions—and could have a significant adverse effect on the Consolidated Financial Statements or the business, results of operations, financial condition, or prospects of Ally and Ally Bank.
The risk-based capital ratios and the Tier 1 leverage ratio play a central role in PCA, which is an enforcement framework used by the U.S. banking agencies to constrain the activities of depository institutions based on their levels of regulatory capital. Five categories have been established using thresholds for the Common Equity Tier 1 risk-based capital ratio, the Tier 1 risk-based capital ratio, the total risk-based capital ratio, and the Tier 1 leverage ratio: well capitalized, adequately capitalized, undercapitalized, significantly undercapitalized, and critically undercapitalized. FDICIA generally prohibits a depository institution from making any capital distribution, including any payment of a cash dividend or a management fee to its BHC, if the depository institution would become undercapitalized after the distribution. An undercapitalized institution is also subject to growth limitations and must submit and fulfill a capital restoration plan. Although BHCs are not subject to the PCA framework, the FRB is empowered to compel a BHC to take measures—such as the execution of financial or performance guarantees—when PCA is required in connection with one of its depository-institution subsidiaries. At both March 31, 2026, and December 31, 2025, Ally Bank met the capital ratios required to be well capitalized under the PCA framework.
Under FDICIA and the PCA framework, IDIs such as Ally Bank must be well capitalized or, with a waiver from the FDIC, adequately capitalized in order to accept brokered deposits, and even adequately capitalized institutions are subject to some restrictions on the rates they may offer for brokered deposits. Our brokered deposits totaled $5.6 billion at March 31, 2026, which represented 3.7% of total deposit liabilities.
The following table summarizes our capital ratios under U.S. Basel III.
March 31, 2026
December 31, 2025
Required minimum (a)Well-capitalized minimum
($ in millions)AmountRatioAmountRatio
Capital ratios
Common Equity Tier 1 (to risk-weighted assets)
Ally Financial Inc.$15,695 10.11 %$15,629 10.23 %4.50 %(b)
Ally Bank17,914 12.38 17,853 12.50 4.50 6.50 %
Tier 1 (to risk-weighted assets)
Ally Financial Inc.$17,934 11.56 %$17,885 11.70 %6.00 %6.00 %
Ally Bank17,914 12.38 17,853 12.50 6.00 8.00 
Total (to risk-weighted assets)
Ally Financial Inc.$20,793 13.40 %$20,731 13.56 %8.00 %10.00 %
Ally Bank19,744 13.65 19,659 13.77 8.00 10.00 
Tier 1 leverage (to adjusted quarterly average assets) (c)
Ally Financial Inc.$17,934 9.16 %$17,885 9.25 %4.00 %(b)
Ally Bank17,914 9.72 17,853 9.82 4.00 5.00 %
(a)In addition to the minimum risk-based capital requirements for the Common Equity Tier 1 capital, Tier 1 capital, and total capital ratios, Ally was subject to a minimum capital conservation buffer of 2.6% at both March 31, 2026, and December 31, 2025, and Ally Bank was subject to a minimum capital conservation buffer of 2.5% at both March 31, 2026, and December 31, 2025.
(b)Currently, there is no ratio component for determining whether a BHC is “well-capitalized.”
(c)Federal regulatory reporting guidelines require the calculation of adjusted quarterly average assets using a daily average methodology.
Under U.S. Basel III, Category I and II firms calculate their risk-weighted assets under two different methodologies—the standardized approach, and the advanced approaches that rely on internal models. These firms are generally bound to the more stringent of the two calculations. Category III and IV firms, and other banking organizations subject to risk-based capital standards apply only the standardized approach under U.S. Basel III. In March 2026, the U.S. banking agencies issued two proposed rules to customize and implement revisions to the global Basel III capital framework that were approved by the Basel Committee in December 2017.
The first proposed rule would replace this dual-stack framework for Category I and II firms with a single, new risk-weighted assets calculation referred to as the expanded risk-based approach. The advanced approaches would be removed from the regulatory capital framework. The standardized approach, as modified by the second proposed rule, would continue to apply to all other firms that are subject to risk-based capital standards. Banking organizations of any size, however, would have the option to elect to use the expanded risk-based approach instead of the revised standardized approach. Relative to the current dual-stack framework, the expanded risk-based approach is a standardized framework intended to promote simplicity, risk sensitivity, transparency, and consistency across the firms to which it would apply. Risk-weighted assets would be assigned to address credit risk, equity risk, operational risk, market risk, and CVA risk. Notably, operational risk capital requirements would be based on a new standardized calculation that would replace the current models-based approach. The proposal would also introduce a new framework for market risk and adjust the thresholds used to determine which firms—in addition to those in Category I and II—are subject to the market risk and CVA risk capital requirements.
The second proposed rule would make targeted revisions within the standardized approach currently used by Category III and IV firms, and other banking organizations subject to risk-based capital standards. These revisions are intended to improve the calibration and risk sensitivity for certain exposure categories. The proposal would require Category III and IV firms to recognize in regulatory capital most elements of accumulated other comprehensive income and loss. This change would be phased in over a period of five years. For firms subject to the standardized approach that do not elect to use the expanded risk-based approach, the proposal would also reduce the risk weight applicable to all assets not specifically assigned a different risk weight under the capital rule (such as consumer automotive loans and leases) from 100 percent to 90 percent, as well as reduce the risk weight applicable to corporate exposures from 100 percent to 95 percent. Residential mortgage exposures would generally be risk weighted using an LTV-based methodology under the proposal. While these risk weights are generally more punitive than those assigned to similar exposure categories under the proposed expanded risk-based approach, the standardized approach would not separately assign risk-weighted assets to address operational risk. The supervisory formula used to assign risk weights for securitization exposures would be adjusted to align with that of the proposed expanded risk-based approach with an output floor that is reduced from 20 percent to 15 percent.
Both proposals would modify the definition of regulatory capital by removing the threshold-based deduction of mortgage servicing assets, and all firms that use the expanded risk-based approach would be required to apply the more stringent threshold test to determine any capital deduction for certain DTAs and investments in the capital instruments of unconsolidated financial institutions. These proposals were issued without effective dates but generally assume transition periods that begin January 1, 2027, and have comment periods that expire June 18, 2026. As proposed, the phase-in of accumulated other comprehensive income and loss would be expected to significantly affect our
levels of regulatory capital. The impact of lower capital levels would be partially offset by the recalibration of risk weights proposed in the expanded risk-based approach or revised standardized approach. Whether and when final rules related to these proposals may be adopted and take effect, as well as what changes to the proposed rules may be reflected in any final rules after public comments are considered, remain unclear.
In April 2025, the FRB issued a proposed rule that would modify certain aspects of its supervisory stress tests. Under the proposed rule, the stress capital buffer requirement for Category I–III firms subject to the capital plan rule would be calculated using a methodology that averages results from each of the prior two consecutive annual supervisory stress tests. For Category IV firms subject to the capital plan rule, like Ally, the stress capital buffer requirement would be determined under this two-year averaging methodology only if they choose or are otherwise required to be subject to consecutive supervisory stress tests. According to the FRB, this change is intended to reduce the volatility of a firm’s regulatory capital requirement inherent in the current approach of using the results from only the most recent supervisory stress test. Additionally, to provide firms additional time to adjust to their new regulatory capital requirements, the proposal would delay the annual effective date of a firm’s updated stress capital buffer requirement from October 1 to January 1 of the following year.
In October 2025, the FRB issued proposals to enhance the transparency and public accountability of its annual stress test, which is used to set the stress capital buffers for large BHCs, including Ally. The proposals request comment on several elements of the stress test, including the models and scenarios used; an enhanced disclosure process for the scenarios and material model changes in future stress test cycles; modifications to reporting forms; and an adjusted timeline for the annual process to accommodate a comment period for scenarios and material model changes.
In February 2026, the FRB issued final stress test scenarios for the 2026 supervisory stress test, and announced it intends to maintain stress capital buffer requirements at their current level until 2027 when new requirements can be calculated based on models that take public feedback into consideration. Whether and when final rules related to these stress-testing proposals may be adopted and take effect, as well as what changes to the proposed rules may be reflected in any such final rules, remain unclear.
Capital Planning and Stress Tests
Under the Tailoring Rules, we are generally subject to supervisory stress testing on a two-year cycle and exempted from mandated company-run capital stress testing requirements. We are also required to submit an annual capital plan to the FRB. Our annual capital plan must include an assessment of our expected uses and sources of capital and a description of all planned capital actions over a nine-quarter planning horizon, including any issuance of a debt or equity capital instrument, any dividend or other capital distribution, and any similar action that the FRB determines could have an impact on our capital. The plan must also include a detailed description of our process for assessing capital adequacy, including a discussion of how we, under expected and stressful conditions, will maintain capital commensurate with our risks and above the minimum regulatory capital ratios, will serve as a source of strength to Ally Bank, and will maintain sufficient capital to continue our operations by maintaining ready access to funding, meeting our obligations to creditors and other counterparties, and continuing to serve as a credit intermediary.
The Tailoring Rules align capital planning, supervisory stress testing, and stress capital buffer requirements for large banking organizations, like Ally. As a Category IV firm, Ally is expected to have the ability to elect to participate in the supervisory stress test—and receive a correspondingly updated stress capital buffer requirement—in a year in which Ally would not generally be subject to the supervisory stress test. Refer to the section titled Basel Capital Framework above for further discussion about our stress capital buffer requirements. During a year in which Ally does not undergo a supervisory stress test, we would receive an updated stress capital buffer requirement only to reflect our updated planned common-stock dividends. Ally did not elect to participate in the 2023 or 2025 supervisory stress tests, but was subject to the 2024 supervisory stress test.
We submitted our 2024 capital plan to the FRB in April 2024, and received an updated preliminary stress capital buffer requirement from the FRB in June 2024 of 2.6%. The updated 2.6% stress capital buffer requirement was finalized in August 2024, and became effective in October 2024. We submitted our 2025 capital plan to the FRB in April 2025, and received in June 2025 an updated preliminary stress capital buffer requirement that remained unchanged at 2.6%. The 2.6% stress capital buffer requirement was finalized in August 2025, and became effective in October 2025. We submitted our 2026 capital plan to the FRB in April 2026.
In December 2024, we accessed the unsecured debt capital markets and issued $500 million of subordinated notes, which qualify as Tier 2 capital for Ally under U.S. Basel III. During the years ended December 31, 2025, and 2024, we accessed the debt capital markets and issued an aggregate of $1.1 billion and $770 million, respectively, of credit-linked notes based on combined reference portfolios of $10.0 billion and $7.0 billion of consumer automotive loans. The proceeds from these credit-linked notes issuances constitute prefunded credit protection for mezzanine tranches of the respective reference portfolio and are recognized as restricted cash and cash equivalents in other assets on our Condensed Consolidated Balance Sheet. These transactions are structured to enable us to apply the securitization framework under U.S. Basel III when determining RWA for our retained exposure, which recognizes the credit risk mitigation benefits and generally provides lower risk weights relative to those assigned to consumer automotive loans that are not securitized. As of March 31, 2026, and December 31, 2025, $10.7 billion and $12.1 billion, respectively, of our consumer automotive loans and related exposures were included as reference assets in these credit-linked notes transactions.
In December 2025, our Board authorized a share repurchase program, permitting us to repurchase up to $2.0 billion of our common stock under a multi-year program without a set expiration date. Our ability to make capital distributions, including our ability to pay dividends or repurchase shares of our common stock, will continue to be subject to the FRB’s review and our internal governance requirements,
including approval by our Board. The amount and size of any future dividends and share repurchases also will be subject to various factors, including Ally’s capital and liquidity positions, accounting and regulatory considerations (including any restrictions that may be imposed by the FRB and any changes to capital, liquidity, and other regulatory requirements that may be proposed or adopted by the U.S. banking agencies), Ally’s financial and operational performance, alternative uses of capital, the trading price of Ally’s common stock, and general market conditions. The share repurchase program does not obligate Ally to acquire a specific dollar amount or number of shares, and may be extended, modified, or discontinued at any time.
The following table presents information related to our common stock and distributions to our common shareholders.
Common stock repurchased during period (a)Number of common shares outstandingCash dividends declared per common share (b)
($ in millions, except per share data; shares in thousands)Approximate dollar valueNumber of sharesBeginning of periodEnd of period
2025
First quarter$34 877 305,388 307,152 $0.30 
Second quarter1 27 307,152 307,787 0.30 
Third quarter1 25 307,787 307,828 0.30 
Fourth quarter23 543 307,828 308,493 0.30 
2026
First quarter$147 3,624 308,493 307,408 $0.30 
(a)Includes shares of common stock withheld to cover income taxes owed by participants in our share-based incentive plans.
(b)On April 14, 2026, our Board declared a quarterly cash dividend of $0.30 per share on all common stock payable on May 15, 2026, to shareholders of record at the close of business on May 1, 2026.
v3.26.1
Derivative Instruments and Hedging Activities
 3 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments and Hedging Activities Derivative Instruments and Hedging Activities
We enter into derivative instruments, which may include interest rate swaps, foreign-currency forwards, equity options, and interest rate options, in connection with our risk-management activities. Our primary objective for using derivative financial instruments is to manage interest rate risk associated with our fixed-rate and variable-rate assets and liabilities, foreign exchange risks related to our net investments in foreign subsidiaries, as well as foreign-currency denominated assets and liabilities, and other market risks related to our investment portfolio.
Interest Rate Risk
We monitor our mix of fixed-rate and variable-rate assets and liabilities and may enter into interest rate swaps, forwards, and options to achieve a more desired mix of fixed-rate and variable-rate assets and liabilities. We execute these trades to modify our exposure to interest rate risk by converting certain fixed-rate instruments to a variable-rate and certain variable-rate instruments to a fixed-rate. We use a mix of both derivatives that qualify for hedge accounting treatment and economic hedges that do not qualify for hedge accounting treatment.
Derivatives qualifying for hedge accounting treatment can include receive-fixed swaps designated as fair value hedges of specific fixed-rate unsecured debt obligations, receive-fixed swaps designated as fair value hedges of specific fixed-rate FHLB advances, pay-fixed swaps designated as fair value hedges of securities within our available-for-sale portfolio, and pay-fixed swaps designated as fair value hedges of fixed-rate held-for-investment consumer automotive loan assets. Other derivatives qualifying for hedge accounting consist of interest rate floor contracts designated as cash flow hedges of the expected future cash flows in the form of interest receipts on a portion of our dealer floorplan commercial loans.
Our economic hedges include interest rate swaps that we offer as an accommodation to our customers within our Corporate Finance business. We offset the majority of the market risk of these customer swaps by entering into offsetting derivatives transactions with other counterparties.
We also entered into interest rate lock commitments and forward commitments that were executed as part of our mortgage business that met the accounting definition of a derivative.
We may execute other economic hedges, which could consist of interest rate swaps, forwards, and options to mitigate interest rate risk.
Foreign Exchange Risk
We enter into derivative financial instrument contracts to mitigate the risk associated with variability in cash flows related to our various foreign-currency exposures.
We enter into foreign-currency forwards with external counterparties as net investment hedges of foreign exchange exposure on our investment in foreign subsidiaries. Our equity is impacted by the cumulative translation adjustments resulting from the translation of foreign subsidiary results; this impact is reflected in our accumulated other comprehensive income and loss. We also periodically enter into foreign-currency forwards to economically hedge any foreign-denominated debt, centralized lending, and foreign-denominated third-party loans. These foreign-currency forwards used as economic hedges are recorded at fair value, with changes recorded as income or expense offsetting the gains and losses on the associated foreign-currency transactions.
Investment Risk
We enter into equity options to mitigate the risk associated with our exposure to the equity markets.
Credit Risk
We entered into various retail automotive-loan purchase agreements with certain counterparties. As part of those agreements, we may have been required to pay the counterparty at agreed upon measurement dates and determinable amounts if actual credit performance of the acquired loans on the measurement date was better than what was estimated at the time of acquisition. Based upon these terms, these contracts met the accounting definition of a derivative.
We enter into arrangements with certain counterparties through which we issue credit-linked notes covering a specified pool of loans. These notes contain an embedded derivative (referred to as credit-linked note derivatives), which provides us credit protection against the risk of loss when a specified credit event occurs on the reference pool.
Counterparty Credit Risk
Derivative financial instruments contain an element of credit risk if counterparties are unable to meet the terms of the agreements. Credit risk associated with derivative financial instruments is measured as the net replacement cost should the counterparties that owe us under the contract completely fail to perform under the terms of those contracts, with adjustments to reflect the exchange of collateral for margined transactions.
We manage our risk to financial counterparties through internal credit analysis, limits, and monitoring. Additionally, derivatives and repurchase agreements are entered into with approved counterparties using industry standard agreements.
We execute certain OTC derivatives, such as interest rate options, using bilateral agreements with financial counterparties. Bilateral agreements generally require both parties to post collateral in the event the fair values of the derivative financial instruments meet posting thresholds established under the agreements. If either party defaults on the obligation, the secured party may seize the collateral. Payments related to the exchange of collateral for OTC derivatives are recognized as collateral.
We also execute certain derivatives, such as interest rate swaps, with clearinghouses, which require us to post and receive collateral. For these clearinghouse derivatives, these payments are recognized as settlements rather than collateral.
Certain derivative instruments contain provisions that require us to either post additional collateral or immediately settle any outstanding liability balances upon the occurrence of a specified credit-risk-related event. No such specified credit-risk-related events occurred during the three months ended March 31, 2026, or 2025.
We placed cash and noncash collateral with counterparties totaling $13 million and $290 million, respectively, supporting our derivative positions at March 31, 2026, compared to $4 million and $328 million, of cash and noncash collateral, respectively, at December 31, 2025. These amounts include noncash collateral placed at clearinghouses and exclude cash and noncash collateral pledged under repurchase agreements. The receivables for cash collateral placed are included on our Condensed Consolidated Balance Sheet in other assets. We granted our counterparties the right to sell or pledge the noncash collateral.
We received cash collateral from counterparties totaling $3 million at March 31, 2026. These amounts exclude cash and noncash collateral pledged under repurchase agreements. The payables for cash collateral received are included on our Condensed Consolidated Balance Sheet in accrued expenses and other liabilities.
Balance Sheet Presentation
The following table summarizes the amounts of derivative instruments reported on our Condensed Consolidated Balance Sheet. The amounts are presented on a gross basis, are segregated by derivatives that are designated and qualifying as hedging instruments or those that are not, and are further segregated by type of contract within those two categories.
Derivative contracts in a receivable and payable position exclude open trade equity on derivatives cleared through central clearing counterparties. Any associated margin exchanged with our central clearing counterparties are treated as settlements of the derivative exposure, rather than collateral. Such payments are recognized as settlements of the derivatives contracts in a receivable and payable position on our Condensed Consolidated Balance Sheet.
Notional amounts are reference amounts from which contractual obligations are derived and are not recorded on the balance sheet. In our view, derivative notional is not an accurate measure of our derivative exposure when viewed in isolation from other factors, such as market rate fluctuations and counterparty credit risk.
March 31, 2026December 31, 2025
Derivative contracts in a
Notional amount
Derivative contracts in a
Notional amount
($ in millions)
receivable position
payable position
receivable position
payable position
Derivatives designated as accounting hedges
Interest rate contracts
Swaps
$— $— $22,507 $— $— $23,257 
Purchased options
— — 2,250 — — 3,450 
Foreign exchange contracts
Forwards
2 — 187 — 4 199 
Total derivatives designated as accounting hedges
2 — 24,944 — 4 26,906 
Derivatives not designated as accounting hedges
Interest rate contracts
Swaps1 1 216 — — — 
Total interest rate risk
1 1 216 — — — 
Foreign exchange contracts
Forwards— — 35 — — 71 
Total foreign exchange risk— — 35 — — 71 
Credit contracts
Credit-linked note derivatives— 1 1,224 — — 1,381 
Total credit risk— 1 1,224 — — 1,381 
Equity contracts
Written options
— 1 — — — — 
Total equity risk
— 1 — — — — 
Total derivatives not designated as accounting hedges
1 3 1,475 — — 1,452 
Total derivatives
$3 $3 $26,419 $— $4 $28,358 
The following table presents amounts recorded on our Condensed Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges.

Carrying amount of the hedged itemsCumulative amount of fair value hedging adjustment included in the carrying amount of the hedged items
TotalDiscontinued (a)
($ in millions)
March 31, 2026December 31, 2025March 31, 2026December 31, 2025March 31, 2026December 31, 2025
Assets
Available-for-sale securities (b)$14,968 $15,240 $(68)$7 $(51)$(54)
Finance receivables and loans, net (c)23,942 27,808 (23)7 1 1 
Liabilities
Long-term debt$3,395 $3,378 $76 $79 $76 $79 
(a)Represents the fair value hedging adjustment on qualifying hedges for which the hedging relationship was discontinued. This represents a subset of the amounts reported in the total hedging adjustment.
(b)These amounts include the amortized cost basis and unallocated basis adjustments of closed portfolios of available-for-sale securities used to designate hedging relationships in which the hedged item is the stated amount of assets in the closed portfolios anticipated to be outstanding for the designated hedge period. At March 31, 2026, and December 31, 2025, the amortized cost basis and unallocated basis adjustments of the closed portfolios used in these hedging relationships was $13.5 billion and $13.7 billion, respectively, of which $13.2 billion and $13.4 billion, respectively, represents the amortized cost basis and unallocated basis adjustments of closed portfolios designated in an active hedge relationship. At March 31, 2026, and December 31, 2025, the total cumulative basis adjustments associated with these hedging relationships was a $72 million liability and a $8 million liability, respectively, of which the portion related to discontinued hedging relationships was a $51 million liability and a $54 million liability, respectively. At both March 31, 2026, and December 31, 2025, the notional amounts of the designated hedged items were $11.0 billion, with cumulative basis adjustments of a $21 million liability and a $46 million asset, respectively, which would be allocated across the entire remaining closed pool upon dedesignation of the hedge relationship. Refer to Note 6 for a reconciliation of the amortized cost basis and fair value of available-for-sale securities.
(c)These amounts include the carrying value of closed portfolios of loan receivables used to designate hedging relationships in which the hedged item is the stated amount of assets in the closed portfolios anticipated to be outstanding for the designated hedge period. At March 31, 2026, and December 31, 2025, the carrying value of the closed portfolios used in these hedging relationships was $23.9 billion and $27.8 billion, respectively, of which $19.1 billion and $21.8 billion, respectively, represents the carrying value of closed portfolios designated in an active hedge relationship. At March 31, 2026, and December 31, 2025, the total cumulative basis adjustments associated with these hedging relationships was a $23 million liability and $7 million asset, respectively, of which the portion related to discontinued hedging relationships was a $1 million asset at both March 31, 2026, and December 31, 2025. At March 31, 2026, and December 31, 2025, the notional amounts of the designated hedged items were $10.0 billion and $10.8 billion, respectively, with cumulative basis adjustments of a $24 million liability and a $6 million asset, respectively, which would be allocated across the entire remaining closed pool upon dedesignation of the hedge relationship.
Statement of Income Presentation
The following table summarizes the location and amounts of gains and losses on derivative instruments not designated as accounting hedges reported in our Condensed Consolidated Statement of Comprehensive Income.
Three months ended March 31,
($ in millions)20262025
Gain (loss) recognized in earnings
Interest rate contracts
Gain on mortgage and automotive loans, net$— $1 
Total interest rate contracts— 1 
Foreign exchange contracts
Other operating expenses1 — 
Total foreign exchange contracts
1 — 
Credit contracts
Other income, net of losses(1)— 
Total credit contracts(1)— 
Total gain recognized in earnings$— $1 
The following table summarizes the location and amounts of gains and losses on derivative instruments designated as qualifying fair value and cash flow hedges reported in our Condensed Consolidated Statement of Comprehensive Income.
Interest and fees on finance receivables and loansInterest and dividends on investment securities and other earning assetsInterest on long-term debt
Three months ended March 31, ($ in millions)
202620252026202520262025
Gain (loss) on fair value hedging relationships
Interest rate contracts 
Hedged available-for-sale securities$— $— $(77)$130 $— $— 
Derivatives designated as hedging instruments on available-for-sale securities— — 77 (130)— — 
Hedged fixed-rate consumer automotive loans(30)29 — — — — 
Derivatives designated as hedging instruments on fixed-rate consumer automotive loans30 (29)— — — — 
Total gain on fair value hedging relationships— — — — — — 
Loss on cash flow hedging relationships
Interest rate contracts
Hedged variable-rate commercial loans
Reclassified from accumulated other comprehensive loss into income(5)(7)— — — — 
Total loss on cash flow hedging relationships$(5)$(7)$— $— $— $— 
Total amounts presented in the Condensed Consolidated Statement of Comprehensive Income
$2,658 $2,709 $234 $230 $265 $271 
During the next 12 months, we estimate $3 million of losses will be reclassified into pretax earnings from derivatives designated as cash flow hedges.
The following table summarizes the location and amounts of gains and losses related to interest and amortization on derivative instruments designated as qualifying fair value and cash flow hedges reported in our Condensed Consolidated Statement of Comprehensive Income.
Interest and fees on finance receivables and loansInterest and dividends on investment securities and other earning assetsInterest on long-term debt
Three months ended March 31, ($ in millions)
202620252026202520262025
Gain on fair value hedging relationships
Interest rate contracts
Amortization of deferred unsecured debt basis adjustments$— $— $— $— $2 $2 
Amortization of deferred basis adjustments of available-for-sale securities— — 3 5 — — 
Interest for qualifying accounting hedges of available-for-sale securities— — 1 17 — — 
Amortization of deferred loan basis adjustments— 2 — — — — 
Interest for qualifying accounting hedges of consumer automotive loans held for investment5 19 — — — — 
Total gain on fair value hedging relationships$5 $21 $4 $22 $2 $2 
The following table summarizes the effect of cash flow hedges on accumulated other comprehensive loss.
Three months ended March 31,
($ in millions)20262025
Interest rate contracts
Gain recognized in other comprehensive income$5 $7 
The following table summarizes the effect of net investment hedges on accumulated other comprehensive loss.
Three months ended March 31,
($ in millions)20262025
Foreign exchange contracts (a) (b)
Gain recognized in other comprehensive income$3 $— 
(a)There were no amounts excluded from effectiveness testing for the three months ended March 31, 2026, or 2025.
(b)Gains and losses reclassified from accumulated other comprehensive loss are reported as other income, net of losses, in our Condensed Consolidated Statement of Comprehensive Income. There were no amounts reclassified for the three months ended March 31, 2026, or 2025.
v3.26.1
Income Taxes
 3 Months Ended
Mar. 31, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
We recognized total income tax expense from continuing operations of $81 million for the three months ended March 31, 2026, compared to an income tax benefit of $59 million for the same period in 2025. The increase in income tax expense for the three months ended March 31, 2026, was primarily attributable to the tax effects of a loss on investments recognized as a result of our balance sheet repositioning of a portion of our available-for-sale securities during the three months ended March 31, 2025.
As of each reporting date, we consider existing evidence, both positive and negative, that could impact our view with regard to future realization of deferred tax assets. We continue to believe it is more likely than not that the benefit for certain foreign tax credit carryforwards and state net operating loss carryforwards will not be realized. In recognition of this risk, we continue to provide a partial valuation allowance on the deferred tax assets relating to these carryforwards and it is reasonably possible that the valuation allowance may change in the next 12 months.
v3.26.1
Fair Value
 3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Fair Value Fair Value
Fair Value Measurements
For purposes of this disclosure, fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (exit price) in the principal or most advantageous market in an orderly transaction between market participants at the measurement date under current market conditions. Fair value is based on the assumptions we believe market participants would use when pricing an asset or liability. Additionally, entities are required to consider all aspects of nonperformance risk, including the entity’s own credit standing, when measuring the fair value of a liability.
U.S. GAAP specifies a three-level hierarchy that is used when measuring and disclosing fair value. The fair value hierarchy gives the highest priority to quoted prices available in active markets (i.e., observable inputs) and the lowest priority to data lacking transparency (i.e., unobservable inputs). An instrument’s categorization within the fair value hierarchy is based on the lowest level of significant input to its valuation. The following is a description of the three hierarchy levels.
Level 1    Inputs are quoted prices in active markets for identical assets or liabilities at the measurement date. Additionally, the entity must have the ability to access the active market, and the quoted prices cannot be adjusted by the entity.
Level 2    Inputs are other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices in active markets for similar assets or liabilities; quoted prices in inactive markets for identical or similar assets or liabilities; or inputs that are observable or can be corroborated by observable market data by correlation or other means for substantially the full term of the assets or liabilities.
Level 3    Unobservable inputs are supported by little or no market activity. The unobservable inputs represent management’s best assumptions of how market participants would price the assets or liabilities. Generally, Level 3 assets and liabilities are valued using pricing models, discounted cash flow methodologies, or similar techniques that require significant judgment or estimation.
Judgment is used in estimating inputs to our internal valuation models used to estimate our Level 3 fair value measurements. Level 3 inputs such as interest rate movements, prepayment speeds, credit losses, and discount rates are inherently difficult to estimate. Changes to these inputs can have a significant effect on fair value measurements and amounts that could be realized.
The following are descriptions of the valuation methodologies used to measure material assets and liabilities at fair value and details of the valuation models, key inputs to those models, and significant assumptions utilized.
•Equity securities — We hold various marketable equity securities measured at fair value with changes in fair value recognized in net income. Measurements based on observable market prices are classified as Level 1.
•Available-for-sale securities — We carry our available-for-sale securities at fair value based on external pricing sources. We classify our securities as Level 1 when fair value is determined using quoted prices available for the same instruments trading in active markets. We classify our securities as Level 2 when fair value is determined using prices for similar instruments trading in active markets. We perform pricing validation procedures for our available-for-sale securities.
•Derivative instruments — We enter into a variety of derivative financial instruments as part of our risk-management strategies. Certain of these derivatives are exchange traded, such as equity options. To determine the fair value of these instruments, we utilize the quoted market prices for those particular derivative contracts; therefore, we classified these contracts as Level 1.
We also execute OTC and centrally cleared derivative contracts, such as interest rate swaps, foreign-currency denominated forward contracts, interest rate options, and agency to-be-announced securities. We utilize third-party-developed valuation models that are widely accepted in the market to value these derivative contracts. The specific terms of the contract and market observable inputs (such as interest rate forward curves, interpolated volatility assumptions, or equity pricing) are used in the model. We classified these derivative contracts as Level 2 because all significant inputs into these models were market observable.
We also entered into interest rate lock commitments and forward commitments that were executed as part of our mortgage operations, certain of which met the accounting definition of a derivative and therefore were recorded as derivatives on our Condensed Consolidated Balance Sheet. Interest rate lock commitments were valued with unobservable inputs, so they are classified as Level 3. Certain forward commitments are Level 2 and others are Level 3 depending on the valuation model inputs.
We purchased automotive finance receivables and loans from third parties as part of forward flow arrangements and, from time-to-time, executed opportunistic ad-hoc bulk purchases. As part of those agreements, we were required to pay the counterparty at agreed upon measurement dates and determinable amounts if actual credit performance of the acquired loans on the measurement date was better than what was estimated at the time of acquisition. Because these contracts met the accounting definition of a derivative, we recognized a liability at fair value for these deferred purchase price payments. The fair value of these liabilities was determined using a discounted cash flow method. To estimate cash flows, we utilized various significant assumptions, including market observable inputs (for example, forward interest rates) and internally developed inputs (for example, prepayment speeds, delinquency levels, and expected credit losses). These liabilities were valued using internal loss models with unobservable inputs, and were classified as Level 3.
We enter into arrangements with certain counterparties through which we issue credit-linked notes covering a specified pool of loans. These notes contain an embedded derivative, which provides us credit protection against the risk of loss when a specified credit event occurs on the reference pool. The embedded derivatives are valued using both market observable inputs and unobservable inputs, as such they are classified as Level 3.
We are required to consider all aspects of nonperformance risk, including our own credit standing, when measuring fair value of derivative assets and liabilities. We reduce credit risk on the majority of our derivatives by entering into legally enforceable agreements that enable the posting and receiving of collateral associated with the fair value of our derivative positions on an ongoing basis. In the event that we do not enter into legally enforceable agreements that enable the posting and receiving of collateral, we will consider our credit risk in the valuation of derivative liabilities through a DVA and the credit risk of our counterparties in the valuation of derivative assets through a CVA, if warranted. When measuring these valuation adjustments, we generally use credit default swap spreads.
Recurring Fair Value
The following tables display the assets and liabilities measured at fair value on a recurring basis including financial instruments elected for the fair value option. We often economically hedge the fair value change of our assets or liabilities with derivatives. The tables below display the hedges separately from the hedged items; therefore, they do not directly display the impact of our risk-management activities.
Recurring fair value measurements
March 31, 2026 ($ in millions)
Level 1Level 2Level 3Total
Assets
Investment securities
Equity securities (a) (b)$804 $— $— $804 
Available-for-sale securities
Debt securities
U.S. Treasury and federal agencies
2,397 — — 2,397 
U.S. States and political subdivisions
— 483 34 517 
Foreign government32 167 — 199 
Agency mortgage-backed residential
— 12,695 — 12,695 
Mortgage-backed residential
— 193 — 193 
Agency mortgage-backed commercial— 5,107 — 5,107 
Asset-backed— 2 — 2 
Corporate debt
— 1,928 — 1,928 
Total available-for-sale securities2,429 20,575 34 23,038 
Derivative contracts in a receivable position
Interest rate— 1 — 1 
Foreign exchange— 2 — 2 
Total derivative contracts in a receivable position— 3 — 3 
Total assets$3,233 $20,578 $34 $23,845 
Liabilities
Accrued expenses and other liabilities
Derivative contracts in a payable position
Interest rate$— $1 $— $1 
Credit — — 1 1 
Equity1 — — 1 
Total derivative contracts in a payable position
1 1 1 3 
Total liabilities$1 $1 $1 $3 
(a)Our direct investment in any one industry did not exceed 15%. When performing the concentration calculation, mutual funds and ETFs are not allocated to any one industry.
(b)Excludes $59 million of equity securities that are measured at fair value using the net asset value practical expedient and therefore are not classified in the fair value hierarchy.
Recurring fair value measurements
December 31, 2025 ($ in millions)
Level 1Level 2Level 3Total
Assets
Investment securities
Equity securities (a) (b)$819 $— $— $819 
Available-for-sale securities
Debt securities
U.S. Treasury and federal agencies
2,279 — — 2,279 
U.S. States and political subdivisions
— 517 34 551 
Foreign government31 157 — 188 
Agency mortgage-backed residential
— 12,901 — 12,901 
Mortgage-backed residential
— 198 — 198 
Agency mortgage-backed commercial— 4,932 — 4,932 
Asset-backed— 12 — 12 
Corporate debt
— 1,912 — 1,912 
Total available-for-sale securities2,310 20,629 34 22,973 
Total assets$3,129 $20,629 $34 $23,792 
Liabilities
Accrued expenses and other liabilities
Derivative contracts in a payable position
Foreign exchange$— $4 $— $4 
Total derivative contracts in a payable position
— 4 — 4 
Total liabilities$— $4 $— $4 
(a)Our direct investment in any one industry did not exceed 11%. When performing the concentration calculation, mutual funds and ETFs are not allocated to any one industry.
(b)Excludes $57 million of equity securities that are measured at fair value using the net asset value practical expedient and therefore are not classified in the fair value hierarchy.
The following tables present the reconciliation for all Level 3 assets and liabilities measured at fair value on a recurring basis. We often economically hedge the fair value change of our assets or liabilities with derivatives and other financial instruments. The Level 3 items presented below may be hedged by derivatives and other financial instruments that are classified as Level 1 or Level 2. Thus, the following tables do not fully reflect the impact of our risk-management activities.
Available-for-sale securitiesLoans
held-for-sale (a)
($ in millions)2026202520262025
Assets
Fair value at January 1,$34 $35 $— $5 
Net realized/unrealized gains
Included in earnings— — — — 
Included in OCI— — — — 
Purchases and originations— — — 8 
Sales— — — (10)
Issuances— — — — 
Settlements— — — — 
Transfers into Level 3— — — — 
Transfers out of Level 3— — — — 
Fair value at March 31,
$34 $35 $— $3 
Net unrealized gains still held at March 31,
Included in earnings$— $— $— $— 
Included in OCI— — — — 
(a)Consumer mortgage loans carried at fair value due to fair value option elections.
Derivative liabilities, net of derivative assets (a)
($ in millions)20262025
Liabilities
Fair value at January 1,$— $3 
Net realized/unrealized losses (gains)
Included in earnings1 (1)
Included in OCI— — 
Purchases and originations— — 
Sales— — 
Issuances— — 
Settlements— — 
Transfers into Level 3— — 
Transfers out of Level 3 (b)— 2 
Fair value at March 31,
$1 $4 
Net unrealized losses still held at March 31,
Included in earnings$1 $— 
Included in OCI— — 
(a)Net realized/unrealized losses (gains) are reported as (loss) gain on mortgage and automotive loans, net, and other income, net of losses, in our Condensed Consolidated Statement of Comprehensive Income.
(b)Represents the settlement value of interest rate derivative assets that are transferred to loans held-for-sale within Level 2 of the fair value hierarchy during the three months ended March 31, 2025. These transfers are deemed to have occurred at the end of the reporting period.
Nonrecurring Fair Value
We may be required to measure certain assets and liabilities at fair value from time to time. These periodic fair value measures typically result from the application of lower-of-cost or fair value accounting or certain impairment measures. These items would constitute nonrecurring fair value measures.
The following tables display assets and liabilities measured at fair value on a nonrecurring basis and still held at March 31, 2026, and December 31, 2025, respectively. The amounts are generally as of the end of each period presented, which approximate the fair value measurements that occurred during each period.
Nonrecurring fair value measurements
Lower-of-cost-or-fair-value reserve, valuation reserve, or cumulative adjustments
Total gain (loss) included in earnings
March 31, 2026 ($ in millions)
Level 1
Level 2
Level 3
Total
Assets
Loans held-for-sale, net$— $— $336 $336 $(15)n/m(a)
Commercial finance receivables and loans, net (b)
Other
— — 12 12 (96)n/m(a)
Total commercial finance receivables and loans, net
— — 12 12 (96)n/m(a)
Other assets
Nonmarketable equity investments— — 2 2 (1)n/m(a)
Repossessed and foreclosed assets (c)— — 8 8 (1)n/m(a)
Total assets
$— $— $358 $358 $(113)n/m
n/m = not meaningful
(a)We consider the applicable valuation reserve, allowance for loan losses, or cumulative adjustments to be the most relevant indicator of the impact on earnings caused by the fair value measurement. Accordingly, the table above excludes total gains and losses included in earnings for these items. The carrying values are inclusive of the respective valuation reserve, loan loss allowance, or cumulative adjustment.
(b)Represents collateral-dependent loans held for investment for which a nonrecurring measurement was made. The related allowance for loan losses represents the cumulative fair value adjustments for those specific receivables.
(c)The allowance provided for repossessed and foreclosed assets represents any cumulative valuation adjustment recognized to adjust the assets to fair value.
Nonrecurring fair value measurementsLower-of-cost-or-fair-value reserve, valuation reserve, or cumulative adjustmentsTotal gain (loss) included in earnings
December 31, 2025 ($ in millions)
Level 1Level 2Level 3Total
Assets
Loans held-for-sale, net$— $— $545 $545 $(32)n/m(a)
Commercial finance receivables and loans, net (b)
Other— — 27 27 (97)n/m(a)
Total commercial finance receivables and loans, net— — 27 27 (97)n/m(a)
Other assets
Nonmarketable equity investments— 9 1 10 4 n/m(a)
Repossessed and foreclosed assets (c)— — 7 7 (1)n/m(a)
Total assets$— $9 $580 $589 $(126)n/m
n/m = not meaningful
(a)We consider the applicable valuation reserve, allowance for loan losses, or cumulative adjustments to be the most relevant indicator of the impact on earnings caused by the fair value measurement. Accordingly, the table above excludes total gains and losses included in earnings for these items. The carrying values are inclusive of the respective valuation reserve, loan loss allowance, or cumulative adjustment.
(b)Represents collateral-dependent loans held for investment for which a nonrecurring measurement was made. The related allowance for loan losses represents the cumulative fair value adjustments for those specific receivables.
(c)The allowance provided for repossessed and foreclosed assets represents any cumulative valuation adjustment recognized to adjust the assets to fair value.
Fair Value Option for Financial Assets
We elected the fair value option for an insignificant amount of conforming mortgage loans held-for-sale and certain non-conforming jumbo mortgage loans held-for-sale to mitigate earnings volatility by better matching the accounting for the assets with the related derivatives. Our intent in electing fair value measurement was to mitigate a divergence between accounting gains or losses and economic exposure for certain assets and liabilities.
Fair Value of Financial Instruments
The following table presents the carrying and estimated fair value of financial instruments, except for those recorded at fair value on a recurring basis presented in the previous section of this note titled Recurring Fair Value. When possible, we use quoted market prices to determine fair value. Where quoted market prices are not available, the fair value is internally derived based on appropriate valuation methodologies with respect to the amount and timing of future cash flows and estimated discount rates. However, considerable judgment is required in interpreting current market data to develop the market assumptions and inputs necessary to estimate fair value. As such, the actual amount received to sell an asset or the amount paid to settle a liability could differ from our estimates. Fair value information presented herein was based on information available at March 31, 2026, and December 31, 2025.
Estimated fair value
($ in millions)
Carrying value
Level 1
Level 2
Level 3
Total
March 31, 2026
Financial assets
Held-to-maturity securities
$4,337 $— $4,387 $— $4,387 
Loans held-for-sale, net
337 — — 338 338 
Finance receivables and loans, net
136,350 — — 139,266 139,266 
FHLB/FRB stock (a)
789 — 789 — 789 
Financial liabilities
Deposit liabilities
$40,215 $— $— $40,362 $40,362 
Short-term borrowings
4,126 — — 4,123 4,123 
Long-term debt
17,349 — 12,891 5,469 18,360 
December 31, 2025
Financial assets
Held-to-maturity securities$4,371 $— $4,451 $— $4,451 
Loans held-for-sale, net549 — — 560 560 
Finance receivables and loans, net133,964 — — 137,579 137,579 
FHLB/FRB stock (a)811 — 811 — 811 
Financial liabilities
Deposit liabilities$42,310 $— $— $42,523 $42,523 
Short-term borrowings4,695 — — 4,706 4,706 
Long-term debt17,070 — 12,642 5,707 18,349 
(a)Included in other assets on our Condensed Consolidated Balance Sheet.
In addition to the financial instruments presented in the above table, we have various financial instruments for which the carrying value approximates the fair value due to their short-term nature and limited credit risk. These instruments include cash and cash equivalents, restricted cash, cash collateral, accrued interest receivable, accrued interest payable, trade receivables and payables, on-demand deposit liabilities, and other short-term receivables and payables. Included in cash and cash equivalents are highly liquid investments that are readily convertible to known amounts of cash and which are subject to an insignificant risk of change in value due to interest rate, quoted price, or penalty on withdrawal. Classified as Level 1 under the fair value hierarchy, cash and cash equivalents generally expose us to limited credit risk and are so near maturity that they present insignificant risk of changes in value because of changes in interest rates.
v3.26.1
Offsetting Assets and Liabilities
 3 Months Ended
Mar. 31, 2026
Offsetting [Abstract]  
Offsetting Assets and Liabilities Offsetting Assets and Liabilities
Our derivative contracts and repurchase/reverse repurchase transactions are generally supported by qualifying master netting and master repurchase agreements. These agreements are legally enforceable bilateral agreements that (i) create a single legal obligation for all individual transactions covered by the agreement to the nondefaulting entity upon an event of default of the counterparty, including bankruptcy, insolvency, or similar proceeding, and (ii) provide the nondefaulting entity the right to accelerate, terminate, and close-out on a net basis all transactions under the agreement and to liquidate or set off collateral promptly upon an event of default of the counterparty.
To further mitigate the risk of counterparty default related to derivative instruments, we maintain collateral agreements with certain counterparties. The agreements require both parties to maintain collateral in the event the fair values of the derivative financial instruments meet established thresholds. In the event that either party defaults on the obligation, the secured party may seize the collateral. Generally, our collateral arrangements are bilateral such that we and the counterparty post collateral for the obligation. Contractual terms provide for standard and customary exchange of collateral based on changes in the market value of the outstanding derivatives. A party posts additional collateral when their obligation rises or removes collateral when it falls, such that the net replacement cost of the nondefaulting party is covered in the event of counterparty default.
In certain instances, as it relates to our derivative instruments, we have the option to report derivative assets and liabilities as well as assets and liabilities associated with cash collateral received or delivered that is governed by a master netting agreement on a net basis as long as certain qualifying criteria are met. Similarly, for our repurchase/reverse repurchase transactions, we have the option to report recognized assets and liabilities subject to a master netting agreement on a net basis if certain qualifying criteria are met. At March 31, 2026, these instruments are reported as gross assets and gross liabilities on our Condensed Consolidated Balance Sheet. For additional information on derivative instruments and hedging activities, refer to Note 18.
The composition of offsetting derivative instruments, financial assets, and financial liabilities was as follows.
Gross amounts of recognized assets/liabilitiesGross amounts offset on the Condensed Consolidated Balance SheetNet amounts of assets/liabilities presented on the Condensed Consolidated Balance SheetGross amounts not offset on the Condensed Consolidated Balance Sheet
($ in millions)
Financial instruments
Collateral (a) (b) (c)
Net amount
March 31, 2026
Assets
Derivative assets$3 $— $3 $(1)$(2)$— 
Total assets
$3 $— $3 $(1)$(2)$— 
Liabilities
Derivative liabilities (d)$3 $— $3 $(1)$(1)$1 
Securities sold under agreements to repurchase (e)526 — 526 — (526)— 
Total liabilities$529 $— $529 $(1)$(527)$1 
December 31, 2025
Assets
Derivative assets$— $— $— $— $— $— 
Total assets
$— $— $— $— $— $— 
Liabilities
Derivative liabilities$4 $— $4 $— $(4)$— 
Securities sold under agreements to repurchase (e)545 — 545 — (545)— 
Total liabilities$549 $— $549 $— $(549)$— 
(a)Financial collateral received or pledged shown as a balance based on the sum of all net asset and liability positions between Ally and each individual derivative counterparty.
(b)Amounts disclosed are limited to the financial asset or liability balance and, accordingly, exclude excess collateral received or pledged and noncash collateral received. We do not record noncash collateral received on our Condensed Consolidated Balance Sheet unless certain conditions are met.
(c)Certain agreements grant us the right to sell or pledge the noncash assets we receive as collateral. We have not sold or pledged any of the noncash collateral received under these agreements.
(d)Includes derivative liabilities with no offsetting arrangements of $1 million as of March 31, 2026.
(e)For additional information on securities sold under agreements to repurchase, refer to Note 12.
v3.26.1
Segment Information
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
Operating segments are defined as components of an enterprise that engage in business activity from which revenues are earned and expenses incurred for which discrete financial information is available that is evaluated regularly by our CODM in deciding how to allocate resources and in assessing performance. We define our CODM as the CEO. The CODM uses pretax income to evaluate income generated from segment assets, and to assess a segment’s performance by comparing the results, relative to other segments. Additionally, the budgeting and forecasting process monitors budget versus actual results with emphasis on pretax income, which are also used in assessing the performance of a segment.
We report our results of operations on a business-line basis through three operating segments: Automotive Finance operations, Insurance operations, and Corporate Finance operations, with the remaining activity reported in Corporate and Other. The operating segments are determined based on the products and services offered, and reflect the manner in which financial information is currently evaluated by our CODM and management. The following is a description of each of our reportable operating segments.
Dealer Financial Services
Dealer Financial Services comprises the following two segments.
•Automotive Finance operations — One of the largest full-service automotive finance operations in the United States providing automotive financing services to consumers, automotive dealers and retailers, companies, and municipalities. Our automotive finance services include providing retail installment sales contracts, loans and operating leases, offering term loans to dealers, financing dealer floorplans and other lines of credit to dealers, warehouse lines to automotive retailers, fleet financing, providing financing to companies and municipalities for the purchase or lease of vehicles, and vehicle-remarketing services.
•Insurance operations — A complementary automotive-focused business offering both consumer finance protection and insurance products sold primarily through the automotive dealer channel, and commercial insurance products sold directly to dealers. As part of our focus on offering dealers a broad range of consumer financial and insurance products, we provide VSCs, VMCs, and GAP products. We also underwrite select commercial insurance coverages, which primarily insure dealers’ vehicle inventory.
Corporate Finance operations
Our Corporate Finance operations provide senior secured asset-based and leveraged cash flow loans to primarily U.S.-based middle-market companies, with a focus on businesses owned by private equity sponsors. These loans are typically used for leveraged buyouts, refinancing and recapitalizations, mergers and acquisitions, growth, turnarounds, and debtor-in-possession financings. We also provide, through our Private Credit Finance business, asset managers and other financing sources with partial funding for their direct-lending activities, which is principally leveraged loans. We have a commercial real estate product primarily focused on lending to skilled nursing facilities, senior housing, and medical office buildings. Additionally, we have an energy and infrastructure vertical that finances large-scale energy and infrastructure projects.
Corporate and Other
Corporate and Other primarily consists of centralized corporate treasury activities, such as management of the cash and corporate investment securities and loan portfolios, short- and long-term debt, retail and brokered deposit liabilities, derivative instruments, original issue discount, and the residual impacts of our corporate FTP and treasury ALM activities. Corporate and Other also includes certain equity investments, which primarily consist of FHLB and FRB stock—as well as other equity investments through Ally Ventures, our strategic investment business, and reclassifications and eliminations between the reportable operating segments. Financial results related to Ally Invest, our digital brokerage and advisory offering, Ally Credit Card, the management of our consumer mortgage portfolio, and CRA loans and investments are also included within Corporate and Other. Consumer mortgage originations ceased during the second quarter of 2025, which has and will continue to result in a gradual run-off of our consumer mortgage loan portfolio. Additionally, we closed the sale of Ally Credit Card on April 1, 2025.
We utilize an FTP methodology for the majority of our business operations. The FTP methodology assigns charge rates and credit rates to classes of assets and liabilities on a match funded basis, utilizing a benchmark rate curve plus an assumed credit spread. The assumed credit spread is calculated based on a composite investment grade unsecured yield curve or based on advance rates published by the FHLB for any asset that is eligible to be pledged as collateral to the FHLB. While the baseline FTP components at Ally assume 100% debt funding, the methodology also incorporates a credit on the allocated capital for each business line based on the business line’s allocated cost of funding. For business lines not subject to an FTP funding allocation, the FTP methodology applies a capital charge to the amount of excess equity that the business line holds, relative to its regulatory capital and other adjustments. The net residual impact of the FTP methodology is included within the results of Corporate and Other.
The information presented in our reportable operating segments is based in part on internal allocations and methodologies, including a COH methodology, which involves management judgment. COH methodology is used for measuring the profit and loss of our reportable operating segments. We have various enterprise functions, such as technology, marketing, finance, compliance, internal audit, and risk. Operating expenses from the enterprise functions are either directly allocated to the reportable operating segment, indirectly allocated to the reportable operating segment utilizing the COH methodology, or remain in Corporate and Other. COH methodology considers the reportable operating segment expense base and enterprise function expenses. The reportable operating segment expense base is used to determine the allocation mix. This mix is applied to the allocable expenses in Corporate and Other to determine the COH for the respective reportable operating segment. Allocable enterprise function costs are primarily technology, marketing expenses, and marketing sponsorships. Generally, costs that remain within Corporate and Other that are not allocated to our reportable operating segments include operating costs of deposits, treasury activities, and other corporate activities.
Financial information for our reportable operating segments is summarized as follows.
Three months ended March 31, ($ in millions)
Automotive Finance operationsInsurance operationsCorporate Finance operationsCorporate and OtherConsolidated (a)
2026
Net financing revenue and other interest income
Total financing revenue and other interest income$2,687 $49 $243 $395 $3,374 
Total interest expense1,128 13 130 246 1,517 
Net depreciation expense on operating lease assets268 — — — 268 
Net financing revenue and other interest income1,291 36 113 149 1,589 
Other revenue105 342 35 31 513 
Total net revenue1,396 378 148 180 2,102 
Provision for credit losses468 — 8 (9)467 
Noninterest expense
Compensation and benefits expense191 32 26 242 491 
Insurance losses and loss adjustment expenses— 121 — — 121 
Other operating expenses
Technology and communications expenses28 4 1 68 101 
Other (b)373 193 19 (63)522 
Total other operating expenses401 197 20 5 623 
Total noninterest expense592 350 46 247 1,235 
Income (loss) from continuing operations before income tax expense (benefit)$336 $28 $94 $(58)$400 
Total assets$117,612 $9,888 $13,803 $55,966 $197,269 
2025
Net financing revenue and other interest income
Total financing revenue and other interest income$2,571 $44 $221 $557 $3,393 
Total interest expense1,065 14 117 479 1,675 
Net depreciation expense on operating lease assets240 — — — 240 
Net financing revenue and other interest income1,266 30 104 78 1,478 
Other revenue97 364 29 (427)63 
Total net revenue1,363 394 133 (349)1,541 
Provision for credit losses434 — 14 (257)191 
Noninterest expense
Compensation and benefits expense183 30 25 267 505 
Insurance losses and loss adjustment expenses— 161 — — 161 
Goodwill impairment (c)— — — 305 305 
Other operating expenses
Technology and communications expenses29 5 1 68 103 
Other (b)342 196 17 5 560 
Total other operating expenses371 201 18 73 663 
Total noninterest expense554 392 43 645 1,634 
Income (loss) from continuing operations before income tax expense (benefit)$375 $2 $76 $(737)$(284)
Total assets$111,672 $9,489 $11,002 $61,168 $193,331 
(a)Net financing revenue and other interest income after the provision for credit losses totaled $1.1 billion and $1.3 billion for the three months ended March 31, 2026, and 2025, respectively.
(b)Primarily consists of insurance commissions, advertising and marketing, and property and equipment depreciation expenses. Refer to Note 5 for additional information.
(c)Impairment of goodwill related to Ally Credit Card for the three months ended March 31, 2025. Refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information on Ally Credit Card.
v3.26.1
Contingencies and Other Risks
 3 Months Ended
Mar. 31, 2026
Loss Contingency [Abstract]  
Contingencies and Other Risks Contingencies and Other Risks
As a financial-services company, we are regularly involved in pending or threatened legal proceedings and other matters and are or may be subject to potential liability in connection with them. These legal matters may be formal or informal and include litigation and arbitration with one or more identified claimants, certified or purported class actions with yet-to-be-identified claimants, and regulatory or other governmental information-gathering requests, examinations, investigations, and enforcement proceedings. Our legal matters exist in varying stages of adjudication, arbitration, negotiation, or investigation and span our business lines and operations. Claims may be based in law or equity — such as those arising under contracts or in tort and those involving banking, consumer-protection, securities, tax, employment, and other laws — and some can present novel legal theories and allege substantial or indeterminate damages.
Ally and its subsidiaries, including Ally Bank, also are or may be subject to potential liability under other contingent exposures, including indemnification, domestic and foreign taxes, self-insurance, and other miscellaneous contingencies.
We accrue for a legal matter or other contingent exposure when a loss becomes probable and the amount of loss can be reasonably estimated. Accruals are evaluated each quarter and may be adjusted, upward or downward, based on our best judgment after consultation with counsel. No assurance exists that our accruals will not need to be adjusted in the future. When a probable or reasonably possible loss on a legal matter or other contingent exposure could be material to our consolidated financial condition, results of operations, or cash flows, we provide disclosure in this note as prescribed by ASC Topic 450, Contingencies. Refer to Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information related to our policy for establishing accruals.
The course and outcome of legal matters are inherently unpredictable. This is especially so when a matter is still in its early stages, the damages sought are indeterminate or unsupported, significant facts are unclear or disputed, novel questions of law or other meaningful legal uncertainties exist, a request to certify a proceeding as a class action is outstanding or granted, multiple parties are named, or regulatory or other governmental entities are involved. Other contingent exposures and their ultimate resolution are similarly unpredictable for reasons that can vary based on the circumstances.
As a result, we often are unable to determine how or when threatened or pending legal matters and other contingent exposures will be resolved and what losses may be incrementally and ultimately incurred. Actual losses may be higher or lower than any amounts accrued or estimated for those matters and other exposures, possibly to a significant degree.
Subject to the foregoing, based on our current knowledge and after consultation with counsel, we do not believe that the ultimate outcomes of currently threatened or pending legal matters and other contingent exposures are likely to be material to our consolidated financial condition after taking into account existing accruals. In light of the uncertainties inherent in these matters and other exposures, however, one or more of them could be material to our results of operations or cash flows during a particular reporting period, depending on factors such as the amount of the loss or liability and the level of our income for that period.
v3.26.1
Subsequent Events
 3 Months Ended
Mar. 31, 2026
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
Declaration of Common Dividend
On April 14, 2026, our Board declared a quarterly cash dividend of $0.30 per share on all common stock. The dividend is payable on May 15, 2026, to shareholders of record at the close of business on May 1, 2026.
Series D Preferred Stock Offering and Redemption of Series B Preferred Stock
On May 1, 2026, we issued 1,000,000 shares of 7.100% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series D with $0.01 par value and liquidation preference of $1,000 per share. Dividends, if declared by our Board, will be paid on a non-cumulative basis quarterly, in arrears, at a rate equal to (i) 7.100% from the original issue date to, but excluding, August 15, 2031, and (ii) from the August 15, 2031 dividend date and during each subsequent reset period at a rate per annum equal to the five-year treasury rate plus 3.148%. We intend to treat the Series D Preferred Stock as “Additional Tier 1” capital (or its equivalent) for purposes of the capital adequacy rules of the Federal Reserve (or, as and if applicable, the capital adequacy rules or regulations of any successor appropriate federal banking agency) applicable to us.
On May 4, 2026, we announced that we will redeem all 1,350,000 outstanding shares of our 4.700% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B on May 15, 2026, at a redemption price equal to $1,000 per share plus any declared and unpaid dividends up to, but excluding, the redemption date. This represents 100% of the issued and outstanding Series B Preferred Stock and an aggregate liquidation preference of $1.35 billion.
v3.26.1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2026
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Stephanie N. Richard [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On January 30, 2026, Stephanie N. Richard, Chief Risk Officer, adopted an arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act for the sale of up to 20,000 shares of common stock in the amounts and at prices determined in accordance with the formulae set forth in the arrangement. The arrangement will expire on May 5, 2027, subject to early termination in accordance with the terms of the arrangement.
Name Stephanie N. Richard
Title Chief Risk Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date January 30, 2026
Expiration Date May 5, 2027
Arrangement Duration 460 days
Aggregate Available 20,000
v3.26.1
Description of Business, Basis of Presentation, and Changes in Significant Accounting Policies (Policies)
 3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation
Our accounting and reporting policies conform to U.S. GAAP. Additionally, where applicable, the policies conform to the accounting and reporting guidelines prescribed by bank regulatory authorities. Certain reclassifications may have been made to the prior periods’ financial statements and notes to conform to the current period’s presentation, which did not have a material impact on our Condensed Consolidated Financial Statements. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the related disclosure, including those of contingent assets and liabilities at the date of the financial statements. It also includes estimates related to the income and expenses during the reporting period and the related disclosures. In developing the estimates and assumptions, management uses all available evidence; however, actual results could differ because of uncertainties associated with estimating the amounts, timing, and likelihood of possible outcomes. Our most significant estimates pertain to the allowance for loan losses, the valuations of automotive operating lease assets and residuals, the fair value of financial instruments, and the determination of the provision for income taxes.
Income Taxes
Income Taxes
In calculating the provision for interim income taxes, in accordance with ASC 740, Income Taxes, we apply an estimated annual effective tax rate to year-to-date ordinary income. At the end of each interim period, we estimate the effective tax rate expected to be applicable for the full fiscal year. This method differs from that described in Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K, which describes our annual significant income tax accounting policy and related methodology.
Recently Issued Accounting Standards
Recently Issued Accounting Standards
Expense Disaggregation Disclosures (ASU 2024-03)
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income (Subtopic 220-40): Expense Disaggregation Disclosures. The purpose of this ASU is to provide additional disclosure that will allow investors to better understand an entity’s performance, better assess an entity’s prospects for future cash flows, and more easily compare an entity’s performance over time and in relation to other similar entities. This ASU will require that an entity disclose, on an interim and annual basis, a disaggregation in the notes to the financial statements of certain income statement line items if the line item includes any of the five required expense categories, which are defined as (1) purchases of inventory, (2) employee compensation, (3) depreciation (including amortization of a finance ROU asset and leasehold improvements), (4) intangible asset amortization, and (5) depletion expense. For the “employee compensation” category, banking entities may continue to present compensation expense on the face of the income statement in accordance with Regulation S-X Rule 210.9-04. The disclosure should include a qualitative description of other expenses included within the income statement line item that are otherwise not disaggregated. This ASU will also require entities to disclose their total selling expenses for each reporting period. Selling expenses are not defined within the ASU, which will require entities to determine and disclose how they define selling expenses on an annual basis. The amendments are effective on January 1, 2027, for annual reporting, and for interim reporting thereafter, with early adoption permitted. The amendments must be applied using either a prospective or retrospective approach. We do not expect the impact of these amendments to be material.
Targeted Improvements to the Accounting for Internal-Use Software (ASU 2025-06)
In September 2025, the FASB issued ASU 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The purpose of this ASU is to improve the accounting for internal-use software costs by aligning the accounting with modern software development processes. This ASU removes all references to sequential software development project stages from U.S. GAAP, but does not change the types of costs that are eligible to be capitalized. Under the updated guidance, entities will be required to begin capitalizing software project costs when (1) management has authorized and committed to funding the software project and (2) it is probable that the project will be completed, and the software will be used to perform the function intended (called the “probable-to-complete” threshold). When evaluating whether the probable-to-complete threshold is met, entities must consider whether there is significant development uncertainty associated with the software, including determining whether the software project contains technological innovations or novel, unique, or unproven functions or features. Entities should also consider if there are significant performance requirements (e.g., functions or features) of the software project that have not yet been identified or continue to be substantially revised. The amendments do not define what is considered “significant” and instead will require management judgment. The amendments are effective January 1, 2028, with early adoption permitted. The amendments can be applied using a prospective approach, a retrospective approach, or a modified approach that bases the adoption of the amendments on the completion status of the software project as of the adoption date. We are currently evaluating the impact of these amendments.
Purchased Loans (ASU 2025-08)
In November 2025, the FASB issued ASU 2025-08, Financial Instruments—Credit Losses (Topic 326): Purchased Loans. This ASU expands the gross-up approach applied to PCD financial assets to loans that are purchased and considered seasoned, excluding credit card loans, debt securities, and trade receivables accounted for under the revenue recognition guidance. Under the expanded gross-up approach, the amortized cost basis for a seasoned loan receivable will be the purchase price plus the initial measurement of the allowance for loan losses, on the acquisition date. Any remaining discount embedded in the purchase price will be amortized into interest income over the term of the loan. The purchased seasoned loan designation would be evaluated on a loan-by-loan basis. The resulting accounting will reflect no day-one provision expense on qualifying seasoned loans and a lower yield over time than what is currently presented under the non-PCD model. Loans acquired in a business combination would be considered seasoned. For a loan acquired through an asset transfer or by consolidating a VIE, the acquisition must be at least 90 days after loan origination and the acquirer must not have been involved in originating the loan for the loan to be considered seasoned. The amendments are effective January 1, 2027, with early adoption permitted and must be adopted on a prospective basis. We are currently evaluating the impact of these amendments.
Fair Value Measurements
The following are descriptions of the valuation methodologies used to measure material assets and liabilities at fair value and details of the valuation models, key inputs to those models, and significant assumptions utilized.
•Equity securities — We hold various marketable equity securities measured at fair value with changes in fair value recognized in net income. Measurements based on observable market prices are classified as Level 1.
•Available-for-sale securities — We carry our available-for-sale securities at fair value based on external pricing sources. We classify our securities as Level 1 when fair value is determined using quoted prices available for the same instruments trading in active markets. We classify our securities as Level 2 when fair value is determined using prices for similar instruments trading in active markets. We perform pricing validation procedures for our available-for-sale securities.
•Derivative instruments — We enter into a variety of derivative financial instruments as part of our risk-management strategies. Certain of these derivatives are exchange traded, such as equity options. To determine the fair value of these instruments, we utilize the quoted market prices for those particular derivative contracts; therefore, we classified these contracts as Level 1.
We also execute OTC and centrally cleared derivative contracts, such as interest rate swaps, foreign-currency denominated forward contracts, interest rate options, and agency to-be-announced securities. We utilize third-party-developed valuation models that are widely accepted in the market to value these derivative contracts. The specific terms of the contract and market observable inputs (such as interest rate forward curves, interpolated volatility assumptions, or equity pricing) are used in the model. We classified these derivative contracts as Level 2 because all significant inputs into these models were market observable.
We also entered into interest rate lock commitments and forward commitments that were executed as part of our mortgage operations, certain of which met the accounting definition of a derivative and therefore were recorded as derivatives on our Condensed Consolidated Balance Sheet. Interest rate lock commitments were valued with unobservable inputs, so they are classified as Level 3. Certain forward commitments are Level 2 and others are Level 3 depending on the valuation model inputs.
We purchased automotive finance receivables and loans from third parties as part of forward flow arrangements and, from time-to-time, executed opportunistic ad-hoc bulk purchases. As part of those agreements, we were required to pay the counterparty at agreed upon measurement dates and determinable amounts if actual credit performance of the acquired loans on the measurement date was better than what was estimated at the time of acquisition. Because these contracts met the accounting definition of a derivative, we recognized a liability at fair value for these deferred purchase price payments. The fair value of these liabilities was determined using a discounted cash flow method. To estimate cash flows, we utilized various significant assumptions, including market observable inputs (for example, forward interest rates) and internally developed inputs (for example, prepayment speeds, delinquency levels, and expected credit losses). These liabilities were valued using internal loss models with unobservable inputs, and were classified as Level 3.
We enter into arrangements with certain counterparties through which we issue credit-linked notes covering a specified pool of loans. These notes contain an embedded derivative, which provides us credit protection against the risk of loss when a specified credit event occurs on the reference pool. The embedded derivatives are valued using both market observable inputs and unobservable inputs, as such they are classified as Level 3.
We are required to consider all aspects of nonperformance risk, including our own credit standing, when measuring fair value of derivative assets and liabilities. We reduce credit risk on the majority of our derivatives by entering into legally enforceable agreements that enable the posting and receiving of collateral associated with the fair value of our derivative positions on an ongoing basis. In the event that we do not enter into legally enforceable agreements that enable the posting and receiving of collateral, we will consider our credit risk in the valuation of derivative liabilities through a DVA and the credit risk of our counterparties in the valuation of derivative assets through a CVA, if warranted. When measuring these valuation adjustments, we generally use credit default swap spreads.
v3.26.1
Revenue from Contracts with Customers (Tables)
 3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table presents a disaggregated view of our revenue from contracts with customers. For further information regarding our revenue recognition policies and details about the nature of our respective revenue streams, refer to Note 1 and Note 3 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K.
Three months ended March 31, ($ in millions)
Automotive Finance operationsInsurance operationsCorporate Finance operationsCorporate and OtherConsolidated
2026
Revenue from contracts with customers
Noninsurance contracts (a) (b) (c)$— $242 $— $— $242 
Remarketing fee income32 — — — 32 
Brokerage commissions and other revenue— — — 19 19 
Banking fees and interchange income— — — 5 5 
Brokered/agent commissions— 2 — — 2 
Other6 — — 1 7 
Total revenue from contracts with customers38 244 — 25 307 
All other revenue67 98 35 6 206 
Total other revenue (d)$105 $342 $35 $31 $513 
2025
Revenue from contracts with customers
Noninsurance contracts (a) (b) (c)$— $241 $— $— $241 
Remarketing fee income31 — — — 31 
Brokerage commissions and other revenue— — — 20 20 
Banking fees and interchange income (e)— — — 19 19 
Brokered/agent commissions— 5 — — 5 
Other5 1 — 1 7 
Total revenue from contracts with customers36 247 — 40 323 
All other revenue61 117 29 (467)(260)
Total other revenue (d)$97 $364 $29 $(427)$63 
(a)We had opening balances of $3.0 billion in unearned revenue associated with outstanding contracts at both January 1, 2026, and 2025, and $239 million and $238 million of these balances were recognized as insurance premiums and service revenue earned in our Condensed Consolidated Statement of Comprehensive Income during the three months ended March 31, 2026, and 2025, respectively.
(b)At March 31, 2026, we had unearned revenue of $3.0 billion associated with outstanding contracts, and with respect to this balance we expect to recognize revenue of $653 million during the remainder of 2026, $751 million in 2027, $599 million in 2028, $440 million in 2029, and $544 million thereafter. At March 31, 2025, we had unearned revenue of $3.0 billion associated with outstanding contracts.
(c)We had deferred insurance assets of $1.8 billion at both March 31, 2026, and December 31, 2025, and recognized $138 million of expense during the three months ended March 31, 2026. We had deferred insurance assets of $1.8 billion at both March 31, 2025, and December 31, 2024, and recognized $141 million of expense during the three months ended March 31, 2025.
(d)Represents a component of total net revenue. Refer to Note 22 for further information on our reportable operating segments.
(e)Interchange income is reported net of customer rewards related to Ally Credit Card. Customer rewards expense was $6 million for the three months ended March 31, 2025. We closed the sale of Ally Credit Card on April 1, 2025. Refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information.
v3.26.1
Other Income, Net of Losses (Tables)
 3 Months Ended
Mar. 31, 2026
Other Nonoperating Income (Expense) [Abstract]  
Schedule of Other Income, by Component
Details of other income, net of losses, were as follows.
Three months ended March 31,
($ in millions)20262025
Late charges and other administrative fees$36 $51 
Remarketing fees32 31 
Income from equity-method investments (a)17 26 
Other, net92 89 
Total other income, net of losses (b)$177 $197 
(a)Refer to Note 10 for further information on our equity-method investments.
(b)Includes the activity of Ally Credit Card prior to the sale on April 1, 2025.
v3.26.1
Reserves for Insurance Losses and Loss Adjustment Expenses (Tables)
 3 Months Ended
Mar. 31, 2026
Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net [Abstract]  
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense and Rollforward of Our Reserves for Insurance Losses and Loss Adjustment Expenses
The following table shows a rollforward of our reserves for insurance losses and loss adjustment expenses.
($ in millions)20262025
Total gross reserves for insurance losses and loss adjustment expenses at January 1,$233 $189 
Less: Reinsurance recoverable69 60 
Net reserves for insurance losses and loss adjustment expenses at January 1,164 129 
Net insurance losses and loss adjustment expenses incurred related to:
Current year122 161 
Prior years (a)(1)— 
Total net insurance losses and loss adjustment expenses incurred121 161 
Net insurance losses and loss adjustment expenses paid or payable related to:
Current year(50)(44)
Prior years(55)(54)
Total net insurance losses and loss adjustment expenses paid or payable(105)(98)
Net reserves for insurance losses and loss adjustment expenses at March 31,180 192 
Plus: Reinsurance recoverable (b)71 76 
Total gross reserves for insurance losses and loss adjustment expenses at March 31, (c)$251 $268 
(a)There have been no material adverse changes to the reserve for prior years.
(b)Included in premiums receivable and other insurance assets on our Condensed Consolidated Balance Sheet.
(c)Included in accrued expenses and other liabilities on our Condensed Consolidated Balance Sheet.
v3.26.1
Other Operating Expenses (Tables)
 3 Months Ended
Mar. 31, 2026
Operating Expenses [Abstract]  
Schedule of Other Operating Cost and Expense, by Component
Details of other operating expenses were as follows.
Three months ended March 31,
($ in millions)20262025
Insurance commissions$152 $161 
Technology and communications101 103 
Advertising and marketing60 61 
Property and equipment depreciation59 63 
Lease and loan administration45 46 
Regulatory and licensing fees36 44 
Professional services35 31 
Vehicle remarketing and repossession34 33 
Amortization of intangible assets— 3 
Other101 118 
Total other operating expenses (a)$623 $663 
(a)Includes the activity of Ally Credit Card prior to the sale on April 1, 2025. Refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information.
v3.26.1
Investment Securities (Tables)
 3 Months Ended
Mar. 31, 2026
Investments, Debt and Equity Securities [Abstract]  
Schedule of Investment Portfolio The amortized cost basis, fair value, and gross unrealized gains and losses on available-for-sale and held-to-maturity securities were as follows.
March 31, 2026December 31, 2025
Amortized cost basisGross unrealized
Fair value
Amortized cost basisGross unrealized
Fair value
($ in millions)gainslossesgainslosses
Available-for-sale securities
Debt securities
U.S. Treasury and federal agencies$2,444 $8 $(55)$2,397 $2,308 $22 $(51)$2,279 
U.S. States and political subdivisions593 — (76)517 624 1 (74)551 
Foreign government202 1 (4)199 191 1 (4)188 
Agency mortgage-backed residential (a)14,787 16 (2,108)12,695 14,966 19 (2,084)12,901 
Mortgage-backed residential226 — (33)193 230 — (32)198 
Agency mortgage-backed commercial (a)5,729 8 (630)5,107 5,540 14 (622)4,932 
Asset-backed2 — — 2 12 — — 12 
Corporate debt1,991 8 (71)1,928 1,954 19 (61)1,912 
Total available-for-sale securities (b) (c) (d) (e) (f)$25,974 $41 $(2,977)$23,038 $25,825 $76 $(2,928)$22,973 
Held-to-maturity securities
Debt securities
Agency mortgage-backed residential$1,337 $3 $(157)$1,183 $1,303 $8 $(157)$1,154 
Mortgage-backed residential2,957 203 — 3,160 3,018 228 — 3,246 
Asset-backed retained notes43 1 — 44 50 1 — 51 
Total held-to-maturity securities (d) (f) (g)$4,337 $207 $(157)$4,387 $4,371 $237 $(157)$4,451 
(a)Fair value includes basis adjustments for securities in closed portfolios with active hedges under the portfolio layer method. This includes a $31 million liability and a $13 million asset for agency mortgage-backed residential securities at March 31, 2026, and December 31, 2025, respectively, and a $10 million asset and a $33 million asset for agency mortgage-backed commercial securities at March 31, 2026, and December 31, 2025, respectively. These basis adjustments would be allocated to the amortized cost basis of specific securities within the pool if the hedge was dedesignated. Refer to Note 18 for additional information.
(b)Certain available-for-sale securities are included in fair value hedging relationships. Refer to Note 18 for additional information.
(c)Certain entities related to our Insurance operations are required to deposit securities with state regulatory authorities. These deposited securities totaled $14 million at both March 31, 2026, and December 31, 2025.
(d)Investment securities with a fair value of $3.5 billion and $3.7 billion were pledged as collateral at March 31, 2026, and December 31, 2025, respectively. This primarily included $2.7 billion pledged to secure advances from the FHLB at both March 31, 2026, and December 31, 2025. This also included securities pledged for other purposes as required by contractual obligations or law, under which agreements we granted the counterparty the right to sell or pledge $866 million and $932 million of the underlying available-for-sale securities at March 31, 2026, and December 31, 2025, respectively.
(e)Totals do not include accrued interest receivable, which was $86 million and $87 million at March 31, 2026, and December 31, 2025, respectively. Accrued interest receivable is included in other assets on our Condensed Consolidated Balance Sheet.
(f)There was no allowance for credit losses recorded at both March 31, 2026, and December 31, 2025, as management determined that there were no expected credit losses in our portfolio of available-for-sale and held-to-maturity securities.
(g)Totals do not include accrued interest receivable, which was $12 million and $13 million at March 31, 2026, and December 31, 2025, respectively. Accrued interest receivable is included in other assets on our Condensed Consolidated Balance Sheet.
Schedule of Investments Classified by Contractual Maturity Date
The maturity distribution of debt securities outstanding is summarized in the following tables based upon contractual maturities. Call or prepayment options may cause actual maturities to differ from contractual maturities.
TotalDue in one year or lessDue after one year through five yearsDue after five years through ten yearsDue after ten years
($ in millions)AmountYieldAmountYieldAmountYieldAmountYieldAmountYield
March 31, 2026
Fair value of available-for-sale securities (a)
U.S. Treasury and federal agencies$2,397 3.5 %$68 1.5 %$2,050 3.7 %$279 2.3 %$— — %
U.S. States and political subdivisions517 3.4 39 5.1 54 3.7 53 4.5 371 3.1 
Foreign government199 2.8 14 1.9 92 2.3 93 3.4 — — 
Agency mortgage-backed residential (b)12,695 2.9 — — 1 2.8 — — 12,694 2.9 
Mortgage-backed residential193 2.7 — — — — — — 193 2.7 
Agency mortgage-backed commercial (b)5,107 2.7 144 3.1 1,647 3.3 2,491 2.4 825 2.3 
Asset-backed2 1.5 1 1.5 1 1.3 — — — — 
Corporate debt1,928 3.6 214 2.6 892 2.5 700 4.9 122 5.4 
Total available-for-sale securities$23,038 3.0 $480 2.8 $4,737 3.3 $3,616 3.0 $14,205 2.9 
Amortized cost basis of available-for-sale securities$25,974 $483 $4,871 $4,046 $16,574 
Amortized cost basis of held-to-maturity securities (c)
Agency mortgage-backed residential$1,337 3.5 %$— — %$— — %$— — %$1,337 3.5 %
Mortgage-backed residential2,957 2.8 — — 4 2.9 1 5.3 2,952 2.8 
Asset-backed retained notes
43 5.4 — — 30 5.3 13 5.7 — — 
Total held-to-maturity securities
$4,337 3.0 $— — $34 5.0 $14 5.7 $4,289 3.0 
December 31, 2025
Fair value of available-for-sale securities (a)
U.S. Treasury and federal agencies$2,279 3.4 %$84 0.8 %$1,771 3.9 %$424 2.0 %$— — %
U.S. States and political subdivisions551 3.4 48 4.8 50 3.7 65 4.3 388 3.1 
Foreign government188 2.8 14 2.0 75 2.3 99 3.3 — — 
Agency mortgage-backed residential (b)12,901 2.9 — — 1 2.8 — — 12,900 2.9 
Mortgage-backed residential198 2.7 — — — — — — 198 2.7 
Agency mortgage-backed commercial (b)4,932 2.7 87 3.4 1,453 3.5 2,314 2.4 1,078 2.3 
Asset-backed12 1.5 — — 12 1.5 — — — — 
Corporate debt1,912 3.4 232 2.4 866 2.5 679 4.6 135 5.5 
Total available-for-sale securities$22,973 3.0 $465 2.5 $4,228 3.4 $3,581 2.9 $14,699 2.9 
Amortized cost basis of available-for-sale securities$25,825 $468 $4,298 $3,968 $17,091 
Amortized cost basis of held-to-maturity securities (c)
Agency mortgage-backed residential
$1,303 3.5 %$— — %$— — %$— — %$1,303 3.5 %
Mortgage-backed residential3,018 2.8 — — 5 2.9 1 5.5 3,012 2.8 
Asset-backed retained notes
50 5.4 — — 35 5.3 15 5.7 — — 
Total held-to-maturity securities
$4,371 3.0 $— — $40 5.0 $16 5.7 $4,315 3.0 
(a)Yield is calculated using the effective yield of each security at the end of the period, weighted based on the fair value by security for the securities within each maturity distribution range. The effective yield considers the contractual coupon and amortized cost basis inclusive of hedge basis adjustments for dedesignated hedges, and excludes expected capital gains and losses. Yield does not consider hedging effects for securities in active hedges.
(b)Fair value includes basis adjustments for securities in closed portfolios with active hedges under the portfolio layer method. This includes a $31 million liability and a $13 million asset for agency mortgage-backed residential securities at March 31, 2026, and December 31, 2025, respectively, and a $10 million asset and a $33 million asset for agency mortgage-backed commercial securities at March 31, 2026, and December 31, 2025, respectively. These basis adjustments would be allocated to the amortized cost basis of specific securities within the pool if the hedge was dedesignated. Refer to Note 18 for additional information.
(c)Yield is calculated using the effective yield of each security at the end of the period, weighted based on amortized cost basis by security for the securities within each maturity distribution range. The effective yield considers the contractual coupon and amortized cost basis and excludes capital gains, capital losses, and the premium or discount on securities transferred from available-for-sale to held-to-maturity.
Schedule of Investment Income
The following table presents interest and dividends on investment securities.
Three months ended March 31,
($ in millions)20262025
Taxable interest$214 $210 
Taxable dividends4 5 
Interest and dividends exempt from U.S. federal income tax5 6 
Interest and dividends on investment securities$223 $221 
Schedule of Realized Gain (Loss)
The following table presents gross gains and losses realized upon the sales of available-for-sale securities, and net gains or losses on equity securities held during the period.
Three months ended March 31,
($ in millions)20262025
Available-for-sale securities
Gross realized gains$3 $— 
Gross realized losses (a)— (495)
Net realized gain (loss) on available-for-sale securities3 (495)
Net realized gain on equity securities35 8 
Net unrealized loss on equity securities(59)(12)
Other loss on investments, net$(21)$(499)
(a)Includes losses reclassified from accumulated other comprehensive loss related to the balance sheet repositioning of our available-for-sale securities portfolio during the three months ended March 31, 2025.
Schedule of Held to Maturity Debt Securities by Credit Quality
The following table presents the credit quality of our held-to-maturity securities, based on the latest available information as of March 31, 2026, and December 31, 2025. The credit ratings are sourced from nationally recognized statistical rating organizations, which include S&P, Moody’s, Fitch, and DBRS. The ratings presented are a composite of the ratings sourced from the agencies or, if the ratings cannot be sourced from the agencies, are based on the asset type of the particular security. All our held-to-maturity securities were current in their payment of principal and interest as of both March 31, 2026, and December 31, 2025. We have not recorded any interest income reversals on our held-to-maturity securities during the three months ended March 31, 2026, or March 31, 2025.
($ in millions)AAAAAABBBTotal (a)
March 31, 2026
Debt securities
Agency mortgage-backed residential$— $1,337 $— $— $1,337 
Mortgage-backed residential2,893 63 1 — 2,957 
Asset-backed retained notes38 3 1 1 43 
Total held-to-maturity securities$2,931 $1,403 $2 $1 $4,337 
December 31, 2025
Debt securities
Agency mortgage-backed residential$— $1,303 $— $— $1,303 
Mortgage-backed residential2,951 66 1 — 3,018 
Asset-backed retained notes45 2 2 1 50 
Total held-to-maturity securities$2,996 $1,371 $3 $1 $4,371 
(a)Rating agencies indicate that they base their ratings on many quantitative and qualitative factors, which may include capital adequacy, liquidity, asset quality, business mix, level and quality of earnings, and the current operating, legislative, and regulatory environment. A credit rating is not a recommendation to buy, sell, or hold securities, and the ratings are subject to revision or withdrawal at any time by the assigning rating agency.
Schedule of Available-for-Sale Securities in Unrealized Loss Position
The following table summarizes available-for-sale securities in an unrealized loss position, which we evaluated to determine if a credit loss exists requiring the recognition of an allowance for credit losses. For additional information on our methodology, refer to Note 1. As of March 31, 2026, and December 31, 2025, we did not have the intent to sell available-for-sale securities in an unrealized loss position and we do not believe it is more likely than not that we will be required to sell these securities before recovery of their amortized cost basis. We have not recorded any interest income reversals on our available-for-sale securities during the three months ended March 31, 2026, or March 31, 2025.
March 31, 2026December 31, 2025
Less than 12 months12 months or longerLess than 12 months12 months or longer
($ in millions)
Fair value
Unrealized loss
Fair value
Unrealized loss
Fair valueUnrealized lossFair valueUnrealized loss
Available-for-sale securities
Debt securities
U.S. Treasury and federal agencies$267 $(1)$572 $(54)$— $— $609 $(51)
U.S. States and political subdivisions47 (1)398 (75)24 — 429 (74)
Foreign government91 (1)67 (3)51 (1)72 (3)
Agency mortgage-backed residential (a)552 (7)9,938 (2,101)120 — 10,310 (2,084)
Mortgage-backed residential— — 193 (33)— — 198 (32)
Agency mortgage-backed commercial (a)678 (6)3,548 (624)299 (1)3,629 (621)
Asset-backed— — 2 — — — 12 — 
Corporate debt423 (7)1,030 (64)86 (1)1,123 (60)
Total available-for-sale securities
$2,058 $(23)$15,748 $(2,954)$580 $(3)$16,382 $(2,925)
(a)Includes basis adjustments for certain securities that are included in closed portfolios with active hedges under the portfolio layer method at March 31, 2026, and December 31, 2025. The basis adjustments would be allocated to the amortized cost basis of specific securities within the pool if the hedge was dedesignated. Refer to Note 18 for additional information.
v3.26.1
Finance Receivables and Loans, Net (Tables)
 3 Months Ended
Mar. 31, 2026
Receivables [Abstract]  
Schedule of Accounts, Notes, Loans and Financing Receivable
The composition of finance receivables and loans reported at amortized cost basis was as follows.
($ in millions)March 31, 2026December 31, 2025
Consumer automotive (a)$86,662 $85,568 
Consumer mortgage (b)15,311 15,572 
Total consumer101,973 101,140 
Commercial
Commercial and industrial
Automotive18,972 18,339 
Other11,093 10,309 
Commercial real estate7,852 7,666 
Total commercial37,917 36,314 
Total finance receivables and loans (c) (d)$139,890 $137,454 
(a)Certain finance receivables and loans are included in fair value hedging relationships. Refer to Note 18 for additional information.
(b)Includes loans originated as interest-only mortgage loans of $2 million at both March 31, 2026, and December 31, 2025, of which all have exited the interest-only period.
(c)Totals include net unearned income, unamortized premiums and discounts, and deferred fees and costs of $2.5 billion and $2.4 billion at March 31, 2026, and December 31, 2025, respectively.
(d)Totals do not include accrued interest receivable, which was $790 million and $800 million at March 31, 2026, and December 31, 2025, respectively. Accrued interest receivable is included in other assets on our Condensed Consolidated Balance Sheet.
Schedule of Allowance for Credit Losses on Financing Receivables
The following tables present an analysis of the activity in the allowance for loan losses on finance receivables and loans for the three months ended March 31, 2026, and 2025, respectively.
Three months ended March 31, 2026 ($ in millions)
Consumer automotiveConsumer mortgageCommercialTotal
Allowance at January 1, 2026$3,208 $12 $270 $3,490 
Charge-offs (a)(671)— (1)(672)
Recoveries247 8 — 255 
Net charge-offs(424)8 (1)(417)
Provision for credit losses467 (9)9 467 
Other(1)— 1 — 
Allowance at March 31, 2026
$3,250 $11 $279 $3,540 
(a)Refer to Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for information regarding our charge-off policies.
Three months ended March 31, 2025 ($ in millions)
Consumer automotiveConsumer mortgageConsumer other (a)CommercialTotal
Allowance at January 1, 2025$3,170 $19 $319 $206 $3,714 
Charge-offs (b)(676)— (68)(1)(745)
Recoveries231 1 5 1 238 
Net charge-offs(445)1 (63)— (507)
Provision for credit losses418 — (257)30 191 
Other1 (2)1 — — 
Allowance at March 31, 2025
$3,144 $18 $— $236 $3,398 
(a)Consists of Credit Card. We closed the sale of Ally Credit Card on April 1, 2025. Refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information.
(b)Refer to Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for information regarding our charge-off policies.
Schedule of Sales of Financing Receivables and Loans
The following table presents sales of finance receivables and loans and transfers of finance receivables and loans from held-for-investment to held-for-sale based on net carrying value.
Three months ended March 31,
($ in millions)20262025
Consumer other (a)$— $2,248 
Commercial7 73 
Total sales and transfers$7 $2,321 
(a)Consists of credit card finance receivables and loans. We closed the sale of Ally Credit Card on April 1, 2025. Refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information.
Schedule of Purchases of Financing Receivables and Loans
The following table presents purchases of finance receivables and loans based on unpaid principal balance at the time of purchase.
Three months ended March 31,
($ in millions)20262025
Consumer automotive$1,622 $749 
Consumer mortgage— 8
Commercial2 — 
Total purchases of finance receivables and loans$1,624 $757 
Schedule of Financing Receivables, Nonaccrual Status
The following tables present the amortized cost basis of our finance receivables and loans on nonaccrual status. All consumer or commercial finance receivables and loans that were 90 days or more past due were on nonaccrual status as of March 31, 2026, and December 31, 2025. Refer to Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information on our accounting policy for finance receivables and loans on nonaccrual status.
March 31, 2026
($ in millions)Nonaccrual status at Jan. 1, 2026Nonaccrual statusNonaccrual with no allowance (a)
Consumer automotive$1,155 $1,128 $410 
Consumer mortgage62 62 40 
Total consumer1,217 1,190 450 
Commercial
Commercial and industrial
Automotive15 3 3 
Other124 112 3 
Commercial real estate10 1 1 
Total commercial149 116 7 
Total finance receivables and loans (b)$1,366 $1,306 $457 
(a)Represents a component of nonaccrual status at end of period.
(b)We recorded interest income from cash payments associated with finance receivables and loans on nonaccrual status of $13 million for the three months ended March 31, 2026.
December 31, 2025
($ in millions)Nonaccrual status at Jan. 1, 2025Nonaccrual statusNonaccrual with no allowance (a)
Consumer automotive$1,231 $1,155 $416 
Consumer mortgage54 62 44 
Consumer other (b)90 — — 
Total consumer1,375 1,217 460 
Commercial
Commercial and industrial
Automotive15 15 15 
Other (c)94 124 — 
Commercial real estate2 10 10 
Total commercial111 149 25 
Total finance receivables and loans (d)$1,486 $1,366 $485 
(a)Represents a component of nonaccrual status at end of period.
(b)Consists of credit card finance receivables and loans. We closed the sale of Ally Credit Card on April 1, 2025.
(c)Includes PCD loans acquired during the year ended December 31, 2025.
(d)We recorded interest income from cash payments associated with finance receivables and loans on nonaccrual status of $4 million for the three months ended March 31, 2025.
Schedule of Financing Receivable Credit Quality Indicators
The following tables present the amortized cost basis of our consumer finance receivables and loans by credit quality indicator based on delinquency status and origination year.
Origination yearRevolving loans converted to term
March 31, 2026 ($ in millions)
202620252024202320222021 and priorRevolving loansTotal
Consumer automotive
Current$10,303 $30,792 $17,844 $11,317 $7,695 $4,750 $— $— $82,701 
30–59 days past due24 563 567 529 477 356 — — 2,516 
60–89 days past due1 200 236 236 226 153 — — 1,052 
90 or more days past due— 83 90 89 86 69 — — 417 
Total consumer automotive (a)10,328 31,638 18,737 12,171 8,484 5,328 — — 86,686 
Consumer mortgage
Current— — 12 26 1,670 13,506 — 7 15,221 
30–59 days past due— — — — 3 35 — — 38 
60–89 days past due— — — 1 1 8 — — 10 
90 or more days past due— — — 1 5 34 — 2 42 
Total consumer mortgage— — 12 28 1,679 13,583 — 9 15,311 
Total consumer$10,328 $31,638 $18,749 $12,199 $10,163 $18,911 $— $9 $101,997 
(a)Certain consumer automotive loans are included in fair value hedging relationships. The amortized cost basis excludes a liability of $24 million related to basis adjustments for loans in closed portfolios with active hedges under the portfolio layer method at March 31, 2026. These basis adjustments would be allocated to the amortized cost basis of specific loans within the pool if the hedge was dedesignated. Refer to Note 18 for additional information.
Origination yearRevolving loans converted to term
December 31, 2025 ($ in millions)
202520242023202220212020 and priorRevolving loansTotal
Consumer automotive
Current$33,588 $19,891 $12,759 $8,885 $4,253 $1,696 $— $— $81,072 
30–59 days past due483 638 632 600 339 137 — — 2,829 
60–89 days past due156 272 295 284 148 60 — — 1,215 
90 or more days past due55 99 103 101 59 29 — — 446 
Total consumer automotive (a)34,282 20,900 13,789 9,870 4,799 1,922 — — 85,562 
Consumer mortgage
Current— 15 28 1,690 9,117 4,618 — 7 15,475 
30–59 days past due— — 2 5 11 17 — — 35 
60–89 days past due— — — 1 6 7 — — 14 
90 or more days past due— — — 5 16 25 — 2 48 
Total consumer mortgage— 15 30 1,701 9,150 4,667 — 9 15,572 
Total consumer$34,282 $20,915 $13,819 $11,571 $13,949 $6,589 $— $9 $101,134 
(a)Certain consumer automotive loans are included in fair value hedging relationships. The amortized cost basis excludes an asset of $6 million related to basis adjustments for loans in closed portfolios with active hedges under the portfolio layer method at December 31, 2025. These basis adjustments would be allocated to the amortized cost basis of specific loans within the pool if the hedge was dedesignated. Refer to Note 18 for additional information.
The following tables present the amortized cost basis of our commercial finance receivables and loans by credit quality indicator based on risk rating and origination year.
Origination yearRevolving loans converted to term
March 31, 2026 ($ in millions)
202620252024202320222021 and priorRevolving loansTotal
Commercial
Commercial and industrial
Automotive
Pass$630 $923 $340 $243 $254 $167 $14,816 $— $17,373 
Special mention— 5 — 15 9 5 1,509 — 1,543 
Substandard— — 1 — 1 — 54 — 56 
Total automotive630 928 341 258 264 172 16,379 — 18,972 
Other
Pass256 684 596 193 235 368 7,124 228 9,684 
Special mention— 69 71 — 262 368 390 6 1,166 
Substandard— — — — — 80 51 — 131 
Doubtful— — — — — 93 19 — 112 
Total other256 753 667 193 497 909 7,584 234 11,093 
Commercial real estate
Pass389 2,079 998 754 1,032 2,166 66 69 7,553 
Special mention7 22 45 35 65 105 — — 279 
Substandard— — — 2 15 1 — — 18 
Doubtful— — — 2 — — — — 2 
Total commercial real estate396 2,101 1,043 793 1,112 2,272 66 69 7,852 
Total commercial$1,282 $3,782 $2,051 $1,244 $1,873 $3,353 $24,029 $303 $37,917 
Origination yearRevolving loans converted to term
December 31, 2025 ($ in millions)
202520242023202220212020 and priorRevolving loansTotal
Commercial
Commercial and industrial
Automotive
Pass$942 $391 $257 $266 $113 $86 $14,861 $— $16,916 
Special mention2 1 15 10 — 5 1,328 — 1,361 
Substandard1 1 — 1 — — 59 — 62 
Total automotive945 393 272 277 113 91 16,248 — 18,339 
Other
Pass757 594 173 306 215 166 6,647 191 9,049 
Special mention— 47 — 236 115 260 347 8 1,013 
Substandard— — — — 20 61 42 — 123 
Doubtful— — — — — 107 17 — 124 
Total other757 641 173 542 350 594 7,053 199 10,309 
Commercial real estate
Pass1,981 1,069 759 1,080 919 1,461 55 59 7,383 
Special mention— 45 44 67 45 61 — — 262 
Substandard— — 2 15 — 1 — — 18 
Doubtful— — 2 1 — — — — 3 
Total commercial real estate1,981 1,114 807 1,163 964 1,523 55 59 7,666 
Total commercial$3,683 $2,148 $1,252 $1,982 $1,427 $2,208 $23,356 $258 $36,314 
The following tables present gross charge-offs of our finance receivables and loans for each portfolio class by origination year during the three months ended March 31, 2026, and during the year ended December 31, 2025, respectively. Refer to Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information on our charge-off policy.
Origination yearRevolving loans converted to term
March 31, 2026 ($ in millions)
202620252024202320222021 and priorRevolving loansTotal
Consumer automotive$1 $147 $162 $158 $125 $78 $— $— $671 
Total consumer1 147 162 158 125 78 — — 671 
Commercial
Commercial and industrial
Other— — — — — 1 — — 1 
Total commercial— — — — — 1 — — 1 
Total finance receivables and loans$1 $147 $162 $158 $125 $79 $— $— $672 
Origination yearRevolving loans converted to term
December 31, 2025 ($ in millions)
202520242023202220212020 and priorRevolving loansTotal
Consumer automotive$168 $564 $747 $660 $318 $153 $— $— $2,610 
Consumer mortgage (a)— — — 1 1 1 — — 3 
Consumer other (b)— — — — — — 64 4 68 
Total consumer168 564 747 661 319 154 64 4 2,681 
Commercial
Commercial and industrial
Automotive— — — — 1 — 1 — 2 
Total commercial— — — — 1 — 1 — 2 
Total finance receivables and loans$168 $564 $747 $661 $320 $154 $65 $4 $2,683 
(a)Excludes $5 million of write-downs from transfers to held-for-sale during the year ended December 31, 2025.
(b)Consists of Credit Card. We closed the sale of Ally Credit Card on April 1, 2025.
Schedule of Past Due Financing Receivables
The following table presents an analysis of our past-due commercial finance receivables and loans recorded at amortized cost basis.
($ in millions)30–59 days past due60–89 days past due90 days or more past dueTotal past dueCurrentTotal finance receivables and loans
March 31, 2026
Commercial
Commercial and industrial
Automotive$— $— $— $— $18,972 $18,972 
Other— — 71 71 11,022 11,093 
Commercial real estate— — 2 2 7,850 7,852 
Total commercial$— $— $73 $73 $37,844 $37,917 
December 31, 2025
Commercial
Commercial and industrial
Automotive$— $— $— $— $18,339 $18,339 
Other— — 70 70 10,239 10,309 
Commercial real estate— — 3 3 7,663 7,666 
Total commercial$— $— $73 $73 $36,241 $36,314 
Schedule of Loan Modifications
The following tables present the amortized cost basis of loans that were modified subsequent to origination during the three months ended March 31, 2026, and 2025, respectively, for each portfolio segment, by modification type. For additional information on loan modification types in scope of this disclosure, refer to Note 1 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K. The below tables exclude consumer mortgage finance receivables and loans currently enrolled in a trial modification program. Trial modifications generally represent a three-month period during which the borrower makes monthly payments under the anticipated modified payment terms. If the borrower successfully completes the trial loan modification program, the contractual terms of the loan are updated and the modification is considered permanent. As of March 31, 2026, and December 31, 2025, there were $9 million and $8 million of consumer mortgage finance receivables and loans in a trial modification program, respectively.
Payment extensions
Three months ended March 31, 2026
($ in millions)
Payment deferralsContractual maturity extensionsPrincipal forgivenessInterest rate concessionsCombinationTotal (a)
Consumer automotive$— $199 $3 $— $— $202 
Consumer mortgage— 1 — — 2 3 
Total consumer— 200 3 — 2 205 
Commercial
Commercial and industrial
Automotive7 — — — — 7 
Other— 54 — — — 54 
Total commercial7 54 — — — 61 
Total finance receivables and loans$7 $254 $3 $— $2 $266 
(a)Represents 0.2% of total finance receivables and loans outstanding as of March 31, 2026.
Payment extensions
Three months ended March 31, 2025
($ in millions)
Payment deferralsContractual maturity extensionsPrincipal forgivenessInterest rate concessionsCombinationTotal (a)
Consumer automotive$— $105 $1 $— $— $106 
Consumer mortgage— — — — 1 1 
Total consumer— 105 1 — 1 107 
Commercial
Commercial and industrial
Automotive2 — — — — 2 
Other4 22 — — — 26 
Total commercial6 22 — — — 28 
Total finance receivables and loans$6 $127 $1 $— $1 $135 
(a)Represents 0.1% of total finance receivables and loans outstanding as of March 31, 2025.
The following tables present the financial effect of loan modifications that occurred during the three months ended March 31, 2026, and 2025, respectively.
Payment extensions (a)Principal forgivenessInterest rate concessions (a)Combination (a) (b) (c)
Three months ended
March 31, 2026
($ in millions)
Number of months extended/deferredAmount forgivenInitial rateRevised rateRemaining termRevised remaining termInitial rateRevised rate
Consumer automotive36$1 — %— %— — — %— %
Consumer mortgage204— — — 2914023.8 2.0 
Commercial
Commercial and industrial
Automotive7$— — %— %— — — %— %
Other20— — — — — — — 
Total commercial18$— — — — — — — 
(a)Calculated using a weighted-average balance for each portfolio class.
(b)Term is presented in number of months.
(c)Some consumer mortgage combination loan modifications include deferrals of principal. The weighted average number of months deferred for these loans was 159 months.
Payment extensions (a)Principal forgivenessInterest rate concessions (a)Combination (a) (b)
Three months ended
March 31, 2025
($ in millions)
Number of months extended/deferredAmount forgivenInitial rateRevised rateRemaining termRevised remaining termInitial rateRevised rate
Consumer automotive29$— — %— %— — — %— %
Consumer mortgage— — — — 2914804.5 2.8 
Commercial
Commercial and industrial
Automotive7$— — %— %——— %— %
Other16— — — ——— — 
Total commercial15$— — — ——— — 
(a)Calculated using a weighted-average balance for each portfolio class.
(b)Term is presented in number of months.
The following tables present the subsequent performance of loans recorded at amortized cost basis, by portfolio segment and credit quality indicator, that were modified within the 12 months prior to March 31, 2026, and 2025, respectively.
March 31, 2026 ($ in millions)
Current30–59 days past due60–89 days past due90 or more days past dueTotal
Consumer automotive
Contractual maturity extensions$585 $97 $33 $9 $724 
Principal forgiveness— — 1 8 9 
Combination1 — — — 1 
Total consumer automotive586 97 34 17 734 
Consumer mortgage
Payment deferrals— 1 — — 1 
Contractual maturity extensions2 1 — — 3 
Interest rate concessions— — — 1 1 
Combination6 — — — 6 
Total consumer mortgage8 2 — 1 11 
Total consumer$594 $99 $34 $18 $745 
March 31, 2026 ($ in millions)
PassSpecial mentionSubstandardDoubtfulTotal
Commercial and industrial
Automotive
Payment deferrals$— $— $7 $— $7 
Interest rate concessions— — 13 — 13 
Total automotive— — 20 — 20 
Other
Payment deferrals35 — — — 35 
Contractual maturity extensions74 71 19 — 164 
Total other109 71 19 — 199 
Commercial real estate
Payment deferrals— 3 — — 3 
Interest rate concessions— — 7 — 7 
Total commercial real estate— 3 7 — 10 
Total commercial$109 $74 $46 $— $229 
March 31, 2025 ($ in millions)
Current30–59 days past due60–89 days past due90 or more days past dueTotal
Consumer automotive
Contractual maturity extensions$328 $62 $23 $7 $420 
Principal forgiveness— — — 5 5 
Combination2 — — — 2 
Total consumer automotive330 62 23 12 427 
Consumer mortgage
Contractual maturity extensions1 — — 1 2 
Combination1 — — — 1 
Total consumer mortgage2 — — 1 3 
Total consumer$332 $62 $23 $13 $430 
March 31, 2025 ($ in millions)
PassSpecial mentionSubstandardDoubtfulTotal
Commercial and industrial
Automotive
Payment deferrals $— $— $4 $— $4 
Combination— — — 3 3 
Total automotive— — 4 3 7 
Other
Payment deferrals— — 4 — 4 
Contractual maturity extensions25 — 22 — 47 
Combination— — 14 — 14 
Total other25 — 40 — 65 
Commercial real estate
Payment deferrals— — — 1 1 
Total commercial real estate— — — 1 1 
Total commercial$25 $— $44 $4 $73 
v3.26.1
Leasing (Tables)
 3 Months Ended
Mar. 31, 2026
Leases [Abstract]  
Schedule of Lessee, Operating Lease, Liability, Maturity
The following table presents future minimum rental payments we are required to make under operating leases that have commenced as of March 31, 2026, and that have noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$29 
202733 
202828 
202910 
20309 
2031 and thereafter24 
Total undiscounted cash flows133 
Difference between undiscounted cash flows and discounted cash flows(12)
Total lease liability$121 
Schedule of Lease, Cost
The following table details the components of total net operating lease expense.
Three months ended March 31,
($ in millions)20262025
Operating lease expense$8 $8 
Variable lease expense2 1 
Total lease expense, net (a)$10 $9 
(a)Included in other operating expenses in our Condensed Consolidated Statement of Comprehensive Income.
Schedule of Property Subject to or Available for Operating Lease
The following table details our investment in operating leases.
($ in millions)March 31, 2026December 31, 2025
Vehicles$10,131 $10,163 
Accumulated depreciation(1,432)(1,391)
Investment in operating leases, net$8,699 $8,772 
Schedule of Lessor, Operating Lease, Payments to be Received, Maturity
The following table presents future minimum rental payments we have the right to receive under operating leases with noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$1,118 
20271,041 
2028460 
202975 
20303 
Total lease payments from operating leases$2,697 
Schedule of Depreciation Expense on Operating Lease Assets The following table summarizes the components of depreciation expense on operating lease assets.
Three months ended March 31,
($ in millions)20262025
Depreciation expense on operating lease assets (excluding remarketing losses) (a)$258 $221 
Remarketing losses, net10 19 
Net depreciation expense on operating lease assets$268 $240 
(a)Includes variable lease payments related to excess mileage and excessive wear and tear on vehicles of $5 million and $6 million during the three months ended March 31, 2026, and 2025, respectively.
Schedule of Finance Lease, Liability, Maturity
The following table presents future minimum rental payments we have the right to receive under finance leases with noncancelable lease terms expiring after March 31, 2026.
($ in millions)
2026$102 
2027123 
202895 
202966 
203038 
2031 and thereafter15 
Total undiscounted cash flows439 
Difference between undiscounted cash flows and discounted cash flows(64)
Present value of lease payments recorded as lease receivable$375 
v3.26.1
Securitizations and Variable Interest Entities (Tables)
 3 Months Ended
Mar. 31, 2026
Securitizations And Variable Interest Entities [Abstract]  
Schedule of Variable Interest Entities
The following table presents our involvement in consolidated and nonconsolidated VIEs in which we hold variable interests. We have excluded certain transactions with nonconsolidated entities from the balances presented in the table below, where our only continuing involvement relates to financial interests obtained through the ordinary course of business, primarily from lending and investing arrangements. For additional detail related to the assets and liabilities of consolidated variable interest entities, refer to our Condensed Consolidated Balance Sheet.
($ in millions)Carrying value of total assetsCarrying value of total liabilitiesAssets sold to nonconsolidated VIEs (a)Maximum exposure to loss in nonconsolidated VIEs
March 31, 2026
On‑balance sheet variable interest entities
Consumer automotive$12,625 (b)$2,191 (c)$— $— 
Off-balance sheet variable interest entities
Consumer automotive (d)46 (e)— 3,379 3,425 (f)
Commercial other2,778 (g)736 (h)— 3,539 (i)
Total$15,449 $2,927 $3,379 $6,964 
December 31, 2025
On-balance sheet variable interest entities
Consumer automotive$12,149 (b)$1,619 (c)$— $— 
Off-balance sheet variable interest entities
Consumer automotive (d)53 (e)— 3,192 3,245 (f)
Commercial other2,822 (g)820 (h)— 3,690 (i)
Total$15,024 $2,439 $3,192 $6,935 
(a)Represents the current unpaid principal balance of outstanding consumer automotive finance receivables and loans within the VIEs.
(b)Includes $8.9 billion of assets that were not encumbered by VIE beneficial interests held by third parties at both March 31, 2026, and December 31, 2025. Ally or consolidated affiliates hold the interests in these assets.
(c)Includes $131 million and $137 million of liabilities that were not obligations to third-party beneficial interest holders at March 31, 2026, and December 31, 2025, respectively.
(d)Includes activity where we sell loans through a pass-through program to a third party.
(e)Represents retained notes and certificated residual interests, of which $43 million and $50 million were classified as held-to-maturity securities at March 31, 2026, and December 31, 2025, respectively, and $3 million were classified as other assets at both March 31, 2026, and December 31, 2025. These assets represent our compliance with the risk retention rules under the Dodd-Frank Act, requiring us to retain at least five percent of the credit risk of the assets underlying asset-backed securitizations.
(f)Maximum exposure to loss represents the current unpaid principal balance of outstanding loans based on our customary representation and warranty provisions. This measure is based on the unlikely event that all the loans have underwriting defects or other defects that trigger a representation and warranty provision and the collateral supporting the loans are worthless. This required disclosure is not an indication of our expected loss.
(g)Amounts are classified as other assets except for $57 million and $56 million classified as equity securities at March 31, 2026, and December 31, 2025, respectively.
(h)Amounts are classified as accrued expenses and other liabilities.
(i)For certain nonconsolidated affordable housing entities, maximum exposure to loss represents the yield we guaranteed investors through long-term guarantee contracts. The amount disclosed is based on the unlikely event that the yield delivered to investors in the form of LIHTCs and other tax credits is recaptured. For nonconsolidated equity investments, maximum exposure to loss represents our outstanding investment, additional committed capital, and LIHTCs and other tax credits subject to recapture. The amount disclosed is based on the unlikely event that our committed capital is funded, our investments become worthless, and the tax credits previously delivered to us are recaptured. This required disclosure is not an indication of our expected loss.
Schedule of Cash Flows with Nonconsolidated Special-Purpose Entities
The following table summarizes cash flows received and paid related to SPEs and asset-backed financings where the transfer is accounted for as a sale and we have a continuing involvement with the transferred consumer automotive and credit card assets (for example, servicing) that were outstanding during the three months ended March 31, 2026, and March 31, 2025. Additionally, this table contains information regarding cash flows received from and paid to nonconsolidated SPEs that existed during each period.
Three months ended March 31,
($ in millions)20262025
Consumer automotive
Cash proceeds from transfers completed during the period$480 $191 
Servicing fees20 14 
Cash flows received on retained interests in securitization entities8 12 
Other cash flows received2 1 
Consumer other (a)
Cash proceeds from transfers completed during the period— 8 
Servicing fees— 1 
(a)Includes activity from Ally Credit Card. We closed the sale of Ally Credit Card on April 1, 2025.
Schedule of Quantitative Information and Net Credit Losses about Securitized and Other Financial Assets Managed Together
The following tables present quantitative information about off-balance sheet securitizations and whole-loan sales where we have continuing involvement.
Total amountAmount 60 days or more past due
($ in millions)March 31, 2026December 31, 2025March 31, 2026December 31, 2025
Off-balance-sheet securitization entities
Consumer automotive$858 $1,002 $16 $18 
Whole-loan sales (a)
Consumer automotive2,521 2,190 143 143 
Total$3,379 $3,192 $159 $161 
(a)Whole-loan sales are not part of a securitization transaction, but represent consumer automotive pools of loans sold to third-party investors.
Net credit losses
Three months ended March 31,
($ in millions)20262025
Off-balance-sheet securitization entities
Consumer automotive$4 $5 
Whole-loan sales (a)
Consumer automotive41 23 
Consumer other (b)— 7 
Total$45 $35 
(a)Whole-loan sales are not part of a securitization transaction, but represent consumer automotive and credit card pools of loans sold to third-party investors.
(b)Includes activity from Ally Credit Card. We closed the sale of Ally Credit Card on April 1, 2025.
v3.26.1
Other Assets (Tables)
 3 Months Ended
Mar. 31, 2026
Other Assets [Abstract]  
Schedule of Other Assets
The components of other assets were as follows.
($ in millions)March 31, 2026December 31, 2025
Property and equipment at cost$2,275 $2,280 
Accumulated depreciation(1,150)(1,130)
Net property and equipment1,125 1,150 
Net deferred tax assets2,368 2,334 
Proportional amortization investments (a) (b)2,032 2,094 
Restricted cash and cash equivalents (c)1,390 1,543 
Accrued interest, fees, and rent receivables (d)930 941 
Nonmarketable equity investments901 922 
Equity-method investments (e)741 715 
Restricted cash held for securitization trusts (f)321 236 
Other accounts receivable210 403 
Goodwill190 190 
Operating lease right-of-use assets107 109 
Other assets995 986 
Total other assets (g)$11,310 $11,623 
(a)Proportional amortization investments includes qualifying LIHTC, NMTC, and HTC investments.
(b)Presented gross of the associated unfunded commitment. Refer to Note 13 for further information.
(c)Primarily represents restricted cash equivalents funded through the issuance of credit-linked notes. Additionally, includes a number of arrangements with third parties where certain restrictions are placed on balances we hold due to collateral agreements associated with operational processes with a third-party bank, partner, or letter of credit arrangements and corresponding collateral requirements. Refer to Note 17 for further information about the issuance of credit-linked notes.
(d)Primarily relates to accrued interest, fees, and rent receivables related to our consumer automotive and commercial automotive finance receivables and loans.
(e)Primarily relates to investments made in connection with our CRA program.
(f)Includes restricted cash collected from customer payments on securitized receivables, which are distributed by us to investors as payments on the related secured debt, and cash reserve deposits utilized as a form of credit enhancement for various securitization transactions.
(g)Includes gross intangible assets of $80 million at both March 31, 2026, and December 31, 2025, and accumulated amortization of $80 million at both March 31, 2026, and December 31, 2025.
Schedule of Activity in Proportional Amortization Investment
The following table summarizes information about our proportional amortization investments.
 Three months ended March 31,
($ in millions)20262025
Tax credits and other tax benefits from proportional amortization investments (a) (b)$79 $56 
Investment amortization expense recognized as a component of income tax expense (a)62 45 
Net benefit from proportional amortization investments (a)$17 $11 
(a)Amounts are included within income tax expense from continuing operations on our Condensed Consolidated Statement of Comprehensive Income and as a component of operating activities within deferred income taxes, other assets, and other liabilities on our Condensed Consolidated Statement of Cash Flows.
(b)There were no impairment losses recognized during the three months ended March 31, 2026, and March 31, 2025, resulting from the forfeiture or ineligibility of tax credits or other circumstances.
Schedule of Equity Securities without Readily Determinable Fair Value
The total carrying value of the nonmarketable equity investments held at March 31, 2026, and December 31, 2025, including cumulative unrealized gains and losses, was as follows.
($ in millions)March 31, 2026December 31, 2025
FRB stock$454 $452 
FHLB stock335 359 
Equity investments without a readily determinable fair value
Cost basis94 94 
Adjustments
Upward adjustments56 57 
Downward adjustments (including impairment)(38)(40)
Carrying amount, equity investments without a readily determinable fair value112 111 
Nonmarketable equity investments$901 $922 
During the three months ended March 31, 2026, and March 31, 2025, unrealized gains and losses included in the carrying value of the nonmarketable equity investments still held as of March 31, 2026, and March 31, 2025, were as follows.
Three months ended March 31,
($ in millions)20262025
Upward adjustments$— $— 
Downward adjustments (including impairment) (a)$(1)$— 
(a)No impairment on FHLB and FRB stock was recognized during the three months ended March 31, 2026, and March 31, 2025.
Schedule of Goodwill
The carrying balance of goodwill by reportable operating segment was as follows.
($ in millions)Automotive Finance operationsInsurance operationsCorporate and Other (a)Total
Goodwill at December 31, 2024
$20 $27 $504 $551 
Goodwill impairment— — (305)(305)
Transfer to assets of operations held-for-sale (b)— — (56)(56)
Goodwill at December 31, 2025
$20 $27 $143 $190 
Goodwill impairment— — — — 
Goodwill at March 31, 2026
$20 $27 $143 $190 
(a)Includes $143 million of goodwill associated with Ally Invest at both March 31, 2026, and December 31, 2025.
(b)We closed the sale of Ally Credit Card on April 1, 2025. Refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for further information on Ally Credit Card.
v3.26.1
Deposit Liabilities (Tables)
 3 Months Ended
Mar. 31, 2026
Deposits [Abstract]  
Schedule of Deposit Liabilities
Deposit liabilities consisted of the following.
($ in millions)March 31, 2026December 31, 2025
Noninterest-bearing deposits$137 $125 
Interest-bearing deposits
Savings, money market, and spending accounts112,800 109,214 
Certificates of deposit40,215 42,310 
Total deposit liabilities$153,152 $151,649 
v3.26.1
Debt (Tables)
 3 Months Ended
Mar. 31, 2026
Debt Disclosure [Abstract]  
Schedule of Short-term Debt
The following table presents the composition of our short-term borrowings portfolio.
March 31, 2026December 31, 2025
($ in millions)
Unsecured
Secured (a)
Total
Unsecured
Secured (a)
Total
Federal Home Loan Bank
$— $3,600 $3,600 $— $4,150 $4,150 
Securities sold under agreements to repurchase
— 526 526 — 545 545 
Total short-term borrowings$— $4,126 $4,126 $— $4,695 $4,695 
(a)Refer to the section below titled Long-Term Debt for further details on assets restricted as collateral for payment of the related debt.
Schedule of Long-term Debt
The following table presents the composition of our long-term debt portfolio.
March 31, 2026December 31, 2025
($ in millions)UnsecuredSecuredTotalUnsecuredSecuredTotal
Long-term debt (a) (b)
Due within one year$(20)$2,459 $2,439 $— $2,659 $2,659 
Due after one year9,939 4,971 14,910 10,012 4,399 14,411 
Total long-term debt (c)$9,919 $7,430 $17,349 $10,012 $7,058 $17,070 
(a)Includes basis adjustments related to the application of hedge accounting. Refer to Note 18 for additional information.
(b)Includes scheduled amortization of original issue discount.
(c)Includes advances from the FHLB of Pittsburgh of $4.2 billion at both March 31, 2026, and December 31, 2025.
Schedule of Maturities of Long-term Debt
The following table presents the scheduled remaining maturity of long-term debt at March 31, 2026, assuming no early redemptions will occur. The amounts below include adjustments to the carrying value resulting from the application of hedge accounting. The actual payment of secured debt may vary based on the payment activity of the related pledged assets.
($ in millions)202620272028202920302031 and thereafter
Total
Unsecured
Long-term debt
$59 $1,595 $876 $1,748 $793 $5,518 $10,589 
Original issue discount
(63)(95)(107)(123)(143)(139)(670)
Total unsecured
(4)1,500 769 1,625 650 5,379 9,919 
Secured
Long-term debt
2,079 2,751 2,056 435 85 24 7,430 
Total long-term debt
$2,075 $4,251 $2,825 $2,060 $735 $5,403 $17,349 
Schedule of Pledged Assets for the Payment of the Related Secured Borrowings and Repurchase Agreements
The following table summarizes assets restricted as collateral for the payment of the related debt obligation.
($ in millions)March 31, 2026December 31, 2025
Consumer automotive finance receivables$37,151 $36,807 
Consumer mortgage finance receivables15,342 15,604 
Commercial finance receivables7,899 7,686 
Investment securities (amortized cost basis of $3,012 and $3,114) (a)
3,187 3,292 
Other assets (b)1,224 1,381 
Total assets restricted as collateral (c) (d)$64,803 $64,770 
Secured debt (e)$11,556 $11,753 
(a)A portion of the restricted investment securities at both March 31, 2026, and December 31, 2025, was restricted under repurchase agreements. Refer to the section above titled Short-Term Borrowings for information on the repurchase agreements.
(b)Includes the collateral accounts restricted for the payment of credit-linked notes recorded within restricted cash and cash equivalents. Excludes restricted cash and cash reserves for securitization trusts. Refer to Note 10 and Note 17 for additional information.
(c)All restricted assets are those of Ally Bank.
(d)Ally Bank has an advance agreement with the FHLB, and had assets pledged to secure borrowings that were restricted as collateral to the FHLB totaling $25.9 billion and $26.0 billion at March 31, 2026, and December 31, 2025, respectively. These assets were primarily composed of consumer mortgage finance receivables and loans as well as mortgage-backed securities. Ally Bank has access to the FRB Discount Window and had assets pledged and restricted as collateral to the FRB totaling $33.6 billion and $33.7 billion at March 31, 2026, and December 31, 2025, respectively. These assets were composed of consumer automotive finance receivables and loans. Availability under these programs is only for the operations of Ally Bank and cannot be used to fund the operations or liabilities of Ally or its other subsidiaries.
(e)Includes $4.1 billion and $4.7 billion of short-term borrowings at March 31, 2026, and December 31, 2025, respectively.
v3.26.1
Accrued Expenses and Other Liabilities (Tables)
 3 Months Ended
Mar. 31, 2026
Accounts Payable and Accrued Liabilities [Abstract]  
Schedule of Accrued Expenses and Other Liabilities
The components of accrued expenses and other liabilities were as follows.
($ in millions)
March 31, 2026December 31, 2025
Unfunded commitments for proportional amortization investments (a)$735 $819 
Accounts payable544 420 
Reserves for insurance losses and loss adjustment expenses (b)251 233 
Employee compensation and benefits242 417 
Deferred revenue135 141 
Operating lease liabilities121 124 
Other liabilities488 551 
Total accrued expenses and other liabilities$2,516 $2,705 
(a)Primarily relates to unfunded commitments for investments in qualified affordable housing projects.
(b)Refer to Note 4 for further information.
v3.26.1
Preferred Stock (Tables)
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Preferred Stock
The following table summarizes information about our preferred stock. For additional information regarding our preferred stock, refer to Note 17 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K.
March 31, 2026December 31, 2025
Series B preferred stock (a) (b)
Issuance dateApril 22, 2021April 22, 2021
Carrying value ($ in millions)
$1,335$1,335
Par value (per share)
$0.01$0.01
Liquidation preference (per share)
$1,000$1,000
Number of shares authorized1,350,0001,350,000
Number of shares issued and outstanding1,350,0001,350,000
Dividend/coupon
Prior to May 15, 20264.700%4.700%
On and after May 15, 2026
Five Year Treasury + 3.868%
Five Year Treasury + 3.868%
Series C preferred stock (a)
Issuance dateJune 2, 2021June 2, 2021
Carrying value ($ in millions)
$989$989
Par value (per share)
$0.01$0.01
Liquidation preference (per share)
$1,000$1,000
Number of shares authorized1,000,0001,000,000
Number of shares issued and outstanding1,000,0001,000,000
Dividend/coupon
Prior to May 15, 20284.700%4.700%
On and after May 15, 2028
Seven Year Treasury + 3.481%
Seven Year Treasury + 3.481%
(a)We may, at our option, redeem the Series B and Series C shares on any dividend payment date on or after May 15, 2026, or May 15, 2028, respectively, or at any time within 90 days following a regulatory event that precludes the instruments from being included in additional Tier 1 capital.
(b)On May 4, 2026, we announced our intent to redeem all of our issued and outstanding 4.700% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series B on May 15, 2026. Refer to Note 24 for additional information.
v3.26.1
Accumulated Other Comprehensive Loss (Tables)
 3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Accumulated Other Comprehensive Loss
The following table presents changes, net of tax, in each component of accumulated other comprehensive loss.
Investment securities
($ in millions)
Available-
for-sale securities (a)		Held-to-maturity securitiesTranslation adjustments and net investment hedges (b)Cash flow hedges (b)Accumulated other comprehensive loss
Balance at January 1, 2025$(3,307)$(616)$20 $(21)$(3,924)
Net change642 15 — 5 662 
Balance at March 31, 2025$(2,665)$(601)$20 $(16)$(3,262)
Balance at January 1, 2026$(2,260)$(551)$23 $2 $(2,786)
Net change(5)14 — 4 13 
Balance at March 31, 2026$(2,265)$(537)$23 $6 $(2,773)
(a)Represents the after-tax difference between the fair value and amortized cost basis of our available-for-sale securities portfolio. Refer to Note 6 for additional information.
(b)For additional information on derivative instruments and hedging activities, refer to Note 18.
Schedule of Reclassification Out of Accumulated Other Comprehensive Loss
The following tables present the before- and after-tax changes in each component of accumulated other comprehensive loss.
Three months ended March 31, 2026 ($ in millions)
Before taxTax effectAfter tax
Investment securities
Available-for-sale securities
Net unrealized losses arising during the period$(4)$1 $(3)
Less: Net realized gains reclassified to income from continuing operations3 (a)(1)(b)2 
Net change(7)2 (5)
Held-to-maturity securities
Less: Amortization of amounts previously recorded upon transfer from available-for-sale(19)(c)5 (b)(14)
Translation adjustments
Net unrealized losses arising during the period(3)1 (2)
Net investment hedges (d)
Net unrealized gains arising during the period3 (1)2 
Cash flow hedges (d)
Less: Net realized losses reclassified to income from continuing operations(5)(e)1 (b)(4)
Net change5 (1)4 
Other comprehensive income$17 $(4)$13 
(a)Includes gains reclassified to other loss on investments, net, in our Condensed Consolidated Statement of Comprehensive Income.
(b)Includes amounts reclassified to income tax expense (benefit) from continuing operations in our Condensed Consolidated Statement of Comprehensive Income.
(c)Includes amounts reclassified to interest and dividends on investment securities and other earning assets in our Condensed Consolidated Statement of Comprehensive Income.
(d)For additional information on derivative instruments and hedging activities, refer to Note 18.
(e)Includes losses reclassified to interest and fees on finance receivables and loans in our Condensed Consolidated Statement of Comprehensive Income.
Three months ended March 31, 2025 ($ in millions)
Before taxTax effectAfter tax
Investment securities
Available-for-sale securities
Net unrealized gains arising during the period$346 $(81)$265 
Less: Net realized losses reclassified to income from continuing operations(495)(a)118 (b)(377)
Net change841 (199)642 
Held-to-maturity securities
Less: Amortization of amounts previously recorded upon transfer from available-for-sale(20)(c)5 (b)(15)
Cash flow hedges (d)
Less: Net realized losses reclassified to income from continuing operations(7)(e)2 (b)(5)
Net change7 (2)5 
Other comprehensive income$868 $(206)$662 
(a)Includes losses reclassified to other loss on investments, net, in our Condensed Consolidated Statement of Comprehensive Income related to the balance sheet repositioning of our available-for-sale securities portfolio. Refer to Note 8 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information.
(b)Includes amounts reclassified to income tax expense (benefit) from continuing operations in our Condensed Consolidated Statement of Comprehensive Income.
(c)Includes amounts reclassified to interest and dividends on investment securities and other earning assets in our Condensed Consolidated Statement of Comprehensive Income.
(d)For additional information on derivative instruments and hedging activities, refer to Note 18.
(e)Includes losses reclassified to interest and fees on finance receivables and loans in our Condensed Consolidated Statement of Comprehensive Income.
v3.26.1
Earnings per Common Share (Tables)
 3 Months Ended
Mar. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table presents the calculation of basic and diluted earnings per common share.
Three months ended March 31,
($ in millions, except per share data; shares in thousands) (a)
20262025
Net income (loss) from continuing operations$319 $(225)
Preferred stock dividends — Series B(16)(16)
Preferred stock dividends — Series C(12)(12)
Net income (loss) from continuing operations attributable to common shareholders$291 $(253)
Net income (loss) attributable to common shareholders$291 $(253)
Basic weighted-average common shares outstanding (b)310,992 309,006 
Diluted weighted-average common shares outstanding (b) (c)313,219 309,006 
Basic earnings per common share
Net income (loss) from continuing operations$0.94 $(0.82)
Net income (loss)$0.94 $(0.82)
Diluted earnings per common share
Net income (loss) from continuing operations$0.93 $(0.82)
Net income (loss)$0.93 $(0.82)
(a)Figures in the table may not recalculate exactly due to rounding. Earnings per share is calculated based on unrounded numbers.
(b)Includes shares related to share-based compensation that vested but were not yet issued.
(c)Due to the antidilutive effect of the net loss from continuing operations for the three months ended March 31, 2025, basic weighted-average common shares outstanding was used to calculate basic and diluted earnings per share. During the three months ended March 31, 2025, there were 2.7 million in share-based awards excluded because their inclusion would have been antidilutive.
v3.26.1
Regulatory Capital and Other Regulatory Matters (Tables)
 3 Months Ended
Mar. 31, 2026
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]  
Schedule of Regulatory Capital Amount and Ratios
The following table summarizes our capital ratios under U.S. Basel III.
March 31, 2026
December 31, 2025
Required minimum (a)Well-capitalized minimum
($ in millions)AmountRatioAmountRatio
Capital ratios
Common Equity Tier 1 (to risk-weighted assets)
Ally Financial Inc.$15,695 10.11 %$15,629 10.23 %4.50 %(b)
Ally Bank17,914 12.38 17,853 12.50 4.50 6.50 %
Tier 1 (to risk-weighted assets)
Ally Financial Inc.$17,934 11.56 %$17,885 11.70 %6.00 %6.00 %
Ally Bank17,914 12.38 17,853 12.50 6.00 8.00 
Total (to risk-weighted assets)
Ally Financial Inc.$20,793 13.40 %$20,731 13.56 %8.00 %10.00 %
Ally Bank19,744 13.65 19,659 13.77 8.00 10.00 
Tier 1 leverage (to adjusted quarterly average assets) (c)
Ally Financial Inc.$17,934 9.16 %$17,885 9.25 %4.00 %(b)
Ally Bank17,914 9.72 17,853 9.82 4.00 5.00 %
(a)In addition to the minimum risk-based capital requirements for the Common Equity Tier 1 capital, Tier 1 capital, and total capital ratios, Ally was subject to a minimum capital conservation buffer of 2.6% at both March 31, 2026, and December 31, 2025, and Ally Bank was subject to a minimum capital conservation buffer of 2.5% at both March 31, 2026, and December 31, 2025.
(b)Currently, there is no ratio component for determining whether a BHC is “well-capitalized.”
(c)Federal regulatory reporting guidelines require the calculation of adjusted quarterly average assets using a daily average methodology.
Schedule of Common Share Distribution Activity
The following table presents information related to our common stock and distributions to our common shareholders.
Common stock repurchased during period (a)Number of common shares outstandingCash dividends declared per common share (b)
($ in millions, except per share data; shares in thousands)Approximate dollar valueNumber of sharesBeginning of periodEnd of period
2025
First quarter$34 877 305,388 307,152 $0.30 
Second quarter1 27 307,152 307,787 0.30 
Third quarter1 25 307,787 307,828 0.30 
Fourth quarter23 543 307,828 308,493 0.30 
2026
First quarter$147 3,624 308,493 307,408 $0.30 
(a)Includes shares of common stock withheld to cover income taxes owed by participants in our share-based incentive plans.
(b)On April 14, 2026, our Board declared a quarterly cash dividend of $0.30 per share on all common stock payable on May 15, 2026, to shareholders of record at the close of business on May 1, 2026.
v3.26.1
Derivative Instruments and Hedging Activities (Tables)
 3 Months Ended
Mar. 31, 2026
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments in Statement of Financial Position
The following table summarizes the amounts of derivative instruments reported on our Condensed Consolidated Balance Sheet. The amounts are presented on a gross basis, are segregated by derivatives that are designated and qualifying as hedging instruments or those that are not, and are further segregated by type of contract within those two categories.
Derivative contracts in a receivable and payable position exclude open trade equity on derivatives cleared through central clearing counterparties. Any associated margin exchanged with our central clearing counterparties are treated as settlements of the derivative exposure, rather than collateral. Such payments are recognized as settlements of the derivatives contracts in a receivable and payable position on our Condensed Consolidated Balance Sheet.
Notional amounts are reference amounts from which contractual obligations are derived and are not recorded on the balance sheet. In our view, derivative notional is not an accurate measure of our derivative exposure when viewed in isolation from other factors, such as market rate fluctuations and counterparty credit risk.
March 31, 2026December 31, 2025
Derivative contracts in a
Notional amount
Derivative contracts in a
Notional amount
($ in millions)
receivable position
payable position
receivable position
payable position
Derivatives designated as accounting hedges
Interest rate contracts
Swaps
$— $— $22,507 $— $— $23,257 
Purchased options
— — 2,250 — — 3,450 
Foreign exchange contracts
Forwards
2 — 187 — 4 199 
Total derivatives designated as accounting hedges
2 — 24,944 — 4 26,906 
Derivatives not designated as accounting hedges
Interest rate contracts
Swaps1 1 216 — — — 
Total interest rate risk
1 1 216 — — — 
Foreign exchange contracts
Forwards— — 35 — — 71 
Total foreign exchange risk— — 35 — — 71 
Credit contracts
Credit-linked note derivatives— 1 1,224 — — 1,381 
Total credit risk— 1 1,224 — — 1,381 
Equity contracts
Written options
— 1 — — — — 
Total equity risk
— 1 — — — — 
Total derivatives not designated as accounting hedges
1 3 1,475 — — 1,452 
Total derivatives
$3 $3 $26,419 $— $4 $28,358 
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location
The following table presents amounts recorded on our Condensed Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges.

Carrying amount of the hedged itemsCumulative amount of fair value hedging adjustment included in the carrying amount of the hedged items
TotalDiscontinued (a)
($ in millions)
March 31, 2026December 31, 2025March 31, 2026December 31, 2025March 31, 2026December 31, 2025
Assets
Available-for-sale securities (b)$14,968 $15,240 $(68)$7 $(51)$(54)
Finance receivables and loans, net (c)23,942 27,808 (23)7 1 1 
Liabilities
Long-term debt$3,395 $3,378 $76 $79 $76 $79 
(a)Represents the fair value hedging adjustment on qualifying hedges for which the hedging relationship was discontinued. This represents a subset of the amounts reported in the total hedging adjustment.
(b)These amounts include the amortized cost basis and unallocated basis adjustments of closed portfolios of available-for-sale securities used to designate hedging relationships in which the hedged item is the stated amount of assets in the closed portfolios anticipated to be outstanding for the designated hedge period. At March 31, 2026, and December 31, 2025, the amortized cost basis and unallocated basis adjustments of the closed portfolios used in these hedging relationships was $13.5 billion and $13.7 billion, respectively, of which $13.2 billion and $13.4 billion, respectively, represents the amortized cost basis and unallocated basis adjustments of closed portfolios designated in an active hedge relationship. At March 31, 2026, and December 31, 2025, the total cumulative basis adjustments associated with these hedging relationships was a $72 million liability and a $8 million liability, respectively, of which the portion related to discontinued hedging relationships was a $51 million liability and a $54 million liability, respectively. At both March 31, 2026, and December 31, 2025, the notional amounts of the designated hedged items were $11.0 billion, with cumulative basis adjustments of a $21 million liability and a $46 million asset, respectively, which would be allocated across the entire remaining closed pool upon dedesignation of the hedge relationship. Refer to Note 6 for a reconciliation of the amortized cost basis and fair value of available-for-sale securities.
(c)These amounts include the carrying value of closed portfolios of loan receivables used to designate hedging relationships in which the hedged item is the stated amount of assets in the closed portfolios anticipated to be outstanding for the designated hedge period. At March 31, 2026, and December 31, 2025, the carrying value of the closed portfolios used in these hedging relationships was $23.9 billion and $27.8 billion, respectively, of which $19.1 billion and $21.8 billion, respectively, represents the carrying value of closed portfolios designated in an active hedge relationship. At March 31, 2026, and December 31, 2025, the total cumulative basis adjustments associated with these hedging relationships was a $23 million liability and $7 million asset, respectively, of which the portion related to discontinued hedging relationships was a $1 million asset at both March 31, 2026, and December 31, 2025. At March 31, 2026, and December 31, 2025, the notional amounts of the designated hedged items were $10.0 billion and $10.8 billion, respectively, with cumulative basis adjustments of a $24 million liability and a $6 million asset, respectively, which would be allocated across the entire remaining closed pool upon dedesignation of the hedge relationship.
Schedule of Derivative Instruments Not Designated as Accounting Hedge
The following table summarizes the location and amounts of gains and losses on derivative instruments not designated as accounting hedges reported in our Condensed Consolidated Statement of Comprehensive Income.
Three months ended March 31,
($ in millions)20262025
Gain (loss) recognized in earnings
Interest rate contracts
Gain on mortgage and automotive loans, net$— $1 
Total interest rate contracts— 1 
Foreign exchange contracts
Other operating expenses1 — 
Total foreign exchange contracts
1 — 
Credit contracts
Other income, net of losses(1)— 
Total credit contracts(1)— 
Total gain recognized in earnings$— $1 
Schedule of Location and Amounts of Gains and Losses on Derivative Instruments
The following table summarizes the location and amounts of gains and losses on derivative instruments designated as qualifying fair value and cash flow hedges reported in our Condensed Consolidated Statement of Comprehensive Income.
Interest and fees on finance receivables and loansInterest and dividends on investment securities and other earning assetsInterest on long-term debt
Three months ended March 31, ($ in millions)
202620252026202520262025
Gain (loss) on fair value hedging relationships
Interest rate contracts 
Hedged available-for-sale securities$— $— $(77)$130 $— $— 
Derivatives designated as hedging instruments on available-for-sale securities— — 77 (130)— — 
Hedged fixed-rate consumer automotive loans(30)29 — — — — 
Derivatives designated as hedging instruments on fixed-rate consumer automotive loans30 (29)— — — — 
Total gain on fair value hedging relationships— — — — — — 
Loss on cash flow hedging relationships
Interest rate contracts
Hedged variable-rate commercial loans
Reclassified from accumulated other comprehensive loss into income(5)(7)— — — — 
Total loss on cash flow hedging relationships$(5)$(7)$— $— $— $— 
Total amounts presented in the Condensed Consolidated Statement of Comprehensive Income
$2,658 $2,709 $234 $230 $265 $271 
Schedule of Location and Amounts of Gains and Losses Related to Interest and Amortization on Derivative Instruments
The following table summarizes the location and amounts of gains and losses related to interest and amortization on derivative instruments designated as qualifying fair value and cash flow hedges reported in our Condensed Consolidated Statement of Comprehensive Income.
Interest and fees on finance receivables and loansInterest and dividends on investment securities and other earning assetsInterest on long-term debt
Three months ended March 31, ($ in millions)
202620252026202520262025
Gain on fair value hedging relationships
Interest rate contracts
Amortization of deferred unsecured debt basis adjustments$— $— $— $— $2 $2 
Amortization of deferred basis adjustments of available-for-sale securities— — 3 5 — — 
Interest for qualifying accounting hedges of available-for-sale securities— — 1 17 — — 
Amortization of deferred loan basis adjustments— 2 — — — — 
Interest for qualifying accounting hedges of consumer automotive loans held for investment5 19 — — — — 
Total gain on fair value hedging relationships$5 $21 $4 $22 $2 $2 
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)
The following table summarizes the effect of cash flow hedges on accumulated other comprehensive loss.
Three months ended March 31,
($ in millions)20262025
Interest rate contracts
Gain recognized in other comprehensive income$5 $7 
Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)
The following table summarizes the effect of net investment hedges on accumulated other comprehensive loss.
Three months ended March 31,
($ in millions)20262025
Foreign exchange contracts (a) (b)
Gain recognized in other comprehensive income$3 $— 
(a)There were no amounts excluded from effectiveness testing for the three months ended March 31, 2026, or 2025.
(b)Gains and losses reclassified from accumulated other comprehensive loss are reported as other income, net of losses, in our Condensed Consolidated Statement of Comprehensive Income. There were no amounts reclassified for the three months ended March 31, 2026, or 2025.
v3.26.1
Fair Value (Tables)
 3 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on a Recurring Basis
The following tables display the assets and liabilities measured at fair value on a recurring basis including financial instruments elected for the fair value option. We often economically hedge the fair value change of our assets or liabilities with derivatives. The tables below display the hedges separately from the hedged items; therefore, they do not directly display the impact of our risk-management activities.
Recurring fair value measurements
March 31, 2026 ($ in millions)
Level 1Level 2Level 3Total
Assets
Investment securities
Equity securities (a) (b)$804 $— $— $804 
Available-for-sale securities
Debt securities
U.S. Treasury and federal agencies
2,397 — — 2,397 
U.S. States and political subdivisions
— 483 34 517 
Foreign government32 167 — 199 
Agency mortgage-backed residential
— 12,695 — 12,695 
Mortgage-backed residential
— 193 — 193 
Agency mortgage-backed commercial— 5,107 — 5,107 
Asset-backed— 2 — 2 
Corporate debt
— 1,928 — 1,928 
Total available-for-sale securities2,429 20,575 34 23,038 
Derivative contracts in a receivable position
Interest rate— 1 — 1 
Foreign exchange— 2 — 2 
Total derivative contracts in a receivable position— 3 — 3 
Total assets$3,233 $20,578 $34 $23,845 
Liabilities
Accrued expenses and other liabilities
Derivative contracts in a payable position
Interest rate$— $1 $— $1 
Credit — — 1 1 
Equity1 — — 1 
Total derivative contracts in a payable position
1 1 1 3 
Total liabilities$1 $1 $1 $3 
(a)Our direct investment in any one industry did not exceed 15%. When performing the concentration calculation, mutual funds and ETFs are not allocated to any one industry.
(b)Excludes $59 million of equity securities that are measured at fair value using the net asset value practical expedient and therefore are not classified in the fair value hierarchy.
Recurring fair value measurements
December 31, 2025 ($ in millions)
Level 1Level 2Level 3Total
Assets
Investment securities
Equity securities (a) (b)$819 $— $— $819 
Available-for-sale securities
Debt securities
U.S. Treasury and federal agencies
2,279 — — 2,279 
U.S. States and political subdivisions
— 517 34 551 
Foreign government31 157 — 188 
Agency mortgage-backed residential
— 12,901 — 12,901 
Mortgage-backed residential
— 198 — 198 
Agency mortgage-backed commercial— 4,932 — 4,932 
Asset-backed— 12 — 12 
Corporate debt
— 1,912 — 1,912 
Total available-for-sale securities2,310 20,629 34 22,973 
Total assets$3,129 $20,629 $34 $23,792 
Liabilities
Accrued expenses and other liabilities
Derivative contracts in a payable position
Foreign exchange$— $4 $— $4 
Total derivative contracts in a payable position
— 4 — 4 
Total liabilities$— $4 $— $4 
(a)Our direct investment in any one industry did not exceed 11%. When performing the concentration calculation, mutual funds and ETFs are not allocated to any one industry.
(b)Excludes $57 million of equity securities that are measured at fair value using the net asset value practical expedient and therefore are not classified in the fair value hierarchy.
Schedule of Fair Value, Assets Measured on a Recurring Basis, Unobservable Input Reconciliation
The following tables present the reconciliation for all Level 3 assets and liabilities measured at fair value on a recurring basis. We often economically hedge the fair value change of our assets or liabilities with derivatives and other financial instruments. The Level 3 items presented below may be hedged by derivatives and other financial instruments that are classified as Level 1 or Level 2. Thus, the following tables do not fully reflect the impact of our risk-management activities.
Available-for-sale securitiesLoans
held-for-sale (a)
($ in millions)2026202520262025
Assets
Fair value at January 1,$34 $35 $— $5 
Net realized/unrealized gains
Included in earnings— — — — 
Included in OCI— — — — 
Purchases and originations— — — 8 
Sales— — — (10)
Issuances— — — — 
Settlements— — — — 
Transfers into Level 3— — — — 
Transfers out of Level 3— — — — 
Fair value at March 31,
$34 $35 $— $3 
Net unrealized gains still held at March 31,
Included in earnings$— $— $— $— 
Included in OCI— — — — 
(a)Consumer mortgage loans carried at fair value due to fair value option elections.
Derivative liabilities, net of derivative assets (a)
($ in millions)20262025
Liabilities
Fair value at January 1,$— $3 
Net realized/unrealized losses (gains)
Included in earnings1 (1)
Included in OCI— — 
Purchases and originations— — 
Sales— — 
Issuances— — 
Settlements— — 
Transfers into Level 3— — 
Transfers out of Level 3 (b)— 2 
Fair value at March 31,
$1 $4 
Net unrealized losses still held at March 31,
Included in earnings$1 $— 
Included in OCI— — 
(a)Net realized/unrealized losses (gains) are reported as (loss) gain on mortgage and automotive loans, net, and other income, net of losses, in our Condensed Consolidated Statement of Comprehensive Income.
(b)Represents the settlement value of interest rate derivative assets that are transferred to loans held-for-sale within Level 2 of the fair value hierarchy during the three months ended March 31, 2025. These transfers are deemed to have occurred at the end of the reporting period.
Schedule of Fair Value Measurements - Nonrecurring Basis
The following tables display assets and liabilities measured at fair value on a nonrecurring basis and still held at March 31, 2026, and December 31, 2025, respectively. The amounts are generally as of the end of each period presented, which approximate the fair value measurements that occurred during each period.
Nonrecurring fair value measurements
Lower-of-cost-or-fair-value reserve, valuation reserve, or cumulative adjustments
Total gain (loss) included in earnings
March 31, 2026 ($ in millions)
Level 1
Level 2
Level 3
Total
Assets
Loans held-for-sale, net$— $— $336 $336 $(15)n/m(a)
Commercial finance receivables and loans, net (b)
Other
— — 12 12 (96)n/m(a)
Total commercial finance receivables and loans, net
— — 12 12 (96)n/m(a)
Other assets
Nonmarketable equity investments— — 2 2 (1)n/m(a)
Repossessed and foreclosed assets (c)— — 8 8 (1)n/m(a)
Total assets
$— $— $358 $358 $(113)n/m
n/m = not meaningful
(a)We consider the applicable valuation reserve, allowance for loan losses, or cumulative adjustments to be the most relevant indicator of the impact on earnings caused by the fair value measurement. Accordingly, the table above excludes total gains and losses included in earnings for these items. The carrying values are inclusive of the respective valuation reserve, loan loss allowance, or cumulative adjustment.
(b)Represents collateral-dependent loans held for investment for which a nonrecurring measurement was made. The related allowance for loan losses represents the cumulative fair value adjustments for those specific receivables.
(c)The allowance provided for repossessed and foreclosed assets represents any cumulative valuation adjustment recognized to adjust the assets to fair value.
Nonrecurring fair value measurementsLower-of-cost-or-fair-value reserve, valuation reserve, or cumulative adjustmentsTotal gain (loss) included in earnings
December 31, 2025 ($ in millions)
Level 1Level 2Level 3Total
Assets
Loans held-for-sale, net$— $— $545 $545 $(32)n/m(a)
Commercial finance receivables and loans, net (b)
Other— — 27 27 (97)n/m(a)
Total commercial finance receivables and loans, net— — 27 27 (97)n/m(a)
Other assets
Nonmarketable equity investments— 9 1 10 4 n/m(a)
Repossessed and foreclosed assets (c)— — 7 7 (1)n/m(a)
Total assets$— $9 $580 $589 $(126)n/m
n/m = not meaningful
(a)We consider the applicable valuation reserve, allowance for loan losses, or cumulative adjustments to be the most relevant indicator of the impact on earnings caused by the fair value measurement. Accordingly, the table above excludes total gains and losses included in earnings for these items. The carrying values are inclusive of the respective valuation reserve, loan loss allowance, or cumulative adjustment.
(b)Represents collateral-dependent loans held for investment for which a nonrecurring measurement was made. The related allowance for loan losses represents the cumulative fair value adjustments for those specific receivables.
(c)The allowance provided for repossessed and foreclosed assets represents any cumulative valuation adjustment recognized to adjust the assets to fair value.
Schedule of Fair Value, by Balance Sheet Grouping
The following table presents the carrying and estimated fair value of financial instruments, except for those recorded at fair value on a recurring basis presented in the previous section of this note titled Recurring Fair Value. When possible, we use quoted market prices to determine fair value. Where quoted market prices are not available, the fair value is internally derived based on appropriate valuation methodologies with respect to the amount and timing of future cash flows and estimated discount rates. However, considerable judgment is required in interpreting current market data to develop the market assumptions and inputs necessary to estimate fair value. As such, the actual amount received to sell an asset or the amount paid to settle a liability could differ from our estimates. Fair value information presented herein was based on information available at March 31, 2026, and December 31, 2025.
Estimated fair value
($ in millions)
Carrying value
Level 1
Level 2
Level 3
Total
March 31, 2026
Financial assets
Held-to-maturity securities
$4,337 $— $4,387 $— $4,387 
Loans held-for-sale, net
337 — — 338 338 
Finance receivables and loans, net
136,350 — — 139,266 139,266 
FHLB/FRB stock (a)
789 — 789 — 789 
Financial liabilities
Deposit liabilities
$40,215 $— $— $40,362 $40,362 
Short-term borrowings
4,126 — — 4,123 4,123 
Long-term debt
17,349 — 12,891 5,469 18,360 
December 31, 2025
Financial assets
Held-to-maturity securities$4,371 $— $4,451 $— $4,451 
Loans held-for-sale, net549 — — 560 560 
Finance receivables and loans, net133,964 — — 137,579 137,579 
FHLB/FRB stock (a)811 — 811 — 811 
Financial liabilities
Deposit liabilities$42,310 $— $— $42,523 $42,523 
Short-term borrowings4,695 — — 4,706 4,706 
Long-term debt17,070 — 12,642 5,707 18,349 
(a)Included in other assets on our Condensed Consolidated Balance Sheet.
v3.26.1
Offsetting Assets and Liabilities (Tables)
 3 Months Ended
Mar. 31, 2026
Offsetting [Abstract]  
Schedule of Offsetting Assets
The composition of offsetting derivative instruments, financial assets, and financial liabilities was as follows.
Gross amounts of recognized assets/liabilitiesGross amounts offset on the Condensed Consolidated Balance SheetNet amounts of assets/liabilities presented on the Condensed Consolidated Balance SheetGross amounts not offset on the Condensed Consolidated Balance Sheet
($ in millions)
Financial instruments
Collateral (a) (b) (c)
Net amount
March 31, 2026
Assets
Derivative assets$3 $— $3 $(1)$(2)$— 
Total assets
$3 $— $3 $(1)$(2)$— 
Liabilities
Derivative liabilities (d)$3 $— $3 $(1)$(1)$1 
Securities sold under agreements to repurchase (e)526 — 526 — (526)— 
Total liabilities$529 $— $529 $(1)$(527)$1 
December 31, 2025
Assets
Derivative assets$— $— $— $— $— $— 
Total assets
$— $— $— $— $— $— 
Liabilities
Derivative liabilities$4 $— $4 $— $(4)$— 
Securities sold under agreements to repurchase (e)545 — 545 — (545)— 
Total liabilities$549 $— $549 $— $(549)$— 
(a)Financial collateral received or pledged shown as a balance based on the sum of all net asset and liability positions between Ally and each individual derivative counterparty.
(b)Amounts disclosed are limited to the financial asset or liability balance and, accordingly, exclude excess collateral received or pledged and noncash collateral received. We do not record noncash collateral received on our Condensed Consolidated Balance Sheet unless certain conditions are met.
(c)Certain agreements grant us the right to sell or pledge the noncash assets we receive as collateral. We have not sold or pledged any of the noncash collateral received under these agreements.
(d)Includes derivative liabilities with no offsetting arrangements of $1 million as of March 31, 2026.
(e)For additional information on securities sold under agreements to repurchase, refer to Note 12.
Schedule of Offsetting Liabilities
The composition of offsetting derivative instruments, financial assets, and financial liabilities was as follows.
Gross amounts of recognized assets/liabilitiesGross amounts offset on the Condensed Consolidated Balance SheetNet amounts of assets/liabilities presented on the Condensed Consolidated Balance SheetGross amounts not offset on the Condensed Consolidated Balance Sheet
($ in millions)
Financial instruments
Collateral (a) (b) (c)
Net amount
March 31, 2026
Assets
Derivative assets$3 $— $3 $(1)$(2)$— 
Total assets
$3 $— $3 $(1)$(2)$— 
Liabilities
Derivative liabilities (d)$3 $— $3 $(1)$(1)$1 
Securities sold under agreements to repurchase (e)526 — 526 — (526)— 
Total liabilities$529 $— $529 $(1)$(527)$1 
December 31, 2025
Assets
Derivative assets$— $— $— $— $— $— 
Total assets
$— $— $— $— $— $— 
Liabilities
Derivative liabilities$4 $— $4 $— $(4)$— 
Securities sold under agreements to repurchase (e)545 — 545 — (545)— 
Total liabilities$549 $— $549 $— $(549)$— 
(a)Financial collateral received or pledged shown as a balance based on the sum of all net asset and liability positions between Ally and each individual derivative counterparty.
(b)Amounts disclosed are limited to the financial asset or liability balance and, accordingly, exclude excess collateral received or pledged and noncash collateral received. We do not record noncash collateral received on our Condensed Consolidated Balance Sheet unless certain conditions are met.
(c)Certain agreements grant us the right to sell or pledge the noncash assets we receive as collateral. We have not sold or pledged any of the noncash collateral received under these agreements.
(d)Includes derivative liabilities with no offsetting arrangements of $1 million as of March 31, 2026.
(e)For additional information on securities sold under agreements to repurchase, refer to Note 12.
v3.26.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
Financial information for our reportable operating segments is summarized as follows.
Three months ended March 31, ($ in millions)
Automotive Finance operationsInsurance operationsCorporate Finance operationsCorporate and OtherConsolidated (a)
2026
Net financing revenue and other interest income
Total financing revenue and other interest income$2,687 $49 $243 $395 $3,374 
Total interest expense1,128 13 130 246 1,517 
Net depreciation expense on operating lease assets268 — — — 268 
Net financing revenue and other interest income1,291 36 113 149 1,589 
Other revenue105 342 35 31 513 
Total net revenue1,396 378 148 180 2,102 
Provision for credit losses468 — 8 (9)467 
Noninterest expense
Compensation and benefits expense191 32 26 242 491 
Insurance losses and loss adjustment expenses— 121 — — 121 
Other operating expenses
Technology and communications expenses28 4 1 68 101 
Other (b)373 193 19 (63)522 
Total other operating expenses401 197 20 5 623 
Total noninterest expense592 350 46 247 1,235 
Income (loss) from continuing operations before income tax expense (benefit)$336 $28 $94 $(58)$400 
Total assets$117,612 $9,888 $13,803 $55,966 $197,269 
2025
Net financing revenue and other interest income
Total financing revenue and other interest income$2,571 $44 $221 $557 $3,393 
Total interest expense1,065 14 117 479 1,675 
Net depreciation expense on operating lease assets240 — — — 240 
Net financing revenue and other interest income1,266 30 104 78 1,478 
Other revenue97 364 29 (427)63 
Total net revenue1,363 394 133 (349)1,541 
Provision for credit losses434 — 14 (257)191 
Noninterest expense
Compensation and benefits expense183 30 25 267 505 
Insurance losses and loss adjustment expenses— 161 — — 161 
Goodwill impairment (c)— — — 305 305 
Other operating expenses
Technology and communications expenses29 5 1 68 103 
Other (b)342 196 17 5 560 
Total other operating expenses371 201 18 73 663 
Total noninterest expense554 392 43 645 1,634 
Income (loss) from continuing operations before income tax expense (benefit)$375 $2 $76 $(737)$(284)
Total assets$111,672 $9,489 $11,002 $61,168 $193,331 
(a)Net financing revenue and other interest income after the provision for credit losses totaled $1.1 billion and $1.3 billion for the three months ended March 31, 2026, and 2025, respectively.
(b)Primarily consists of insurance commissions, advertising and marketing, and property and equipment depreciation expenses. Refer to Note 5 for additional information.
(c)Impairment of goodwill related to Ally Credit Card for the three months ended March 31, 2025. Refer to Note 2 to the Consolidated Financial Statements in our 2025 Annual Report on Form 10-K for additional information on Ally Credit Card.
v3.26.1
Revenue from Contracts with Customers (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers $ 307 $ 323    
All other revenue 206 (260)    
Total other revenue 513 63    
Remarketing losses, net 10 19    
Automotive Finance operations        
Disaggregation of Revenue [Line Items]        
Remarketing losses, net 10 19    
Noninsurance contracts        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 242 241    
Noninsurance contracts | Insurance operations        
Disaggregation of Revenue [Line Items]        
Unearned revenue, remaining performance obligation, amount 3,000 3,000 $ 3,000 $ 3,000
Unearned revenue, revenue recognized 239 238    
Capitalized contract cost, net 1,800 1,800 $ 1,800 $ 1,800
Capitalized contract cost, amortization 138 141    
Noninsurance contracts | Insurance operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-04-01        
Disaggregation of Revenue [Line Items]        
Unearned revenue, remaining performance obligation, amount $ 653      
Remaining performance obligation, expected timing of satisfaction, period 9 months      
Noninsurance contracts | Insurance operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01        
Disaggregation of Revenue [Line Items]        
Unearned revenue, remaining performance obligation, amount $ 751      
Remaining performance obligation, expected timing of satisfaction, period 1 year      
Noninsurance contracts | Insurance operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2028-01-01        
Disaggregation of Revenue [Line Items]        
Unearned revenue, remaining performance obligation, amount $ 599      
Remaining performance obligation, expected timing of satisfaction, period 1 year      
Noninsurance contracts | Insurance operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2029-01-01        
Disaggregation of Revenue [Line Items]        
Unearned revenue, remaining performance obligation, amount $ 440      
Remaining performance obligation, expected timing of satisfaction, period 1 year      
Noninsurance contracts | Insurance operations | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2030-01-01        
Disaggregation of Revenue [Line Items]        
Unearned revenue, remaining performance obligation, amount $ 544      
Remaining performance obligation, expected timing of satisfaction, period      
Remarketing fee income        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers $ 32 31    
Brokerage commissions and other revenue        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 19 20    
Banking fees and interchange income        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 5 19    
Customer rewards expense   6    
Brokered/agent commissions        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 2 5    
Other        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 7 7    
Operating Segments | Automotive Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 38 36    
All other revenue 67 61    
Total other revenue 105 97    
Operating Segments | Insurance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 244 247    
All other revenue 98 117    
Total other revenue 342 364    
Operating Segments | Corporate Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
All other revenue 35 29    
Total other revenue 35 29    
Operating Segments | Noninsurance contracts | Automotive Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Operating Segments | Noninsurance contracts | Insurance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 242 241    
Operating Segments | Noninsurance contracts | Corporate Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Operating Segments | Remarketing fee income | Automotive Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 32 31    
Operating Segments | Remarketing fee income | Insurance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Operating Segments | Remarketing fee income | Corporate Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Operating Segments | Brokerage commissions and other revenue | Automotive Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Operating Segments | Brokerage commissions and other revenue | Insurance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Operating Segments | Brokerage commissions and other revenue | Corporate Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Operating Segments | Banking fees and interchange income | Automotive Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Operating Segments | Banking fees and interchange income | Insurance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Operating Segments | Banking fees and interchange income | Corporate Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Operating Segments | Brokered/agent commissions | Automotive Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Operating Segments | Brokered/agent commissions | Insurance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 2 5    
Operating Segments | Brokered/agent commissions | Corporate Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Operating Segments | Other | Automotive Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 6 5    
Operating Segments | Other | Insurance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 1    
Operating Segments | Other | Corporate Finance operations        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Corporate and Other        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 25 40    
All other revenue 6 (467)    
Total other revenue 31 (427)    
Corporate and Other | Noninsurance contracts        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Corporate and Other | Remarketing fee income        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Corporate and Other | Brokerage commissions and other revenue        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 19 20    
Corporate and Other | Banking fees and interchange income        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 5 19    
Corporate and Other | Brokered/agent commissions        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers 0 0    
Corporate and Other | Other        
Disaggregation of Revenue [Line Items]        
Revenue from contracts with customers $ 1 $ 1    
v3.26.1
Other Income, Net of Losses (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Other Nonoperating Income (Expense) [Abstract]    
Late charges and other administrative fees $ 36 $ 51
Remarketing fees 32 31
Income from equity-method investments 17 26
Other, net 92 89
Total other income, net of losses $ 177 $ 197
v3.26.1
Reserves for Insurance Losses and Loss Adjustment Expenses - Schedule of Rollforward of Our Reserves for Insurance Losses and Loss Adjustment Expenses (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]        
Total gross reserves for insurance losses and loss adjustment expenses, beginning balance $ 233 $ 189    
Less: Reinsurance recoverable 69 60    
Net reserves for insurance losses and loss adjustment expenses 180 192 $ 164 $ 129
Current year 122 161    
Prior years (1) 0    
Total net insurance losses and loss adjustment expenses incurred 121 161    
Current year (50) (44)    
Prior years (55) (54)    
Total net insurance losses and loss adjustment expenses paid or payable (105) (98)    
Plus: Reinsurance recoverable 71 76    
Total gross reserves for insurance losses and loss adjustment expenses, ending balance $ 251 $ 268    
v3.26.1
Other Operating Expenses (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Expenses [Abstract]    
Insurance commissions $ 152 $ 161
Technology and communications 101 103
Advertising and marketing 60 61
Property and equipment depreciation 59 63
Lease and loan administration 45 46
Regulatory and licensing fees 36 44
Professional services 35 31
Vehicle remarketing and repossession 34 33
Amortization of intangible assets 0 3
Other 101 118
Total other operating expenses $ 623 $ 663
v3.26.1
Investment Securities - Schedule of Investment Portfolio (Details) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Available-for-sale securities    
Amortized cost basis $ 25,974,000,000 $ 25,825,000,000
Gross unrealized gains 41,000,000 76,000,000
Gross unrealized losses (2,977,000,000) (2,928,000,000)
Fair value 23,038,000,000 22,973,000,000
Held-to-maturity securities    
Amortized cost basis 4,337,000,000 4,371,000,000
Gross unrealized gains 207,000,000 237,000,000
Gross unrealized losses (157,000,000) (157,000,000)
Fair value 4,387,000,000 4,451,000,000
Debt securities, available-for-sale, accrued interest receivable $ 86,000,000 $ 87,000,000
Debt securities, available-for-sale, accrued interest, after allowance for credit loss, statement of financial position [extensible enumeration] Other assets Other assets
Debt securities, available-for-sale, allowance for credit loss, excluding accrued interest $ 0 $ 0
Debt securities, held-to-maturity, allowance for credit loss, excluding accrued interest 0 0
Debt securities, held-to-maturity, accrued interest receivable 12,000,000 13,000,000
Operating Segments | Insurance operations    
Held-to-maturity securities    
Deposited securities 14,000,000 14,000,000
Asset Pledged as Collateral with Right    
Available-for-sale securities    
Fair value 3,500,000,000 3,700,000,000
Held-to-maturity securities    
Securities with the right to sell or pledge 866,000,000 932,000,000
Asset Pledged as Collateral with Right | Federal Home Loan Bank Advances    
Held-to-maturity securities    
Securities with the right to sell or pledge 2,700,000,000 2,700,000,000
U.S. Treasury and federal agencies    
Available-for-sale securities    
Amortized cost basis 2,444,000,000 2,308,000,000
Gross unrealized gains 8,000,000 22,000,000
Gross unrealized losses (55,000,000) (51,000,000)
Fair value 2,397,000,000 2,279,000,000
U.S. States and political subdivisions    
Available-for-sale securities    
Amortized cost basis 593,000,000 624,000,000
Gross unrealized gains 0 1,000,000
Gross unrealized losses (76,000,000) (74,000,000)
Fair value 517,000,000 551,000,000
Foreign government    
Available-for-sale securities    
Amortized cost basis 202,000,000 191,000,000
Gross unrealized gains 1,000,000 1,000,000
Gross unrealized losses (4,000,000) (4,000,000)
Fair value 199,000,000 188,000,000
Agency mortgage-backed residential    
Available-for-sale securities    
Amortized cost basis 14,787,000,000 14,966,000,000
Gross unrealized gains 16,000,000 19,000,000
Gross unrealized losses (2,108,000,000) (2,084,000,000)
Fair value 12,695,000,000 12,901,000,000
Held-to-maturity securities    
Amortized cost basis 1,337,000,000 1,303,000,000
Gross unrealized gains 3,000,000 8,000,000
Gross unrealized losses (157,000,000) (157,000,000)
Fair value 1,183,000,000 1,154,000,000
Hedged liability, fair value hedge, cumulative increase (decrease) 31,000,000  
Hedged asset, fair value hedge, cumulative increase (decrease)   13,000,000
Mortgage-backed residential    
Available-for-sale securities    
Amortized cost basis 226,000,000 230,000,000
Gross unrealized gains 0 0
Gross unrealized losses (33,000,000) (32,000,000)
Fair value 193,000,000 198,000,000
Held-to-maturity securities    
Amortized cost basis 2,957,000,000 3,018,000,000
Gross unrealized gains 203,000,000 228,000,000
Gross unrealized losses 0 0
Fair value 3,160,000,000 3,246,000,000
Agency mortgage-backed commercial    
Available-for-sale securities    
Amortized cost basis 5,729,000,000 5,540,000,000
Gross unrealized gains 8,000,000 14,000,000
Gross unrealized losses (630,000,000) (622,000,000)
Fair value 5,107,000,000 4,932,000,000
Held-to-maturity securities    
Hedged asset, fair value hedge, cumulative increase (decrease) 10,000,000 33,000,000
Asset-backed    
Available-for-sale securities    
Amortized cost basis 2,000,000 12,000,000
Gross unrealized gains 0 0
Gross unrealized losses 0 0
Fair value 2,000,000 12,000,000
Held-to-maturity securities    
Amortized cost basis 43,000,000 50,000,000
Gross unrealized gains 1,000,000 1,000,000
Gross unrealized losses 0 0
Fair value 44,000,000 51,000,000
Corporate debt    
Available-for-sale securities    
Amortized cost basis 1,991,000,000 1,954,000,000
Gross unrealized gains 8,000,000 19,000,000
Gross unrealized losses (71,000,000) (61,000,000)
Fair value $ 1,928,000,000 $ 1,912,000,000
v3.26.1
Investment Securities - Schedule of Investments Classified by Contractual Maturity Date (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Amount      
Total available-for-sale securities $ 23,038   $ 22,973
Due in one year or less 480   465
Due after one year through five years 4,737   4,228
Due after five years through ten years 3,616   3,581
Due after ten years $ 14,205   $ 14,699
Yield      
Total 3.00%   3.00%
Due in one year or less 2.80%   2.50%
Due after one year through five years 3.30%   3.40%
Due after five years through ten years 3.00%   2.90%
Due after ten years 2.90%   2.90%
Amortized cost basis of available-for-sale securities      
Amortized cost basis $ 25,974   $ 25,825
Due in one year or less 483   468
Due after one year through five years 4,871   4,298
Due after five years through ten years 4,046   3,968
Due after ten years 16,574   17,091
Amount      
Amortized cost basis 4,337   4,371
Due in one year or less 0   0
Due after one year through five years 34   40
Due after five years through ten years 14   16
Due after ten years $ 4,289   $ 4,315
Yield      
Total 3.00%   3.00%
Due in one year or less 0.00%   0.00%
Due after one year through five years 5.00%   5.00%
Due after five years through ten years 5.70%   5.70%
Due after ten years 3.00%   3.00%
Cash equivalents $ 444   $ 107
Taxable interest 214 $ 210  
Taxable dividends 4 5  
Interest and dividends exempt from U.S. federal income tax 5 6  
Interest and dividends on investment securities and other earning assets 223 $ 221  
U.S. Treasury and federal agencies      
Amount      
Total available-for-sale securities 2,397   2,279
Due in one year or less 68   84
Due after one year through five years 2,050   1,771
Due after five years through ten years 279   424
Due after ten years $ 0   $ 0
Yield      
Total 3.50%   3.40%
Due in one year or less 1.50%   0.80%
Due after one year through five years 3.70%   3.90%
Due after five years through ten years 2.30%   2.00%
Due after ten years 0.00%   0.00%
Amortized cost basis of available-for-sale securities      
Amortized cost basis $ 2,444   $ 2,308
U.S. States and political subdivisions      
Amount      
Total available-for-sale securities 517   551
Due in one year or less 39   48
Due after one year through five years 54   50
Due after five years through ten years 53   65
Due after ten years $ 371   $ 388
Yield      
Total 3.40%   3.40%
Due in one year or less 5.10%   4.80%
Due after one year through five years 3.70%   3.70%
Due after five years through ten years 4.50%   4.30%
Due after ten years 3.10%   3.10%
Amortized cost basis of available-for-sale securities      
Amortized cost basis $ 593   $ 624
Foreign government      
Amount      
Total available-for-sale securities 199   188
Due in one year or less 14   14
Due after one year through five years 92   75
Due after five years through ten years 93   99
Due after ten years $ 0   $ 0
Yield      
Total 2.80%   2.80%
Due in one year or less 1.90%   2.00%
Due after one year through five years 2.30%   2.30%
Due after five years through ten years 3.40%   3.30%
Due after ten years 0.00%   0.00%
Amortized cost basis of available-for-sale securities      
Amortized cost basis $ 202   $ 191
Agency mortgage-backed residential      
Amount      
Total available-for-sale securities 12,695   12,901
Due in one year or less 0   0
Due after one year through five years 1   1
Due after five years through ten years 0   0
Due after ten years $ 12,694   $ 12,900
Yield      
Total 2.90%   2.90%
Due in one year or less 0.00%   0.00%
Due after one year through five years 2.80%   2.80%
Due after five years through ten years 0.00%   0.00%
Due after ten years 2.90%   2.90%
Amortized cost basis of available-for-sale securities      
Amortized cost basis $ 14,787   $ 14,966
Amount      
Amortized cost basis 1,337   1,303
Due in one year or less 0   0
Due after one year through five years 0   0
Due after five years through ten years 0   0
Due after ten years $ 1,337   $ 1,303
Yield      
Total 3.50%   3.50%
Due in one year or less 0.00%   0.00%
Due after one year through five years 0.00%   0.00%
Due after five years through ten years 0.00%   0.00%
Due after ten years 3.50%   3.50%
Hedged liability, fair value hedge, cumulative increase (decrease) $ 31    
Hedged asset, fair value hedge, cumulative increase (decrease)     $ 13
Mortgage-backed residential      
Amount      
Total available-for-sale securities 193   198
Due in one year or less 0   0
Due after one year through five years 0   0
Due after five years through ten years 0   0
Due after ten years $ 193   $ 198
Yield      
Total 2.70%   2.70%
Due in one year or less 0.00%   0.00%
Due after one year through five years 0.00%   0.00%
Due after five years through ten years 0.00%   0.00%
Due after ten years 2.70%   2.70%
Amortized cost basis of available-for-sale securities      
Amortized cost basis $ 226   $ 230
Amount      
Amortized cost basis 2,957   3,018
Due in one year or less 0   0
Due after one year through five years 4   5
Due after five years through ten years 1   1
Due after ten years $ 2,952   $ 3,012
Yield      
Total 2.80%   2.80%
Due in one year or less 0.00%   0.00%
Due after one year through five years 2.90%   2.90%
Due after five years through ten years 5.30%   5.50%
Due after ten years 2.80%   2.80%
Agency mortgage-backed commercial      
Amount      
Total available-for-sale securities $ 5,107   $ 4,932
Due in one year or less 144   87
Due after one year through five years 1,647   1,453
Due after five years through ten years 2,491   2,314
Due after ten years $ 825   $ 1,078
Yield      
Total 2.70%   2.70%
Due in one year or less 3.10%   3.40%
Due after one year through five years 3.30%   3.50%
Due after five years through ten years 2.40%   2.40%
Due after ten years 2.30%   2.30%
Amortized cost basis of available-for-sale securities      
Amortized cost basis $ 5,729   $ 5,540
Yield      
Hedged asset, fair value hedge, cumulative increase (decrease) 10   33
Asset-backed      
Amount      
Total available-for-sale securities 2   12
Due in one year or less 1   0
Due after one year through five years 1   12
Due after five years through ten years 0   0
Due after ten years $ 0   $ 0
Yield      
Total 1.50%   1.50%
Due in one year or less 1.50%   0.00%
Due after one year through five years 1.30%   1.50%
Due after five years through ten years 0.00%   0.00%
Due after ten years 0.00%   0.00%
Amortized cost basis of available-for-sale securities      
Amortized cost basis $ 2   $ 12
Amount      
Amortized cost basis 43   50
Due in one year or less 0   0
Due after one year through five years 30   35
Due after five years through ten years 13   15
Due after ten years $ 0   $ 0
Yield      
Total 5.40%   5.40%
Due in one year or less 0.00%   0.00%
Due after one year through five years 5.30%   5.30%
Due after five years through ten years 5.70%   5.70%
Due after ten years 0.00%   0.00%
Corporate debt      
Amount      
Total available-for-sale securities $ 1,928   $ 1,912
Due in one year or less 214   232
Due after one year through five years 892   866
Due after five years through ten years 700   679
Due after ten years $ 122   $ 135
Yield      
Total 3.60%   3.40%
Due in one year or less 2.60%   2.40%
Due after one year through five years 2.50%   2.50%
Due after five years through ten years 4.90%   4.60%
Due after ten years 5.40%   5.50%
Amortized cost basis of available-for-sale securities      
Amortized cost basis $ 1,991   $ 1,954
v3.26.1
Investment Securities - Schedule of Investment Income (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Investments, Debt and Equity Securities [Abstract]    
Taxable interest $ 214 $ 210
Taxable dividends 4 5
Interest and dividends exempt from U.S. federal income tax 5 6
Interest and dividends on investment securities $ 223 $ 221
v3.26.1
Investment Securities - Schedule Of Realized Gain (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Investments, Debt and Equity Securities [Abstract]    
Gross realized gains $ 3 $ 0
Gross realized losses 0 (495)
Net realized gain (loss) on available-for-sale securities 3 (495)
Net realized gain on equity securities 35 8
Net unrealized loss on equity securities (59) (12)
Other loss on investments, net $ (21) $ (499)
v3.26.1
Investment securities - Schedule of Investments Classified by Credit Rating (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities $ 4,337 $ 4,371
Agency mortgage-backed residential    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 1,337 1,303
Mortgage-backed residential    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 2,957 3,018
Asset-backed    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 43 50
AAA    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 2,931 2,996
AAA | Agency mortgage-backed residential    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 0 0
AAA | Mortgage-backed residential    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 2,893 2,951
AAA | Asset-backed    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 38 45
AA    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 1,403 1,371
AA | Agency mortgage-backed residential    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 1,337 1,303
AA | Mortgage-backed residential    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 63 66
AA | Asset-backed    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 3 2
A    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 2 3
A | Agency mortgage-backed residential    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 0 0
A | Mortgage-backed residential    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 1 1
A | Asset-backed    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 1 2
BBB    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 1 1
BBB | Agency mortgage-backed residential    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 0 0
BBB | Mortgage-backed residential    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities 0 0
BBB | Asset-backed    
Schedule of Held-to-maturity Securities [Line Items]    
Held-to-maturity securities $ 1 $ 1
v3.26.1
Investment Securities - Schedule of Unrealized Loss on Investments (Details) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Less than 12 months    
Fair value $ 2,058,000,000 $ 580,000,000
Unrealized loss (23,000,000) (3,000,000)
12 months or longer    
Fair value 15,748,000,000 16,382,000,000
Unrealized loss (2,954,000,000) (2,925,000,000)
Credit reserves, available-for-sale 0 0
Credit reserves, held-to-maturity 0 0
U.S. Treasury and federal agencies    
Less than 12 months    
Fair value 267,000,000 0
Unrealized loss (1,000,000) 0
12 months or longer    
Fair value 572,000,000 609,000,000
Unrealized loss (54,000,000) (51,000,000)
U.S. States and political subdivisions    
Less than 12 months    
Fair value 47,000,000 24,000,000
Unrealized loss (1,000,000) 0
12 months or longer    
Fair value 398,000,000 429,000,000
Unrealized loss (75,000,000) (74,000,000)
Foreign government    
Less than 12 months    
Fair value 91,000,000 51,000,000
Unrealized loss (1,000,000) (1,000,000)
12 months or longer    
Fair value 67,000,000 72,000,000
Unrealized loss (3,000,000) (3,000,000)
Agency mortgage-backed residential    
Less than 12 months    
Fair value 552,000,000 120,000,000
Unrealized loss (7,000,000) 0
12 months or longer    
Fair value 9,938,000,000 10,310,000,000
Unrealized loss (2,101,000,000) (2,084,000,000)
Mortgage-backed residential    
Less than 12 months    
Fair value 0 0
Unrealized loss 0 0
12 months or longer    
Fair value 193,000,000 198,000,000
Unrealized loss (33,000,000) (32,000,000)
Agency mortgage-backed commercial    
Less than 12 months    
Fair value 678,000,000 299,000,000
Unrealized loss (6,000,000) (1,000,000)
12 months or longer    
Fair value 3,548,000,000 3,629,000,000
Unrealized loss (624,000,000) (621,000,000)
Asset-backed    
Less than 12 months    
Fair value 0 0
Unrealized loss 0 0
12 months or longer    
Fair value 2,000,000 12,000,000
Unrealized loss 0 0
Corporate debt    
Less than 12 months    
Fair value 423,000,000 86,000,000
Unrealized loss (7,000,000) (1,000,000)
12 months or longer    
Fair value 1,030,000,000 1,123,000,000
Unrealized loss $ (64,000,000) $ (60,000,000)
v3.26.1
Finance Receivables and Loans, Net - Schedule of Accounts, Notes, Loans and Financing Receivables (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total finance receivables and loans $ 139,890 $ 137,454
Unamortized premiums and discounts and deferred fees and costs 2,500 2,400
Accrued interest receivable 790 800
Consumer    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total finance receivables and loans 101,973 101,140
Consumer | Consumer automotive    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total finance receivables and loans 86,662 85,568
Consumer | Consumer mortgage    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total finance receivables and loans 15,311 15,572
Interest-only mortgage loans 2 2
Commercial    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total finance receivables and loans 37,917 36,314
Commercial | Consumer automotive    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total finance receivables and loans 18,972 18,339
Commercial | Consumer mortgage    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total finance receivables and loans 7,852 7,666
Commercial | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total finance receivables and loans $ 11,093 $ 10,309
v3.26.1
Finance Receivables and Loans, Net - Schedule of Allowance for Credit Losses on Financing Receivables (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]      
Allowance, beginning balance $ 3,490 $ 3,714 $ 3,714
Charge-offs (672) (745) (2,683)
Recoveries 255 238  
Net charge-offs (417) (507)  
Provision for credit losses 467 191  
Other 0 0  
Allowance, ending balance 3,540 3,398 3,490
Consumer      
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]      
Charge-offs (671)   (2,681)
Consumer | Consumer automotive      
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]      
Allowance, beginning balance 3,208 3,170 3,170
Charge-offs (671) (676) (2,610)
Recoveries 247 231  
Net charge-offs (424) (445)  
Provision for credit losses 467 418  
Other (1) 1  
Allowance, ending balance 3,250 3,144 3,208
Consumer | Consumer mortgage      
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]      
Allowance, beginning balance 12 19 19
Charge-offs 0 0 (3)
Recoveries 8 1  
Net charge-offs 8 1  
Provision for credit losses (9) 0  
Other 0 (2)  
Allowance, ending balance 11 18 12
Consumer | Other      
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]      
Allowance, beginning balance   319 319
Charge-offs   (68) (68)
Recoveries   5  
Net charge-offs   (63)  
Provision for credit losses   (257)  
Other   1  
Allowance, ending balance   0  
Commercial      
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]      
Allowance, beginning balance 270 206 206
Charge-offs (1) (1) (2)
Recoveries 0 1  
Net charge-offs (1) 0  
Provision for credit losses 9 30  
Other 1 0  
Allowance, ending balance 279 $ 236 270
Commercial | Consumer automotive      
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]      
Charge-offs     $ (2)
Commercial | Other      
Financing Receivable, Excluding Accrued Interest, Allowance for Credit Loss [Roll Forward]      
Charge-offs $ (1)    
v3.26.1
Finance Receivables and Loans, Net - Schedule of Sales of Financing Receivables and Loans (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total sales and transfers $ 7 $ 2,321
Consumer | Other    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total sales and transfers 0 2,248
Commercial    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total sales and transfers $ 7 $ 73
v3.26.1
Finance Receivables and Loans, Net - Schedule of Purchases of Financing Receivables and Loans (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total purchases of finance receivables and loans $ 1,624 $ 757
Consumer | Consumer automotive    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total purchases of finance receivables and loans 1,622 749
Consumer | Consumer mortgage    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total purchases of finance receivables and loans 0 8
Commercial    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Total purchases of finance receivables and loans $ 2 $ 0
v3.26.1
Finance Receivables and Loans, Net - Schedule of Financing Receivables, Nonaccrual Status (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Financing receivable, recorded investment, nonaccrual status $ 1,306   $ 1,366 $ 1,486
Financing receivable, nonaccrual, with no allowance 457   485  
Financing receivable, nonaccrual, interest income 13 $ 4    
Consumer        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Financing receivable, recorded investment, nonaccrual status 1,190   1,217 1,375
Financing receivable, nonaccrual, with no allowance 450   460  
Consumer | Consumer automotive        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Financing receivable, recorded investment, nonaccrual status 1,128   1,155 1,231
Financing receivable, nonaccrual, with no allowance 410   416  
Consumer | Consumer mortgage        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Financing receivable, recorded investment, nonaccrual status 62   62 54
Financing receivable, nonaccrual, with no allowance 40   44  
Consumer | Other        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Financing receivable, recorded investment, nonaccrual status     0 90
Financing receivable, nonaccrual, with no allowance     0  
Commercial        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Financing receivable, recorded investment, nonaccrual status 116   149 111
Financing receivable, nonaccrual, with no allowance 7   25  
Commercial | Consumer automotive        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Financing receivable, recorded investment, nonaccrual status 3   15 15
Financing receivable, nonaccrual, with no allowance 3   15  
Commercial | Consumer mortgage        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Financing receivable, recorded investment, nonaccrual status 1   10 2
Financing receivable, nonaccrual, with no allowance 1   10  
Commercial | Other        
Accounts, Notes, Loans and Financing Receivable [Line Items]        
Financing receivable, recorded investment, nonaccrual status 112   124 $ 94
Financing receivable, nonaccrual, with no allowance $ 3   $ 0  
v3.26.1
Finance Receivables and Loans, Net - Schedule of Financing Receivable Credit Quality Indicators Consumer (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Financing Receivable, Credit Quality Indicator [Line Items]    
Total finance receivables and loans $ 139,890 $ 137,454
Consumer    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total finance receivables and loans 101,973 101,140
Consumer | Consumer automotive, excludes basis adjustment    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 10,328 34,282
Year two, originated, fiscal year before current fiscal year 31,638 20,900
Year three, originated, two years before current fiscal year 18,737 13,789
Year four, originated, three years before current fiscal year 12,171 9,870
Year five, originated, four years before current fiscal year 8,484 4,799
Originated, more than five years before current fiscal year 5,328 1,922
Revolving loans 0 0
Revolving loans converted to term 0 0
Total finance receivables and loans 86,686 85,562
Consumer | Consumer automotive, excludes basis adjustment | Current    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 10,303 33,588
Year two, originated, fiscal year before current fiscal year 30,792 19,891
Year three, originated, two years before current fiscal year 17,844 12,759
Year four, originated, three years before current fiscal year 11,317 8,885
Year five, originated, four years before current fiscal year 7,695 4,253
Originated, more than five years before current fiscal year 4,750 1,696
Revolving loans 0 0
Revolving loans converted to term 0 0
Total finance receivables and loans 82,701 81,072
Consumer | Consumer automotive, excludes basis adjustment | 30–59 days past due    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 24 483
Year two, originated, fiscal year before current fiscal year 563 638
Year three, originated, two years before current fiscal year 567 632
Year four, originated, three years before current fiscal year 529 600
Year five, originated, four years before current fiscal year 477 339
Originated, more than five years before current fiscal year 356 137
Revolving loans 0 0
Revolving loans converted to term 0 0
Total finance receivables and loans 2,516 2,829
Consumer | Consumer automotive, excludes basis adjustment | 60–89 days past due    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 1 156
Year two, originated, fiscal year before current fiscal year 200 272
Year three, originated, two years before current fiscal year 236 295
Year four, originated, three years before current fiscal year 236 284
Year five, originated, four years before current fiscal year 226 148
Originated, more than five years before current fiscal year 153 60
Revolving loans 0 0
Revolving loans converted to term 0 0
Total finance receivables and loans 1,052 1,215
Consumer | Consumer automotive, excludes basis adjustment | 90 or more days past due    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 55
Year two, originated, fiscal year before current fiscal year 83 99
Year three, originated, two years before current fiscal year 90 103
Year four, originated, three years before current fiscal year 89 101
Year five, originated, four years before current fiscal year 86 59
Originated, more than five years before current fiscal year 69 29
Revolving loans 0 0
Revolving loans converted to term 0 0
Total finance receivables and loans 417 446
Consumer | Consumer mortgage    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 0
Year two, originated, fiscal year before current fiscal year 0 15
Year three, originated, two years before current fiscal year 12 30
Year four, originated, three years before current fiscal year 28 1,701
Year five, originated, four years before current fiscal year 1,679 9,150
Originated, more than five years before current fiscal year 13,583 4,667
Revolving loans 0 0
Revolving loans converted to term 9 9
Total finance receivables and loans 15,311 15,572
Consumer | Consumer mortgage | Current    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 0
Year two, originated, fiscal year before current fiscal year 0 15
Year three, originated, two years before current fiscal year 12 28
Year four, originated, three years before current fiscal year 26 1,690
Year five, originated, four years before current fiscal year 1,670 9,117
Originated, more than five years before current fiscal year 13,506 4,618
Revolving loans 0 0
Revolving loans converted to term 7 7
Total finance receivables and loans 15,221 15,475
Consumer | Consumer mortgage | 30–59 days past due    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 0
Year two, originated, fiscal year before current fiscal year 0 0
Year three, originated, two years before current fiscal year 0 2
Year four, originated, three years before current fiscal year 0 5
Year five, originated, four years before current fiscal year 3 11
Originated, more than five years before current fiscal year 35 17
Revolving loans 0 0
Revolving loans converted to term 0 0
Total finance receivables and loans 38 35
Consumer | Consumer mortgage | 60–89 days past due    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 0
Year two, originated, fiscal year before current fiscal year 0 0
Year three, originated, two years before current fiscal year 0 0
Year four, originated, three years before current fiscal year 1 1
Year five, originated, four years before current fiscal year 1 6
Originated, more than five years before current fiscal year 8 7
Revolving loans 0 0
Revolving loans converted to term 0 0
Total finance receivables and loans 10 14
Consumer | Consumer mortgage | 90 or more days past due    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 0
Year two, originated, fiscal year before current fiscal year 0 0
Year three, originated, two years before current fiscal year 0 0
Year four, originated, three years before current fiscal year 1 5
Year five, originated, four years before current fiscal year 5 16
Originated, more than five years before current fiscal year 34 25
Revolving loans 0 0
Revolving loans converted to term 2 2
Total finance receivables and loans 42 48
Consumer | Consumer automotive    
Financing Receivable, Credit Quality Indicator [Line Items]    
Total finance receivables and loans 86,662 85,568
Liability excluded from amortized cost of hedged asset, portfolio layer method 24  
Asset excluded from amortized cost of hedged asset, portfolio layer method   6
Consumer Portfolio Segment, Excludes Basis Adjustment for Automotive Loans    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 10,328 34,282
Year two, originated, fiscal year before current fiscal year 31,638 20,915
Year three, originated, two years before current fiscal year 18,749 13,819
Year four, originated, three years before current fiscal year 12,199 11,571
Year five, originated, four years before current fiscal year 10,163 13,949
Originated, more than five years before current fiscal year 18,911 6,589
Revolving loans 0 0
Revolving loans converted to term 9 9
Total finance receivables and loans $ 101,997 $ 101,134
v3.26.1
Finance Receivables and Loans, Net - Schedule of Financing Receivable Credit Quality Indicators Commercial (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Financing Receivable, Credit Quality Indicator [Line Items]    
Total finance receivables and loans $ 139,890 $ 137,454
Commercial    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 1,282 3,683
Year two, originated, fiscal year before current fiscal year 3,782 2,148
Year three, originated, two years before current fiscal year 2,051 1,252
Year four, originated, three years before current fiscal year 1,244 1,982
Year five, originated, four years before current fiscal year 1,873 1,427
Originated, more than five years before current fiscal year 3,353 2,208
Revolving loans 24,029 23,356
Revolving loans converted to term 303 258
Total finance receivables and loans 37,917 36,314
Commercial | Consumer automotive    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 630 945
Year two, originated, fiscal year before current fiscal year 928 393
Year three, originated, two years before current fiscal year 341 272
Year four, originated, three years before current fiscal year 258 277
Year five, originated, four years before current fiscal year 264 113
Originated, more than five years before current fiscal year 172 91
Revolving loans 16,379 16,248
Revolving loans converted to term 0 0
Total finance receivables and loans 18,972 18,339
Commercial | Consumer automotive | Pass    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 630 942
Year two, originated, fiscal year before current fiscal year 923 391
Year three, originated, two years before current fiscal year 340 257
Year four, originated, three years before current fiscal year 243 266
Year five, originated, four years before current fiscal year 254 113
Originated, more than five years before current fiscal year 167 86
Revolving loans 14,816 14,861
Revolving loans converted to term 0 0
Total finance receivables and loans 17,373 16,916
Commercial | Consumer automotive | Special mention    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 2
Year two, originated, fiscal year before current fiscal year 5 1
Year three, originated, two years before current fiscal year 0 15
Year four, originated, three years before current fiscal year 15 10
Year five, originated, four years before current fiscal year 9 0
Originated, more than five years before current fiscal year 5 5
Revolving loans 1,509 1,328
Revolving loans converted to term 0 0
Total finance receivables and loans 1,543 1,361
Commercial | Consumer automotive | Substandard    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 1
Year two, originated, fiscal year before current fiscal year 0 1
Year three, originated, two years before current fiscal year 1 0
Year four, originated, three years before current fiscal year 0 1
Year five, originated, four years before current fiscal year 1 0
Originated, more than five years before current fiscal year 0 0
Revolving loans 54 59
Revolving loans converted to term 0 0
Total finance receivables and loans 56 62
Commercial | Other    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 256 757
Year two, originated, fiscal year before current fiscal year 753 641
Year three, originated, two years before current fiscal year 667 173
Year four, originated, three years before current fiscal year 193 542
Year five, originated, four years before current fiscal year 497 350
Originated, more than five years before current fiscal year 909 594
Revolving loans 7,584 7,053
Revolving loans converted to term 234 199
Total finance receivables and loans 11,093 10,309
Commercial | Other | Pass    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 256 757
Year two, originated, fiscal year before current fiscal year 684 594
Year three, originated, two years before current fiscal year 596 173
Year four, originated, three years before current fiscal year 193 306
Year five, originated, four years before current fiscal year 235 215
Originated, more than five years before current fiscal year 368 166
Revolving loans 7,124 6,647
Revolving loans converted to term 228 191
Total finance receivables and loans 9,684 9,049
Commercial | Other | Special mention    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 0
Year two, originated, fiscal year before current fiscal year 69 47
Year three, originated, two years before current fiscal year 71 0
Year four, originated, three years before current fiscal year 0 236
Year five, originated, four years before current fiscal year 262 115
Originated, more than five years before current fiscal year 368 260
Revolving loans 390 347
Revolving loans converted to term 6 8
Total finance receivables and loans 1,166 1,013
Commercial | Other | Substandard    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 0
Year two, originated, fiscal year before current fiscal year 0 0
Year three, originated, two years before current fiscal year 0 0
Year four, originated, three years before current fiscal year 0 0
Year five, originated, four years before current fiscal year 0 20
Originated, more than five years before current fiscal year 80 61
Revolving loans 51 42
Revolving loans converted to term 0 0
Total finance receivables and loans 131 123
Commercial | Other | Doubtful    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 0
Year two, originated, fiscal year before current fiscal year 0 0
Year three, originated, two years before current fiscal year 0 0
Year four, originated, three years before current fiscal year 0 0
Year five, originated, four years before current fiscal year 0 0
Originated, more than five years before current fiscal year 93 107
Revolving loans 19 17
Revolving loans converted to term 0 0
Total finance receivables and loans 112 124
Commercial | Commercial real estate    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 396 1,981
Year two, originated, fiscal year before current fiscal year 2,101 1,114
Year three, originated, two years before current fiscal year 1,043 807
Year four, originated, three years before current fiscal year 793 1,163
Year five, originated, four years before current fiscal year 1,112 964
Originated, more than five years before current fiscal year 2,272 1,523
Revolving loans 66 55
Revolving loans converted to term 69 59
Total finance receivables and loans 7,852 7,666
Commercial | Commercial real estate | Pass    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 389 1,981
Year two, originated, fiscal year before current fiscal year 2,079 1,069
Year three, originated, two years before current fiscal year 998 759
Year four, originated, three years before current fiscal year 754 1,080
Year five, originated, four years before current fiscal year 1,032 919
Originated, more than five years before current fiscal year 2,166 1,461
Revolving loans 66 55
Revolving loans converted to term 69 59
Total finance receivables and loans 7,553 7,383
Commercial | Commercial real estate | Special mention    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 7 0
Year two, originated, fiscal year before current fiscal year 22 45
Year three, originated, two years before current fiscal year 45 44
Year four, originated, three years before current fiscal year 35 67
Year five, originated, four years before current fiscal year 65 45
Originated, more than five years before current fiscal year 105 61
Revolving loans 0 0
Revolving loans converted to term 0 0
Total finance receivables and loans 279 262
Commercial | Commercial real estate | Substandard    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 0
Year two, originated, fiscal year before current fiscal year 0 0
Year three, originated, two years before current fiscal year 0 2
Year four, originated, three years before current fiscal year 2 15
Year five, originated, four years before current fiscal year 15 0
Originated, more than five years before current fiscal year 1 1
Revolving loans 0 0
Revolving loans converted to term 0 0
Total finance receivables and loans 18 18
Commercial | Commercial real estate | Doubtful    
Financing Receivable, Credit Quality Indicator [Line Items]    
Year one, originated, current fiscal year 0 0
Year two, originated, fiscal year before current fiscal year 0 0
Year three, originated, two years before current fiscal year 0 2
Year four, originated, three years before current fiscal year 2 1
Year five, originated, four years before current fiscal year 0 0
Originated, more than five years before current fiscal year 0 0
Revolving loans 0 0
Revolving loans converted to term 0 0
Total finance receivables and loans $ 2 $ 3
v3.26.1
Finance Receivables and Loans, Net - Schedule of Past Due Financing Receivables and Loans Commercial (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net $ 139,890 $ 137,454
Commercial    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 37,917 36,314
Commercial | Total past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 73 73
Commercial | 30–59 days past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 0 0
Commercial | 60–89 days past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 0 0
Commercial | 90 or more days past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 73 73
Commercial | Current    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 37,844 36,241
Commercial | Consumer automotive    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 18,972 18,339
Commercial | Consumer automotive | Total past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 0 0
Commercial | Consumer automotive | 30–59 days past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 0 0
Commercial | Consumer automotive | 60–89 days past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 0 0
Commercial | Consumer automotive | 90 or more days past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 0 0
Commercial | Consumer automotive | Current    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 18,972 18,339
Commercial | Other    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 11,093 10,309
Commercial | Other | Total past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 71 70
Commercial | Other | 30–59 days past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 0 0
Commercial | Other | 60–89 days past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 0 0
Commercial | Other | 90 or more days past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 71 70
Commercial | Other | Current    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 11,022 10,239
Commercial | Commercial real estate    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 7,852 7,666
Commercial | Commercial real estate | Total past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 2 3
Commercial | Commercial real estate | 30–59 days past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 0 0
Commercial | Commercial real estate | 60–89 days past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 0 0
Commercial | Commercial real estate | 90 or more days past due    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net 2 3
Commercial | Commercial real estate | Current    
Financing Receivable, Past Due [Line Items]    
Finance receivables and loans, net $ 7,850 $ 7,663
v3.26.1
Finance Receivables and Loans, Net - Schedule of Financing Receivable Gross Charge-Offs (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Financing Receivable, Credit Quality Indicator [Line Items]      
Year one, originated, current fiscal year, writeoff $ 1   $ 168
Year two, originated, fiscal year before current fiscal year, writeoff 147   564
Year three, originated, two years before current fiscal year, writeoff 162   747
Year four, originated, three years before current fiscal year, writeoff 158   661
Year five, originated, four years before current fiscal year, writeoff 125   320
More than five years before current fiscal year, writeoff 79   154
Revolving loans 0   65
Revolving loans converted to term 0   4
Total 672 $ 745 2,683
Consumer      
Financing Receivable, Credit Quality Indicator [Line Items]      
Year one, originated, current fiscal year, writeoff 1   168
Year two, originated, fiscal year before current fiscal year, writeoff 147   564
Year three, originated, two years before current fiscal year, writeoff 162   747
Year four, originated, three years before current fiscal year, writeoff 158   661
Year five, originated, four years before current fiscal year, writeoff 125   319
More than five years before current fiscal year, writeoff 78   154
Revolving loans 0   64
Revolving loans converted to term 0   4
Total 671   2,681
Consumer | Consumer automotive      
Financing Receivable, Credit Quality Indicator [Line Items]      
Year one, originated, current fiscal year, writeoff 1   168
Year two, originated, fiscal year before current fiscal year, writeoff 147   564
Year three, originated, two years before current fiscal year, writeoff 162   747
Year four, originated, three years before current fiscal year, writeoff 158   660
Year five, originated, four years before current fiscal year, writeoff 125   318
More than five years before current fiscal year, writeoff 78   153
Revolving loans 0   0
Revolving loans converted to term 0   0
Total 671 676 2,610
Consumer | Consumer mortgage      
Financing Receivable, Credit Quality Indicator [Line Items]      
Year one, originated, current fiscal year, writeoff     0
Year two, originated, fiscal year before current fiscal year, writeoff     0
Year three, originated, two years before current fiscal year, writeoff     0
Year four, originated, three years before current fiscal year, writeoff     1
Year five, originated, four years before current fiscal year, writeoff     1
More than five years before current fiscal year, writeoff     1
Revolving loans     0
Revolving loans converted to term     0
Total 0 0 3
Write-downs from transfers to held-for-sale     5
Consumer | Other      
Financing Receivable, Credit Quality Indicator [Line Items]      
Year one, originated, current fiscal year, writeoff     0
Year two, originated, fiscal year before current fiscal year, writeoff     0
Year three, originated, two years before current fiscal year, writeoff     0
Year four, originated, three years before current fiscal year, writeoff     0
Year five, originated, four years before current fiscal year, writeoff     0
More than five years before current fiscal year, writeoff     0
Revolving loans     64
Revolving loans converted to term     4
Total   68 68
Commercial      
Financing Receivable, Credit Quality Indicator [Line Items]      
Year one, originated, current fiscal year, writeoff 0   0
Year two, originated, fiscal year before current fiscal year, writeoff 0   0
Year three, originated, two years before current fiscal year, writeoff 0   0
Year four, originated, three years before current fiscal year, writeoff 0   0
Year five, originated, four years before current fiscal year, writeoff 0   1
More than five years before current fiscal year, writeoff 1   0
Revolving loans 0   1
Revolving loans converted to term 0   0
Total 1 $ 1 2
Commercial | Consumer automotive      
Financing Receivable, Credit Quality Indicator [Line Items]      
Year one, originated, current fiscal year, writeoff     0
Year two, originated, fiscal year before current fiscal year, writeoff     0
Year three, originated, two years before current fiscal year, writeoff     0
Year four, originated, three years before current fiscal year, writeoff     0
Year five, originated, four years before current fiscal year, writeoff     1
More than five years before current fiscal year, writeoff     0
Revolving loans     1
Revolving loans converted to term     0
Total     $ 2
Commercial | Other      
Financing Receivable, Credit Quality Indicator [Line Items]      
Year one, originated, current fiscal year, writeoff 0    
Year two, originated, fiscal year before current fiscal year, writeoff 0    
Year three, originated, two years before current fiscal year, writeoff 0    
Year four, originated, three years before current fiscal year, writeoff 0    
Year five, originated, four years before current fiscal year, writeoff 0    
More than five years before current fiscal year, writeoff 1    
Revolving loans 0    
Revolving loans converted to term 0    
Total $ 1    
v3.26.1
Finance Receivables and Loans, Net - Schedule of Loan Modifications (Details)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2026
USD ($)
loan
Mar. 31, 2025
USD ($)
loan
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Financing Receivable, Troubled Debt Restructuring          
Trial modifications, term 3 months        
Trial modifications, amount $ 9   $ 9   $ 8
Total $ 266 $ 135      
Percentage of total 0.20% 0.10%      
Payment deferrals          
Financing Receivable, Troubled Debt Restructuring          
Total $ 7 $ 6      
Contractual maturity extensions          
Financing Receivable, Troubled Debt Restructuring          
Total 254 127      
Principal forgiveness          
Financing Receivable, Troubled Debt Restructuring          
Total 3 1      
Interest rate concessions          
Financing Receivable, Troubled Debt Restructuring          
Total 0 0      
Combination          
Financing Receivable, Troubled Debt Restructuring          
Total 2 1      
Consumer          
Financing Receivable, Troubled Debt Restructuring          
Total 205 107 745 $ 430  
Consumer | Current          
Financing Receivable, Troubled Debt Restructuring          
Total     594 332  
Consumer | 30–59 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     99 62  
Consumer | 60–89 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     34 23  
Consumer | 90 or more days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     18 13  
Consumer | Payment deferrals          
Financing Receivable, Troubled Debt Restructuring          
Total 0 0      
Consumer | Contractual maturity extensions          
Financing Receivable, Troubled Debt Restructuring          
Total 200 105      
Consumer | Principal forgiveness          
Financing Receivable, Troubled Debt Restructuring          
Total 3 1      
Consumer | Interest rate concessions          
Financing Receivable, Troubled Debt Restructuring          
Total 0 0      
Consumer | Combination          
Financing Receivable, Troubled Debt Restructuring          
Total 2 1      
Consumer | Consumer automotive          
Financing Receivable, Troubled Debt Restructuring          
Total $ 202 $ 106 734 427  
Number of loans redefaulted | loan 2,580 1,858      
Amortized cost of loans redefaulted $ 60 $ 46      
Consumer | Consumer automotive | Current          
Financing Receivable, Troubled Debt Restructuring          
Total     586 330  
Consumer | Consumer automotive | 30–59 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     97 62  
Consumer | Consumer automotive | 60–89 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     34 23  
Consumer | Consumer automotive | 90 or more days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     17 12  
Consumer | Consumer automotive | Payment deferrals          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 $ 0      
Payment extensions, number of months extended/deferred 36 months 29 months      
Consumer | Consumer automotive | Contractual maturity extensions          
Financing Receivable, Troubled Debt Restructuring          
Total $ 199 $ 105 724 420  
Consumer | Consumer automotive | Contractual maturity extensions | Current          
Financing Receivable, Troubled Debt Restructuring          
Total     585 328  
Consumer | Consumer automotive | Contractual maturity extensions | 30–59 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     97 62  
Consumer | Consumer automotive | Contractual maturity extensions | 60–89 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     33 23  
Consumer | Consumer automotive | Contractual maturity extensions | 90 or more days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     9 7  
Consumer | Consumer automotive | Principal forgiveness          
Financing Receivable, Troubled Debt Restructuring          
Total 3 1 9 5  
Principal forgiveness, amount forgiven 1 0      
Consumer | Consumer automotive | Principal forgiveness | Current          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Consumer | Consumer automotive | Principal forgiveness | 30–59 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Consumer | Consumer automotive | Principal forgiveness | 60–89 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     1 0  
Consumer | Consumer automotive | Principal forgiveness | 90 or more days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     8 5  
Consumer | Consumer automotive | Interest rate concessions          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 $ 0      
Interest rate concessions, initial rate 0.00% 0.00%      
Interest rate concessions, revised rate 0.00% 0.00%      
Consumer | Consumer automotive | Combination          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 $ 0 1 2  
Interest rate concessions, initial rate 0.00% 0.00%      
Interest rate concessions, revised rate 0.00% 0.00%      
Consumer | Consumer automotive | Combination | Current          
Financing Receivable, Troubled Debt Restructuring          
Total     1 2  
Consumer | Consumer automotive | Combination | 30–59 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Consumer | Consumer automotive | Combination | 60–89 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Consumer | Consumer automotive | Combination | 90 or more days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Consumer | Consumer mortgage          
Financing Receivable, Troubled Debt Restructuring          
Total $ 3 $ 1 11 3  
Number of loans redefaulted | loan 1        
Amortized cost of loans redefaulted $ 1        
Consumer | Consumer mortgage | Current          
Financing Receivable, Troubled Debt Restructuring          
Total     8 2  
Consumer | Consumer mortgage | 30–59 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     2 0  
Consumer | Consumer mortgage | 60–89 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Consumer | Consumer mortgage | 90 or more days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     1 1  
Consumer | Consumer mortgage | Payment deferrals          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 0 1    
Payment extensions, number of months extended/deferred 204 months        
Consumer | Consumer mortgage | Payment deferrals | Current          
Financing Receivable, Troubled Debt Restructuring          
Total     0    
Consumer | Consumer mortgage | Payment deferrals | 30–59 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     1    
Consumer | Consumer mortgage | Payment deferrals | 60–89 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0    
Consumer | Consumer mortgage | Payment deferrals | 90 or more days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0    
Consumer | Consumer mortgage | Contractual maturity extensions          
Financing Receivable, Troubled Debt Restructuring          
Total $ 1 0 3 2  
Consumer | Consumer mortgage | Contractual maturity extensions | Current          
Financing Receivable, Troubled Debt Restructuring          
Total     2 1  
Consumer | Consumer mortgage | Contractual maturity extensions | 30–59 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     1 0  
Consumer | Consumer mortgage | Contractual maturity extensions | 60–89 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Consumer | Consumer mortgage | Contractual maturity extensions | 90 or more days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0 1  
Consumer | Consumer mortgage | Principal forgiveness          
Financing Receivable, Troubled Debt Restructuring          
Total 0 0      
Principal forgiveness, amount forgiven 0 0      
Consumer | Consumer mortgage | Interest rate concessions          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 $ 0 1    
Interest rate concessions, initial rate 0.00% 0.00%      
Interest rate concessions, revised rate 0.00% 0.00%      
Consumer | Consumer mortgage | Interest rate concessions | Current          
Financing Receivable, Troubled Debt Restructuring          
Total     0    
Consumer | Consumer mortgage | Interest rate concessions | 30–59 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0    
Consumer | Consumer mortgage | Interest rate concessions | 60–89 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0    
Consumer | Consumer mortgage | Interest rate concessions | 90 or more days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     1    
Consumer | Consumer mortgage | Combination          
Financing Receivable, Troubled Debt Restructuring          
Total $ 2 $ 1 6 1  
Payment extensions, number of months extended/deferred 159 months        
Interest rate concessions, initial rate 3.80% 4.50%      
Interest rate concessions, revised rate 2.00% 2.80%      
Payment extensions, initial term 291 months 291 months      
Payment extensions, revised term 402 months 480 months      
Consumer | Consumer mortgage | Combination | Current          
Financing Receivable, Troubled Debt Restructuring          
Total     6 1  
Consumer | Consumer mortgage | Combination | 30–59 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Consumer | Consumer mortgage | Combination | 60–89 days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Consumer | Consumer mortgage | Combination | 90 or more days past due          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial          
Financing Receivable, Troubled Debt Restructuring          
Total $ 61 $ 28 229 73  
Commercial | Pass          
Financing Receivable, Troubled Debt Restructuring          
Total     109 25  
Commercial | Special mention          
Financing Receivable, Troubled Debt Restructuring          
Total     74 0  
Commercial | Substandard          
Financing Receivable, Troubled Debt Restructuring          
Total     46 44  
Commercial | Doubtful          
Financing Receivable, Troubled Debt Restructuring          
Total     0 4  
Commercial | Payment deferrals          
Financing Receivable, Troubled Debt Restructuring          
Total $ 7 $ 6      
Payment extensions, number of months extended/deferred 18 months 15 months      
Commercial | Contractual maturity extensions          
Financing Receivable, Troubled Debt Restructuring          
Total $ 54 $ 22      
Commercial | Principal forgiveness          
Financing Receivable, Troubled Debt Restructuring          
Total 0 0      
Principal forgiveness, amount forgiven 0 0      
Commercial | Interest rate concessions          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 $ 0      
Interest rate concessions, initial rate 0.00% 0.00%      
Interest rate concessions, revised rate 0.00% 0.00%      
Commercial | Combination          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 $ 0      
Interest rate concessions, initial rate 0.00% 0.00%      
Interest rate concessions, revised rate 0.00% 0.00%      
Commercial | Consumer automotive          
Financing Receivable, Troubled Debt Restructuring          
Total $ 7 $ 2 20 7  
Commercial | Consumer automotive | Pass          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial | Consumer automotive | Special mention          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial | Consumer automotive | Substandard          
Financing Receivable, Troubled Debt Restructuring          
Total     20 4  
Commercial | Consumer automotive | Doubtful          
Financing Receivable, Troubled Debt Restructuring          
Total     0 3  
Commercial | Consumer automotive | Payment deferrals          
Financing Receivable, Troubled Debt Restructuring          
Total $ 7 $ 2 7 4  
Payment extensions, number of months extended/deferred 7 months 7 months      
Commercial | Consumer automotive | Payment deferrals | Pass          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial | Consumer automotive | Payment deferrals | Special mention          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial | Consumer automotive | Payment deferrals | Substandard          
Financing Receivable, Troubled Debt Restructuring          
Total     7 4  
Commercial | Consumer automotive | Payment deferrals | Doubtful          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial | Consumer automotive | Contractual maturity extensions          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 $ 0      
Commercial | Consumer automotive | Principal forgiveness          
Financing Receivable, Troubled Debt Restructuring          
Total 0 0      
Principal forgiveness, amount forgiven 0 0      
Commercial | Consumer automotive | Interest rate concessions          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 $ 0 13    
Interest rate concessions, initial rate 0.00% 0.00%      
Interest rate concessions, revised rate 0.00% 0.00%      
Commercial | Consumer automotive | Interest rate concessions | Pass          
Financing Receivable, Troubled Debt Restructuring          
Total     0    
Commercial | Consumer automotive | Interest rate concessions | Special mention          
Financing Receivable, Troubled Debt Restructuring          
Total     0    
Commercial | Consumer automotive | Interest rate concessions | Substandard          
Financing Receivable, Troubled Debt Restructuring          
Total     13    
Commercial | Consumer automotive | Interest rate concessions | Doubtful          
Financing Receivable, Troubled Debt Restructuring          
Total     0    
Commercial | Consumer automotive | Combination          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 $ 0   3  
Interest rate concessions, initial rate 0.00% 0.00%      
Interest rate concessions, revised rate 0.00% 0.00%      
Commercial | Consumer automotive | Combination | Pass          
Financing Receivable, Troubled Debt Restructuring          
Total       0  
Commercial | Consumer automotive | Combination | Special mention          
Financing Receivable, Troubled Debt Restructuring          
Total       0  
Commercial | Consumer automotive | Combination | Substandard          
Financing Receivable, Troubled Debt Restructuring          
Total       0  
Commercial | Consumer automotive | Combination | Doubtful          
Financing Receivable, Troubled Debt Restructuring          
Total       3  
Commercial | Other          
Financing Receivable, Troubled Debt Restructuring          
Total $ 54 $ 26 199 65  
Commercial | Other | Pass          
Financing Receivable, Troubled Debt Restructuring          
Total     109 25  
Commercial | Other | Special mention          
Financing Receivable, Troubled Debt Restructuring          
Total     71 0  
Commercial | Other | Substandard          
Financing Receivable, Troubled Debt Restructuring          
Total     19 40  
Commercial | Other | Doubtful          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial | Other | Payment deferrals          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 $ 4 35 4  
Payment extensions, number of months extended/deferred 20 months 16 months      
Commercial | Other | Payment deferrals | Pass          
Financing Receivable, Troubled Debt Restructuring          
Total     35 0  
Commercial | Other | Payment deferrals | Special mention          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial | Other | Payment deferrals | Substandard          
Financing Receivable, Troubled Debt Restructuring          
Total     0 4  
Commercial | Other | Payment deferrals | Doubtful          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial | Other | Contractual maturity extensions          
Financing Receivable, Troubled Debt Restructuring          
Total $ 54 $ 22 164 47  
Commercial | Other | Contractual maturity extensions | Pass          
Financing Receivable, Troubled Debt Restructuring          
Total     74 25  
Commercial | Other | Contractual maturity extensions | Special mention          
Financing Receivable, Troubled Debt Restructuring          
Total     71 0  
Commercial | Other | Contractual maturity extensions | Substandard          
Financing Receivable, Troubled Debt Restructuring          
Total     19 22  
Commercial | Other | Contractual maturity extensions | Doubtful          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial | Other | Principal forgiveness          
Financing Receivable, Troubled Debt Restructuring          
Total 0 0      
Principal forgiveness, amount forgiven 0 0      
Commercial | Other | Interest rate concessions          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 $ 0      
Interest rate concessions, initial rate 0.00% 0.00%      
Interest rate concessions, revised rate 0.00% 0.00%      
Commercial | Other | Combination          
Financing Receivable, Troubled Debt Restructuring          
Total $ 0 $ 0   14  
Interest rate concessions, initial rate 0.00% 0.00%      
Interest rate concessions, revised rate 0.00% 0.00%      
Commercial | Other | Combination | Pass          
Financing Receivable, Troubled Debt Restructuring          
Total       0  
Commercial | Other | Combination | Special mention          
Financing Receivable, Troubled Debt Restructuring          
Total       0  
Commercial | Other | Combination | Substandard          
Financing Receivable, Troubled Debt Restructuring          
Total       14  
Commercial | Other | Combination | Doubtful          
Financing Receivable, Troubled Debt Restructuring          
Total       0  
Commercial | Commercial real estate          
Financing Receivable, Troubled Debt Restructuring          
Total     10 1  
Commercial | Commercial real estate | Pass          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial | Commercial real estate | Special mention          
Financing Receivable, Troubled Debt Restructuring          
Total     3 0  
Commercial | Commercial real estate | Substandard          
Financing Receivable, Troubled Debt Restructuring          
Total     7 0  
Commercial | Commercial real estate | Doubtful          
Financing Receivable, Troubled Debt Restructuring          
Total     0 1  
Commercial | Commercial real estate | Payment deferrals          
Financing Receivable, Troubled Debt Restructuring          
Total     3 1  
Commercial | Commercial real estate | Payment deferrals | Pass          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial | Commercial real estate | Payment deferrals | Special mention          
Financing Receivable, Troubled Debt Restructuring          
Total     3 0  
Commercial | Commercial real estate | Payment deferrals | Substandard          
Financing Receivable, Troubled Debt Restructuring          
Total     0 0  
Commercial | Commercial real estate | Payment deferrals | Doubtful          
Financing Receivable, Troubled Debt Restructuring          
Total     0 $ 1  
Commercial | Commercial real estate | Interest rate concessions          
Financing Receivable, Troubled Debt Restructuring          
Total     7    
Commercial | Commercial real estate | Interest rate concessions | Pass          
Financing Receivable, Troubled Debt Restructuring          
Total     0    
Commercial | Commercial real estate | Interest rate concessions | Special mention          
Financing Receivable, Troubled Debt Restructuring          
Total     0    
Commercial | Commercial real estate | Interest rate concessions | Substandard          
Financing Receivable, Troubled Debt Restructuring          
Total     7    
Commercial | Commercial real estate | Interest rate concessions | Doubtful          
Financing Receivable, Troubled Debt Restructuring          
Total     $ 0    
v3.26.1
Leasing - Ally as the Lessee (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Lessee, Lease, Description [Line Items]      
Noncancelable lease term 367 days    
Lease extension, maximum 48 months    
Cash paid for amounts included in the measurement of lease liabilities $ 9 $ 9  
Right-of-use asset obtained in exchange for operating lease liability $ 7 $ 5  
Operating lease, weighted-average remaining lease term 5 years   5 years
Operating lease, weighted average discount rate 3.68%   3.66%
Minimum      
Lessee, Lease, Description [Line Items]      
Operating lease remaining lease term 1 month    
Maximum      
Lessee, Lease, Description [Line Items]      
Operating lease remaining lease term 10 years    
v3.26.1
Leasing - Schedule of Lessee, Operating Lease, Liability, Maturity (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Leases [Abstract]    
2026 $ 29  
2027 33  
2028 28  
2029 10  
2030 9  
2031 and thereafter 24  
Total undiscounted cash flows 133  
Difference between undiscounted cash flows and discounted cash flows (12)  
Total lease liability $ 121 $ 124
v3.26.1
Leasing - Schedule of Lease, Cost (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Leases [Abstract]    
Operating lease expense $ 8 $ 8
Variable lease expense 2 1
Total lease expense, net $ 10 $ 9
v3.26.1
Leasing - Schedule of Ally as the Lessor (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items]    
Vehicles $ 10,131 $ 10,163
Accumulated depreciation (1,432) (1,391)
Investment in operating leases, net $ 8,699 8,772
Minimum    
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items]    
Lessor, term of contract 24 months  
Maximum    
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items]    
Lessor, term of contract 60 months  
Vehicles    
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items]    
Residual value of leased asset $ 3,400 $ 3,400
Vehicles | 50% Of Contract Residual Value    
Property, Plant, and Equipment, Lessor Asset under Operating Lease [Line Items]    
Residual value guarantee, percentage 50.00% 50.00%
v3.26.1
Leasing - Schedule of Lessor, Operating Lease, Payments to be Received, Maturity (Details)
$ in Millions
Mar. 31, 2026
USD ($)
Leases [Abstract]  
2026 $ 1,118
2027 1,041
2028 460
2029 75
2030 3
Total lease payments from operating leases $ 2,697
v3.26.1
Leasing - Schedule of Depreciation Expense on Operating Lease Assets (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Leases [Abstract]    
Operating lease revenue $ 392 $ 351
Depreciation expense on operating lease assets (excluding remarketing losses) 258 221
Remarketing losses, net 10 19
Net depreciation expense on operating lease assets 268 240
Variable lease payments, excessive wear and tear $ 5 $ 6
v3.26.1
Leasing - Schedule of Sales-type and Direct Financing Leases, Lease Receivable, Maturity (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Leases [Abstract]      
Direct financing lease, net investment in lease $ 375   $ 376
Direct financing lease, interest income 8 $ 11  
2026 102    
2027 123    
2028 95    
2029 66    
2030 38    
2031 and thereafter 15    
Total undiscounted cash flows 439    
Difference between undiscounted cash flows and discounted cash flows (64)    
Present value of lease payments recorded as lease receivable $ 375    
v3.26.1
Securitizations and Variable Interest Entities - Narrative (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Securitizations And Variable Interest Entities [Abstract]    
(Loss) gain on sales of financial assets $ (3,000,000) $ 0
v3.26.1
Securitizations and Variable Interest Entities - Schedule of Variable Interest Entities (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Variable Interest Entity [Line Items]      
Carrying value of total assets $ 197,269 $ 196,002 $ 193,331
Carrying value of total liabilities 181,660 180,504  
Assets sold to nonconsolidated VIEs 3,379 3,192  
Maximum exposure to loss in nonconsolidated VIEs 6,964 6,935  
Non-recourse debt 17,349 17,070  
Held-to-maturity securities 4,337 4,371  
Other assets 11,310 11,623  
Equity securities 863 876  
Variable Interest Entity      
Variable Interest Entity [Line Items]      
Carrying value of total assets 15,449 15,024  
Carrying value of total liabilities 2,927 2,439  
On‑balance sheet variable interest entities      
Variable Interest Entity [Line Items]      
Carrying value of total assets 3,753 3,240  
Carrying value of total liabilities 2,060 1,482  
Non-recourse debt 2,056 1,479  
Other assets 344 260  
On‑balance sheet variable interest entities | Consumer | Consumer automotive      
Variable Interest Entity [Line Items]      
Carrying value of total assets 12,625 12,149  
Carrying value of total liabilities 2,191 1,619  
Assets sold to nonconsolidated VIEs 0 0  
Maximum exposure to loss in nonconsolidated VIEs 0 0  
Assets held-in-trust 8,900 8,900  
On‑balance sheet variable interest entities | Consumer | Consumer automotive | Nonrecourse      
Variable Interest Entity [Line Items]      
Non-recourse debt 131 137  
Off-balance sheet variable interest entities | Consumer | Consumer automotive      
Variable Interest Entity [Line Items]      
Carrying value of total assets 46 53  
Carrying value of total liabilities 0 0  
Assets sold to nonconsolidated VIEs 3,379 3,192  
Maximum exposure to loss in nonconsolidated VIEs 3,425 3,245  
Held-to-maturity securities 43 50  
Other assets 3 3  
Off-balance sheet variable interest entities | Commercial | Other      
Variable Interest Entity [Line Items]      
Carrying value of total assets 2,778 2,822  
Carrying value of total liabilities 736 820  
Assets sold to nonconsolidated VIEs 0 0  
Maximum exposure to loss in nonconsolidated VIEs 3,539 3,690  
Equity securities $ 57 $ 56  
v3.26.1
Securitizations and Variable Interest Entities - Schedule of Cash Flows with Nonconsolidated Special-Purpose Entities (Details) - Off-balance sheet variable interest entities - Consumer - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Consumer automotive    
Cash Flow Received and Paid to Nonconsolidated Securitization Entities [Line Items]    
Cash proceeds from transfers completed during the period $ 480 $ 191
Servicing fees 20 14
Cash flows received on retained interests in securitization entities 8 12
Other cash flows received 2 1
Other    
Cash Flow Received and Paid to Nonconsolidated Securitization Entities [Line Items]    
Cash proceeds from transfers completed during the period 0 8
Servicing fees $ 0 $ 1
v3.26.1
Securitizations and Variable Interest Entities - Schedule of Quantitative Information and Net Credit Losses about Securitized and Other Financial Assets Managed Together (Details) - Off-balance sheet variable interest entities - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Derecognized Assets, Securitized or Asset-backed Financing Arrangement Assets and any Other Financial Assets Managed Together [Line Items]      
Total amount $ 3,379   $ 3,192
Amount 60 days or more past due 159   161
Net credit losses 45 $ 35  
Off-balance-sheet securitization entities | Consumer automotive | Consumer      
Derecognized Assets, Securitized or Asset-backed Financing Arrangement Assets and any Other Financial Assets Managed Together [Line Items]      
Total amount 858   1,002
Amount 60 days or more past due 16   18
Net credit losses 4 5  
Whole-loan sales | Consumer automotive | Consumer      
Derecognized Assets, Securitized or Asset-backed Financing Arrangement Assets and any Other Financial Assets Managed Together [Line Items]      
Total amount 2,521   2,190
Amount 60 days or more past due 143   $ 143
Net credit losses 41 23  
Whole-loan sales | Other | Consumer      
Derecognized Assets, Securitized or Asset-backed Financing Arrangement Assets and any Other Financial Assets Managed Together [Line Items]      
Net credit losses $ 0 $ 7  
v3.26.1
Other Assets - Schedule of Other Assets (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Dec. 31, 2024
Other Assets [Abstract]      
Property and equipment at cost $ 2,275 $ 2,280  
Accumulated depreciation (1,150) (1,130)  
Net property and equipment 1,125 1,150  
Net deferred tax assets 2,368 2,334  
Proportional amortization investments 2,032 2,094  
Restricted cash and cash equivalents 1,390 1,543  
Accrued interest, fees, and rent receivables 930 941  
Nonmarketable equity investments 901 922  
Equity-method investments 741 715  
Restricted cash held for securitization trusts 321 236  
Other accounts receivable 210 403  
Goodwill 190 190 $ 551
Operating lease right-of-use assets 107 109  
Other assets 995 986  
Total other assets $ 11,310 $ 11,623  
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Total other assets Total other assets  
Gross intangible assets $ 80 $ 80  
Accumulated amortization $ 80 $ 80  
v3.26.1
Other Assets - Schedule of Proportional Amortization Investment (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Other Assets [Abstract]    
Tax credits and other tax benefits from proportional amortization investments $ 79,000,000 $ 56,000,000
Investment amortization expense recognized as a component of income tax expense 62,000,000 45,000,000
Net benefit from proportional amortization investments $ 17,000,000 $ 11,000,000
Investment Program, Proportional Amortization Method, Elected, Income Tax Credit and Other Income Tax Benefit, before Amortization, Statement of Income or Comprehensive Income [Extensible Enumeration] Income Tax Expense (Benefit) Income Tax Expense (Benefit)
Investment Program, Proportional Amortization Method, Elected, Income Tax Credit and Other Income Tax Benefit, after Amortization, Statement of Income or Comprehensive Income [Extensible Enumeration] Income Tax Expense (Benefit) Income Tax Expense (Benefit)
Investment Program, Proportional Amortization Method, Applied, Amortization Expense, Statement of Income or Comprehensive Income [Extensible Enumeration] Income Tax Expense (Benefit) Income Tax Expense (Benefit)
Investment Program, Proportional Amortization Method, Elected, Income Tax Credit and Other Income Tax Benefit, before Amortization, Statement of Cash Flows [Extensible Enumeration] Increase (Decrease) in Deferred Income Taxes, Increase (Decrease) in Other Operating Assets, Other liabilities Increase (Decrease) in Deferred Income Taxes, Increase (Decrease) in Other Operating Assets, Other liabilities
Investment Program, Proportional Amortization Method, Applied, Amortization Expense, Statement of Cash Flows [Extensible Enumeration] Increase (Decrease) in Deferred Income Taxes, Increase (Decrease) in Other Operating Assets, Other liabilities Increase (Decrease) in Deferred Income Taxes, Increase (Decrease) in Other Operating Assets, Other liabilities
Investment Program, Proportional Amortization Method, Elected, Income Tax Credit and Other Income Tax Benefit, after Amortization, Statement of Cash Flows [Extensible Enumeration] Increase (Decrease) in Deferred Income Taxes, Increase (Decrease) in Other Operating Assets, Other liabilities Increase (Decrease) in Deferred Income Taxes, Increase (Decrease) in Other Operating Assets, Other liabilities
Investment program, proportional amortization method, elected, impairment loss $ 0 $ 0
v3.26.1
Other Assets - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Goodwill [Line Items]      
Proportional amortization investments $ 2,032   $ 2,094
Unfunded commitments for proportional amortization investments $ 735   819
Unfunded commitments, period to be paid 5 years    
Goodwill impairment $ 0 $ 305 305
Goodwill, transfers     56
Corporate and Other      
Goodwill [Line Items]      
Goodwill impairment $ 0 $ 305 305
Goodwill, transfers     56
Corporate and Other | Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations | Ally Credit Card      
Goodwill [Line Items]      
Goodwill impairment     $ 305
v3.26.1
Other Assets - Schedule of Equity Securities without Readily Determinable Fair Value (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Other Assets [Abstract]      
FRB stock $ 454,000,000   $ 452,000,000
FHLB stock 335,000,000   359,000,000
Equity investments without a readily determinable fair value      
Cost basis 94,000,000   94,000,000
Upward adjustments 56,000,000   57,000,000
Downward adjustments (including impairment) (38,000,000)   (40,000,000)
Carrying amount, equity investments without a readily determinable fair value 112,000,000   111,000,000
Nonmarketable equity investments 901,000,000   $ 922,000,000
Upward adjustments 0 $ 0  
Downward adjustments (including impairment) (1,000,000) 0  
Impairment of FHLB and FRB stock $ 0 $ 0  
v3.26.1
Other Assets - Schedule of Goodwill (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Goodwill [Roll Forward]      
Goodwill beginning balance $ 190 $ 551 $ 551
Goodwill impairment 0 (305) (305)
Transfer to assets of operations held-for-sale     (56)
Goodwill ending balance 190   190
Operating Segments | Automotive Finance operations      
Goodwill [Roll Forward]      
Goodwill beginning balance 20 20 20
Goodwill impairment 0 0 0
Transfer to assets of operations held-for-sale     0
Goodwill ending balance 20   20
Operating Segments | Insurance operations      
Goodwill [Roll Forward]      
Goodwill beginning balance 27 27 27
Goodwill impairment 0 0 0
Transfer to assets of operations held-for-sale     0
Goodwill ending balance 27   27
Corporate and Other      
Goodwill [Roll Forward]      
Goodwill beginning balance 143 504 504
Goodwill impairment 0 $ (305) (305)
Transfer to assets of operations held-for-sale     (56)
Goodwill ending balance 143   143
Corporate and Other | Ally Invest      
Goodwill [Roll Forward]      
Goodwill beginning balance 143    
Goodwill ending balance $ 143   $ 143
v3.26.1
Deposit Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Deposits [Abstract]    
Noninterest-bearing deposits $ 137 $ 125
Interest-bearing deposits    
Savings, money market, and spending accounts 112,800 109,214
Certificates of deposit 40,215 42,310
Total deposit liabilities 153,152 151,649
Certificates of deposit, in excess of $250,000 federal insurance limits $ 5,900 $ 6,200
v3.26.1
Debt - Schedule of Short-term Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Short-term Debt [Line Items]    
Federal Home Loan Bank $ 3,600 $ 4,150
Securities sold under agreements to repurchase 526 545
Total short-term borrowings 4,126 4,695
Cash collateral placed 10 1
U.S. Treasury and federal agencies    
Short-term Debt [Line Items]    
Securities sold under agreements to repurchase 526  
Maturity Within 30 Days    
Short-term Debt [Line Items]    
Securities sold under agreements to repurchase 427  
Maturity 31 to 60 Days    
Short-term Debt [Line Items]    
Securities sold under agreements to repurchase 99  
Unsecured    
Short-term Debt [Line Items]    
Federal Home Loan Bank 0 0
Securities sold under agreements to repurchase 0 0
Total short-term borrowings 0 0
Secured debt    
Short-term Debt [Line Items]    
Federal Home Loan Bank 3,600 4,150
Securities sold under agreements to repurchase 526 545
Total short-term borrowings $ 4,126 $ 4,695
v3.26.1
Debt - Schedule of Long-term Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Debt Instrument [Line Items]    
Long-term debt, due within one year, net of original issue discount $ 2,439  
Long-term debt, due within one year   $ 2,659
Long-term debt, due after one year 14,910 14,411
Total long-term debt 17,349 17,070
Unsecured    
Debt Instrument [Line Items]    
Long-term debt, due within one year, net of original issue discount (20)  
Long-term debt, due within one year   0
Long-term debt, due after one year 9,939 10,012
Total long-term debt 9,919 10,012
Secured debt    
Debt Instrument [Line Items]    
Long-term debt, due within one year 2,459 2,659
Long-term debt, due after one year 4,971 4,399
Total long-term debt 7,430 7,058
Federal Home Loan Bank Advances | Federal Home Loan Bank of Pittsburgh    
Debt Instrument [Line Items]    
Total long-term debt $ 4,200 $ 4,200
v3.26.1
Debt - Schedule of Remaining Maturity of Long-term Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Debt Instrument [Line Items]    
2026 $ 2,075  
2027 4,251  
2028 2,825  
2029 2,060  
2030 735  
2031 and thereafter 5,403  
Total long-term debt 17,349 $ 17,070
Unsecured    
Debt Instrument [Line Items]    
2026, net of original issue discount (4)  
2027 1,500  
2028 769  
2029 1,625  
2030 650  
2031 and thereafter 5,379  
Total long-term debt 9,919 10,012
Secured debt    
Debt Instrument [Line Items]    
Total long-term debt 7,430 $ 7,058
Long-term debt | Unsecured    
Debt Instrument [Line Items]    
2026 59  
2027 1,595  
2028 876  
2029 1,748  
2030 793  
2031 and thereafter 5,518  
Total long-term debt 10,589  
Long-term debt | Secured debt    
Debt Instrument [Line Items]    
2026 2,079  
2027 2,751  
2028 2,056  
2029 435  
2030 85  
2031 and thereafter 24  
Total long-term debt 7,430  
Original issue discount | Unsecured    
Debt Instrument [Line Items]    
Debt instrument, unamortized discount (670)  
Original issue discount | Unsecured | 2026    
Debt Instrument [Line Items]    
Debt instrument, unamortized discount, current (63)  
Original issue discount | Unsecured | 2027    
Debt Instrument [Line Items]    
Debt instrument, unamortized discount, noncurrent (95)  
Original issue discount | Unsecured | 2028    
Debt Instrument [Line Items]    
Debt instrument, unamortized discount, noncurrent (107)  
Original issue discount | Unsecured | 2029    
Debt Instrument [Line Items]    
Debt instrument, unamortized discount, noncurrent (123)  
Original issue discount | Unsecured | 2030    
Debt Instrument [Line Items]    
Debt instrument, unamortized discount, noncurrent (143)  
Original issue discount | Unsecured | 2031 and thereafter    
Debt Instrument [Line Items]    
Debt instrument, unamortized discount, noncurrent $ (139)  
v3.26.1
Debt - Schedule of Pledged Assets Related to Secured Borrowings and Repurchase Agreement (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Pledged Assets related to secured borrowings [Line Items]    
Total assets restricted as collateral $ 64,803 $ 64,770
Secured debt 11,556 11,753
Amortized cost 25,974 25,825
Short-term borrowings 4,126 4,695
Secured debt    
Pledged Assets related to secured borrowings [Line Items]    
Short-term borrowings 4,126 4,695
Asset Pledged as Collateral    
Pledged Assets related to secured borrowings [Line Items]    
Amortized cost 3,012 3,114
Credit-Linked Notes    
Pledged Assets related to secured borrowings [Line Items]    
Total assets restricted as collateral 1,224 1,381
Pledged assets for Federal Home Loan Bank    
Pledged Assets related to secured borrowings [Line Items]    
Total assets restricted as collateral 25,900 26,000
Pledged assets for Federal Reserve Bank    
Pledged Assets related to secured borrowings [Line Items]    
Total assets restricted as collateral 33,600 33,700
Investment securities    
Pledged Assets related to secured borrowings [Line Items]    
Total assets restricted as collateral 3,187 3,292
Consumer | Consumer automotive    
Pledged Assets related to secured borrowings [Line Items]    
Total assets restricted as collateral 37,151 36,807
Consumer | Consumer mortgage    
Pledged Assets related to secured borrowings [Line Items]    
Total assets restricted as collateral 15,342 15,604
Commercial    
Pledged Assets related to secured borrowings [Line Items]    
Total assets restricted as collateral $ 7,899 $ 7,686
v3.26.1
Accrued Expenses and Other Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Dec. 31, 2024
Accounts Payable and Accrued Liabilities [Abstract]        
Unfunded commitments for proportional amortization investments $ 735 $ 819    
Accounts payable 544 420    
Reserves for insurance losses and loss adjustment expenses 251 233 $ 268 $ 189
Employee compensation and benefits 242 417    
Deferred revenue $ 135 $ 141    
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Total accrued expenses and other liabilities Total accrued expenses and other liabilities    
Operating lease liabilities $ 121 $ 124    
Other liabilities 488 551    
Total accrued expenses and other liabilities $ 2,516 $ 2,705    
v3.26.1
Preferred Stock (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 12 Months Ended
May 04, 2026
Mar. 31, 2026
Dec. 31, 2025
Class of Stock [Line Items]      
Carrying value   $ 2,324 $ 2,324
Preferred stock dividends — Series B      
Class of Stock [Line Items]      
Carrying value   $ 1,335 $ 1,335
Par value (in dollars per share)   $ 0.01 $ 0.01
Liquidation preference (in dollars per share)   $ 1,000 $ 1,000
Number of shares authorized (in shares)   1,350,000 1,350,000
Number of shares issued (in shares)   1,350,000 1,350,000
Number of shares outstanding (in shares)   1,350,000 1,350,000
Preferred stock dividends — Series B | Subsequent event      
Class of Stock [Line Items]      
Dividend/coupon rate 4.70%    
Series B Preferred Stock, Prior To May 15, 2026      
Class of Stock [Line Items]      
Dividend/coupon rate   4.70% 4.70%
Series B Preferred Stock, On And After May 15, 2026      
Class of Stock [Line Items]      
Dividend/coupon rate   3.868% 3.868%
Preferred stock dividends — Series C      
Class of Stock [Line Items]      
Carrying value   $ 989 $ 989
Par value (in dollars per share)   $ 0.01 $ 0.01
Liquidation preference (in dollars per share)   $ 1,000 $ 1,000
Number of shares authorized (in shares)   1,000,000 1,000,000
Number of shares issued (in shares)   1,000,000 1,000,000
Number of shares outstanding (in shares)   1,000,000 1,000,000
Series C Preferred Stock, Prior To May 15, 2028      
Class of Stock [Line Items]      
Dividend/coupon rate   4.70% 4.70%
Series C Preferred Stock, On And After May 15, 2028      
Class of Stock [Line Items]      
Dividend/coupon rate   3.481% 3.481%
v3.26.1
Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance $ 15,498 $ 13,903
Net change 13 662
Ending balance 15,609 14,232
Accumulated other comprehensive loss    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (2,786) (3,924)
Net change 13 662
Ending balance (2,773) (3,262)
Available-for-sale securities    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (2,260) (3,307)
Net change (5) 642
Ending balance (2,265) (2,665)
Held-to-maturity securities    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance (551) (616)
Net change 14 15
Ending balance (537) (601)
Translation adjustments and net investment hedges    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance 23 20
Net change 0 0
Ending balance 23 20
Cash flow hedges    
AOCI Attributable to Parent, Net of Tax [Roll Forward]    
Beginning balance 2 (21)
Net change 4 5
Ending balance $ 6 $ (16)
v3.26.1
Accumulated Other Comprehensive Loss - Schedule of Reclassification Out of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income (loss), before tax $ 17 $ 868
Other comprehensive income (loss), tax effect (4) (206)
Other comprehensive income (loss), net of tax 13 662
Available-for-sale securities    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Net unrealized losses arising during the period, before tax (4) 346
Net unrealized losses arising during the period, tax 1 (81)
Net unrealized losses arising during the period, net of tax (3) 265
Reclassification from AOCI, before tax 3 (495)
Reclassification from AOCI, tax (1) 118
Reclassification from AOCI, net of tax 2 (377)
Other comprehensive income (loss), before tax (7) 841
Other comprehensive income (loss), tax effect 2 (199)
Other comprehensive income (loss), net of tax (5) 642
Held-to-maturity securities    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Reclassification from AOCI, before tax (19) (20)
Reclassification from AOCI, tax 5 5
Reclassification from AOCI, net of tax (14) (15)
Other comprehensive income (loss), net of tax 14 15
Translation adjustments    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income (loss), before tax (3)  
Other comprehensive income (loss), tax effect 1  
Other comprehensive income (loss), net of tax (2)  
Net investment hedges    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Other comprehensive income (loss), before tax 3  
Other comprehensive income (loss), tax effect (1)  
Other comprehensive income (loss), net of tax 2  
Cash flow hedges    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Reclassification from AOCI, before tax (5) (7)
Reclassification from AOCI, tax 1 2
Reclassification from AOCI, net of tax (4) (5)
Other comprehensive income (loss), before tax 5 7
Other comprehensive income (loss), tax effect (1) (2)
Other comprehensive income (loss), net of tax $ 4 $ 5
v3.26.1
Earnings per Common Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Class of Stock [Line Items]    
Net income (loss) from continuing operations $ 319 $ (225)
Net income (loss) from continuing operations attributable to common shareholders [1] 291 (253)
Net income (loss) attributable to common shareholders [1] $ 291 $ (253)
Basic weighted-average common shares outstanding (in shares) [1],[2] 310,992 309,006
Diluted weighted-average common shares outstanding (in shares) [1],[2],[3] 313,219 309,006
Basic earnings per common share    
Net income (loss) from continuing operations (in dollars per share) [1] $ 0.94 $ (0.82)
Net income (loss) (in dollars per share) [1] 0.94 (0.82)
Diluted earnings per common share    
Net income (loss) from continuing operations (in dollars per share) [1] 0.93 (0.82)
Net income (loss) (in dollars per share) [1] $ 0.93 $ (0.82)
Antidilutive securities excluded from computation of earnings per share, amount (in shares)   2,700
Preferred stock dividends — Series B    
Class of Stock [Line Items]    
Preferred stock dividends $ (16) $ (16)
Preferred stock dividends — Series C    
Class of Stock [Line Items]    
Preferred stock dividends $ (12) $ (12)
[1] Figures in the table may not recalculate exactly due to rounding. Earnings per share is calculated based on unrounded numbers.
[2]
(b)Includes shares related to share-based compensation that vested but were not yet issued.
[3]
(c)Due to the antidilutive effect of the net loss from continuing operations for the three months ended March 31, 2025, basic weighted-average common shares outstanding was used to calculate basic and diluted earnings per share. During the three months ended March 31, 2025, there were 2.7 million in share-based awards excluded because their inclusion would have been antidilutive.
v3.26.1
Regulatory Capital and Other Regulatory Matters - Schedule of Regulatory Capital Amount and Ratios (Details)
$ in Millions
Mar. 31, 2026
USD ($)
Dec. 31, 2025
USD ($)
Oct. 31, 2025
Oct. 31, 2024
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]        
Common equity tier one capital ratio, minimum 0.045      
Tier one capital to risk-weighted assets, required minimum 0.06      
Capital to risk-weighted assets, required minimum 0.08      
Tier one leverage ratio, minimum 0.04      
Minimum capital conservation buffer 0.025      
Accumulated other comprehensive losses excluded from Common Equity Tier 1 capital $ 2,800 $ 2,800    
Brokered deposits $ 5,600      
Percentage of interest-bearing domestic deposits to deposits, brokered 3.70%      
Common equity tier one capital $ 15,695 $ 15,629    
Common equity tier one capital ratio 0.1011 0.1023    
Tier one capital to risk-weighted assets, amount $ 17,934 $ 17,885    
Tier one capital to risk-weighted assets, ratio 0.1156 0.1170    
Tier one capital to risk-weighted assets, well-capitalized minimum 0.0600      
Capital to risk-weighted assets, amount $ 20,793 $ 20,731    
Capital to risk-weighted assets, ratio 0.1340 0.1356    
Capital to risk weighted assets, well-capitalized minimum 0.1000      
Tier one leverage to adjusted quarterly average assets, amount $ 17,934 $ 17,885    
Tier one leverage to adjusted quarterly average assets, ratio 0.0916 0.0925    
Ally Financial Inc        
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]        
Minimum capital conservation buffer 0.026 0.026 0.026 0.026
Ally Bank        
Compliance with Regulatory Capital Requirements under Banking Regulations [Line Items]        
Common equity tier one capital ratio, minimum 0.0450      
Tier one capital to risk-weighted assets, required minimum 0.0600      
Capital to risk-weighted assets, required minimum 0.0800      
Tier one leverage ratio, minimum 0.0400      
Minimum capital conservation buffer 0.025 0.025    
Common equity tier one capital $ 17,914 $ 17,853    
Common equity tier one capital ratio 0.1238 0.1250    
Common equity tier one capital, well capitalized minimum 0.0650      
Tier one capital to risk-weighted assets, amount $ 17,914 $ 17,853    
Tier one capital to risk-weighted assets, ratio 0.1238 0.1250    
Tier one capital to risk-weighted assets, well-capitalized minimum 0.0800      
Capital to risk-weighted assets, amount $ 19,744 $ 19,659    
Capital to risk-weighted assets, ratio 0.1365 0.1377    
Capital to risk weighted assets, well-capitalized minimum 0.1000      
Tier one leverage to adjusted quarterly average assets, amount $ 17,914 $ 17,853    
Tier one leverage to adjusted quarterly average assets, ratio 0.0972 0.0982    
Tier one leverage to adjusted quarterly average assets, well-capitalized minimum 0.0500      
v3.26.1
Regulatory Capital and Other Regulatory Matters - Schedule of Common Share Repurchases (Details)
 1 Months Ended 3 Months Ended 12 Months Ended
Apr. 14, 2026
$ / shares
Dec. 31, 2024
USD ($)
shares
Mar. 31, 2026
USD ($)
$ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Sep. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2025
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
shares
Oct. 31, 2025
Oct. 31, 2024
Accelerated Share Repurchases [Line Items]                      
Minimum capital conservation buffer     0.025                
Proceeds from issuance of long-term debt     $ 1,081,000,000       $ 24,000,000        
Stock repurchase program, authorized       $ 2,000,000,000.0       $ 2,000,000,000.0      
Stock repurchased during period, value     $ 147,000,000 $ 23,000,000 $ 1,000,000 $ 1,000,000 $ 34,000,000        
Stock repurchased during period, number of shares (in share) | shares     3,624,000 543,000 25,000 27,000 877,000        
Common stock, shares outstanding (in shares) | shares   305,388,000 307,407,671 308,492,929 307,828,000 307,787,000 307,152,000 308,492,929 305,388,000    
Dividends declared (in dollars per share) | $ / shares     $ 0.30 $ 0.30 $ 0.30 $ 0.30 $ 0.30 $ 0.30      
Cash dividends declared per common share (in dollars per share) | $ / shares [1]     $ 0.30       $ 0.30        
Subsequent event                      
Accelerated Share Repurchases [Line Items]                      
Cash dividends declared per common share (in dollars per share) | $ / shares $ 0.30                    
Credit-Linked Notes                      
Accelerated Share Repurchases [Line Items]                      
Proceeds from issuance of long-term debt               $ 1,100,000,000 $ 770,000,000    
Consumer automotive | Credit-Linked Notes | Consumer                      
Accelerated Share Repurchases [Line Items]                      
Debt instrument, reference portfolio amount   $ 7,000,000,000.0   $ 10,000,000,000.0       10,000,000,000.0 $ 7,000,000,000.0    
Debt instrument, reference asset amount     $ 10,700,000,000 $ 12,100,000,000       $ 12,100,000,000      
Ally Financial Inc                      
Accelerated Share Repurchases [Line Items]                      
Minimum capital conservation buffer     0.026 0.026       0.026   0.026 0.026
Unsecured                      
Accelerated Share Repurchases [Line Items]                      
Proceeds from issuance of long-term debt   $ 500,000,000                  
[1] Figures in the table may not recalculate exactly due to rounding. Earnings per share is calculated based on unrounded numbers.
v3.26.1
Derivative Instruments and Hedging Activities - Narrative (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Cash collateral placed with counterparties $ 13 $ 4
Noncash collateral placed with counterparties 290 $ 328
Cash collateral received from counterparties $ 3  
v3.26.1
Derivative Instruments and Hedging Activities - Schedule of Fair Value Amounts of Derivative Instruments Reported on our Condensed Consolidated Balance Sheet (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position $ 3 $ 0
Derivative contracts in a payable position 3 4
Notional amount 26,419 28,358
Total derivatives designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 2 0
Derivative contracts in a payable position 0 4
Notional amount 24,944 26,906
Total derivatives not designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 1 0
Derivative contracts in a payable position 3 0
Notional amount 1,475 1,452
Interest rate | Total derivatives not designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 1 0
Derivative contracts in a payable position 1 0
Notional amount 216 0
Swaps | Total derivatives designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 0 0
Derivative contracts in a payable position 0 0
Notional amount 22,507 23,257
Swaps | Total derivatives not designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 1 0
Derivative contracts in a payable position 1 0
Notional amount 216 0
Purchased options | Total derivatives designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 0 0
Derivative contracts in a payable position 0 0
Notional amount 2,250 3,450
Foreign exchange | Total derivatives not designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 0 0
Derivative contracts in a payable position 0 0
Notional amount 35 71
Forwards | Total derivatives designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 2 0
Derivative contracts in a payable position 0 4
Notional amount 187 199
Forwards | Total derivatives not designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 0 0
Derivative contracts in a payable position 0 0
Notional amount 35 71
Total credit risk | Total derivatives not designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 0 0
Derivative contracts in a payable position 1 0
Notional amount 1,224 1,381
Credit-linked note derivatives | Total derivatives not designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 0 0
Derivative contracts in a payable position 1 0
Notional amount 1,224 1,381
Equity | Total derivatives not designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 0 0
Derivative contracts in a payable position 1 0
Notional amount 0 0
Written options | Total derivatives not designated as accounting hedges    
Derivatives, Fair Value [Line Items]    
Derivative contracts in a receivable position 0 0
Derivative contracts in a payable position 1 0
Notional amount $ 0 $ 0
v3.26.1
Derivative Instruments and Hedging Activities - Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Hedged liability, fair value hedge $ 3,395 $ 3,378
Hedged Liability, Statement of Financial Position [Extensible Enumeration] Long-term debt Long-term debt
Available-for-sale securities    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Hedged asset, fair value hedge $ 14,968 $ 15,240
Hedged asset, fair value hedge, cumulative increase (decrease) $ (68) $ 7
Hedged Asset, Statement of Financial Position [Extensible Enumeration] Available-for-sale securities (amortized cost basis of $25,974 and $25,825) Available-for-sale securities (amortized cost basis of $25,974 and $25,825)
Closed portfolio and beneficial interest, last-of-layer, amortized cost $ 13,500 $ 13,700
Amortized cost 13,200 13,400
Cumulative basis adjustment for active hedges, asset (liability) (72) (8)
Hedged asset, last-of-layer, amount 11,000 11,000
Available-for-sale securities | Total derivatives designated as accounting hedges    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Cumulative basis adjustment for active hedges, asset (liability) (21) 46
Finance receivables and loans, net    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Hedged asset, fair value hedge 23,942 27,808
Hedged asset, fair value hedge, cumulative increase (decrease) $ (23) $ 7
Hedged Asset, Statement of Financial Position [Extensible Enumeration] Finance receivables and loans, net Finance receivables and loans, net
Cumulative basis adjustment for active hedges, asset (liability) $ (23) $ 7
Hedged asset, last-of-layer, amount 10,000 10,800
Closed portfolio, carrying value 19,100 21,800
Finance receivables and loans, net | Total derivatives designated as accounting hedges    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Cumulative basis adjustment for active hedges, asset (liability) (24) 6
Long-term debt    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Hedged liability, fair value hedge, cumulative increase (decrease) 76 79
Discontinued hedge | Available-for-sale securities    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Hedged asset, discontinued fair value hedge, cumulative increase (decrease) (51) (54)
Cumulative basis adjustment for active hedges, asset (liability) (51) (54)
Discontinued hedge | Finance receivables and loans, net    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Hedged asset, discontinued fair value hedge, cumulative increase (decrease) 1 1
Cumulative basis adjustment for active hedges, asset (liability) 1 1
Discontinued hedge | Long-term debt    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Hedged liability, discontinued fair value hedge, cumulative increase (decrease) $ 76 $ 79
v3.26.1
Derivative Instruments and Hedging Activities - Schedule of Statement of Gains and Losses on Derivative Instruments Reported in Statement of Comprehensive Income (Details) - Total derivatives not designated as accounting hedges - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain recognized in earnings $ 0 $ 1
Interest rate    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain recognized in earnings 0 1
Foreign exchange    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain recognized in earnings 1 0
Credit    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain recognized in earnings (1) 0
Gain on mortgage and automotive loans, net | Interest rate    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain recognized in earnings 0 1
Other operating expenses | Foreign exchange    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain recognized in earnings 1 0
Other income, net of losses | Credit    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain recognized in earnings $ (1) $ 0
v3.26.1
Derivative Instruments and Hedging Activities - Schedule of Derivative Instruments Designated as Fair Value Hedges, Gain (Loss) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Derivative Instruments, Gain (Loss) [Line Items]    
Interest and fees on finance receivables and loans $ 2,658 $ 2,709
Interest and dividends on investment securities and other earning assets 234 230
Interest on long-term debt 265 271
Loss on cash flow hedges to be recognized within twelve months 3  
Total derivatives designated as accounting hedges | Interest and fees on finance receivables and loans    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain on fair value hedging relationships 0 0
Total loss on cash flow hedging relationships (5) (7)
Total derivatives designated as accounting hedges | Interest and dividends on investment securities and other earning assets    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain on fair value hedging relationships 0 0
Total loss on cash flow hedging relationships 0 0
Total derivatives designated as accounting hedges | Interest on long-term debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain on fair value hedging relationships 0 0
Total loss on cash flow hedging relationships 0 0
Total derivatives designated as accounting hedges | Hedged available-for-sale securities | Interest and fees on finance receivables and loans    
Derivative Instruments, Gain (Loss) [Line Items]    
Change in unrealized gain (loss) on hedged item in fair value hedge 0 0
Change in unrealized gain (loss) on fair value hedging instruments 0 0
Total derivatives designated as accounting hedges | Hedged available-for-sale securities | Interest and dividends on investment securities and other earning assets    
Derivative Instruments, Gain (Loss) [Line Items]    
Change in unrealized gain (loss) on hedged item in fair value hedge (77) 130
Change in unrealized gain (loss) on fair value hedging instruments 77 (130)
Total derivatives designated as accounting hedges | Hedged available-for-sale securities | Interest on long-term debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Change in unrealized gain (loss) on hedged item in fair value hedge 0 0
Change in unrealized gain (loss) on fair value hedging instruments 0 0
Total derivatives designated as accounting hedges | Fixed-rate automotive loans | Interest and fees on finance receivables and loans    
Derivative Instruments, Gain (Loss) [Line Items]    
Change in unrealized gain (loss) on hedged item in fair value hedge (30) 29
Change in unrealized gain (loss) on fair value hedging instruments 30 (29)
Total derivatives designated as accounting hedges | Fixed-rate automotive loans | Interest and dividends on investment securities and other earning assets    
Derivative Instruments, Gain (Loss) [Line Items]    
Change in unrealized gain (loss) on hedged item in fair value hedge 0 0
Change in unrealized gain (loss) on fair value hedging instruments 0 0
Total derivatives designated as accounting hedges | Fixed-rate automotive loans | Interest on long-term debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Change in unrealized gain (loss) on hedged item in fair value hedge 0 0
Change in unrealized gain (loss) on fair value hedging instruments 0 0
Total derivatives designated as accounting hedges | Hedged variable-rate commercial loans | Interest and fees on finance receivables and loans    
Derivative Instruments, Gain (Loss) [Line Items]    
Interest rate cash flow hedge loss reclassified to earnings (5) (7)
Total derivatives designated as accounting hedges | Hedged variable-rate commercial loans | Interest and dividends on investment securities and other earning assets    
Derivative Instruments, Gain (Loss) [Line Items]    
Interest rate cash flow hedge loss reclassified to earnings 0 0
Total derivatives designated as accounting hedges | Hedged variable-rate commercial loans | Interest on long-term debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Interest rate cash flow hedge loss reclassified to earnings $ 0 $ 0
v3.26.1
Derivative Instruments and Hedging Activities - Schedule of Interest and Amortization on Derivative Instruments (Details) - Total derivatives designated as accounting hedges - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Interest and fees on finance receivables and loans    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain on fair value hedging relationships $ 5 $ 21
Interest and dividends on investment securities and other earning assets    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain on fair value hedging relationships 4 22
Interest on long-term debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Total gain on fair value hedging relationships 2 2
Unsecured | Interest and fees on finance receivables and loans    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain on amortization of deferred basis adjustments 0 0
Unsecured | Interest and dividends on investment securities and other earning assets    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain on amortization of deferred basis adjustments 0 0
Unsecured | Interest on long-term debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain on amortization of deferred basis adjustments 2 2
Hedged available-for-sale securities | Interest and fees on finance receivables and loans    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain on amortization of deferred basis adjustments 0 0
Gain on interest for qualifying hedge 0 0
Hedged available-for-sale securities | Interest and dividends on investment securities and other earning assets    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain on amortization of deferred basis adjustments 3 5
Gain on interest for qualifying hedge 1 17
Hedged available-for-sale securities | Interest on long-term debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain on amortization of deferred basis adjustments 0 0
Gain on interest for qualifying hedge 0 0
Fixed-rate automotive loans | Interest and fees on finance receivables and loans    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain on amortization of deferred basis adjustments 0 2
Gain on interest for qualifying hedge 5 19
Fixed-rate automotive loans | Interest and dividends on investment securities and other earning assets    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain on amortization of deferred basis adjustments 0 0
Gain on interest for qualifying hedge 0 0
Fixed-rate automotive loans | Interest on long-term debt    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain on amortization of deferred basis adjustments 0 0
Gain on interest for qualifying hedge $ 0 $ 0
v3.26.1
Derivative Instruments and Hedging Activities - Schedule of Derivative Instruments Used in Net Investment Hedge Accounting Relationships (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Interest rate | Cash flow hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain recognized in other comprehensive income $ 5,000,000 $ 7,000,000
Foreign exchange | Net investment hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain recognized in other comprehensive income 3,000,000 0
Amounts excluded from effectiveness testing 0 0
Amounts reclassified from accumulated other comprehensive income $ 0 $ 0
v3.26.1
Income Taxes (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Tax Disclosure [Abstract]    
Income tax (benefit) expense from continuing operations $ 81 $ (59)
v3.26.1
Fair Value - Schedule of Fair Value Measurements - Recurring Basis (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Assets    
Equity securities $ 863 $ 876
Total available-for-sale securities $ 23,038 $ 22,973
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Finance receivables and loans, net  
Liabilities    
Investment in any one industry did not exceed percentage 15.00% 11.00%
Carrying amount, equity investments without a readily determinable fair value $ 112 $ 111
Fair value, measurements, recurring    
Assets    
Total available-for-sale securities 23,038 22,973
Total assets, net amount 3  
Total assets 23,845 23,792
Liabilities    
Total derivative contracts in a payable position 3 4
Total liabilities 3 4
Fair value, measurements, recurring | Interest rate    
Liabilities    
Total derivative contracts in a payable position 1  
Fair value, measurements, recurring | Foreign exchange    
Liabilities    
Total derivative contracts in a payable position   4
Fair value, measurements, recurring | Credit    
Liabilities    
Total derivative contracts in a payable position 1  
Fair value, measurements, recurring | Equity    
Liabilities    
Total derivative contracts in a payable position 1  
Fair value, measurements, recurring | Equity securities    
Assets    
Equity securities 804 819
Liabilities    
Carrying amount, equity investments without a readily determinable fair value 59 57
Fair value, measurements, recurring | U.S. Treasury and federal agencies    
Assets    
Total available-for-sale securities 2,397 2,279
Fair value, measurements, recurring | U.S. States and political subdivisions    
Assets    
Total available-for-sale securities 517 551
Fair value, measurements, recurring | Foreign government    
Assets    
Total available-for-sale securities 199 188
Fair value, measurements, recurring | Agency mortgage-backed residential    
Assets    
Total available-for-sale securities 12,695 12,901
Fair value, measurements, recurring | Mortgage-backed residential    
Assets    
Total available-for-sale securities 193 198
Fair value, measurements, recurring | Agency mortgage-backed commercial    
Assets    
Total available-for-sale securities 5,107 4,932
Fair value, measurements, recurring | Asset-backed    
Assets    
Total available-for-sale securities 2 12
Fair value, measurements, recurring | Corporate debt    
Assets    
Total available-for-sale securities 1,928 1,912
Fair value, measurements, recurring | Interest rate    
Assets    
Total assets, net amount 1  
Fair value, measurements, recurring | Foreign exchange    
Assets    
Total assets, net amount 2  
Fair value, measurements, recurring | Level 1    
Assets    
Total available-for-sale securities 2,429 2,310
Total assets, net amount 0  
Total assets 3,233 3,129
Liabilities    
Total derivative contracts in a payable position 1 0
Total liabilities 1 0
Fair value, measurements, recurring | Level 1 | Interest rate    
Liabilities    
Total derivative contracts in a payable position 0  
Fair value, measurements, recurring | Level 1 | Foreign exchange    
Liabilities    
Total derivative contracts in a payable position   0
Fair value, measurements, recurring | Level 1 | Credit    
Liabilities    
Total derivative contracts in a payable position 0  
Fair value, measurements, recurring | Level 1 | Equity    
Liabilities    
Total derivative contracts in a payable position 1  
Fair value, measurements, recurring | Level 1 | Equity securities    
Assets    
Equity securities 804 819
Fair value, measurements, recurring | Level 1 | U.S. Treasury and federal agencies    
Assets    
Total available-for-sale securities 2,397 2,279
Fair value, measurements, recurring | Level 1 | U.S. States and political subdivisions    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 1 | Foreign government    
Assets    
Total available-for-sale securities 32 31
Fair value, measurements, recurring | Level 1 | Agency mortgage-backed residential    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 1 | Mortgage-backed residential    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 1 | Agency mortgage-backed commercial    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 1 | Asset-backed    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 1 | Corporate debt    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 1 | Interest rate    
Assets    
Total assets, net amount 0  
Fair value, measurements, recurring | Level 1 | Foreign exchange    
Assets    
Total assets, net amount 0  
Fair value, measurements, recurring | Level 2    
Assets    
Total available-for-sale securities 20,575 20,629
Total assets, net amount 3  
Total assets 20,578 20,629
Liabilities    
Total derivative contracts in a payable position 1 4
Total liabilities 1 4
Fair value, measurements, recurring | Level 2 | Interest rate    
Liabilities    
Total derivative contracts in a payable position 1  
Fair value, measurements, recurring | Level 2 | Foreign exchange    
Liabilities    
Total derivative contracts in a payable position   4
Fair value, measurements, recurring | Level 2 | Credit    
Liabilities    
Total derivative contracts in a payable position 0  
Fair value, measurements, recurring | Level 2 | Equity    
Liabilities    
Total derivative contracts in a payable position 0  
Fair value, measurements, recurring | Level 2 | Equity securities    
Assets    
Equity securities 0 0
Fair value, measurements, recurring | Level 2 | U.S. Treasury and federal agencies    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 2 | U.S. States and political subdivisions    
Assets    
Total available-for-sale securities 483 517
Fair value, measurements, recurring | Level 2 | Foreign government    
Assets    
Total available-for-sale securities 167 157
Fair value, measurements, recurring | Level 2 | Agency mortgage-backed residential    
Assets    
Total available-for-sale securities 12,695 12,901
Fair value, measurements, recurring | Level 2 | Mortgage-backed residential    
Assets    
Total available-for-sale securities 193 198
Fair value, measurements, recurring | Level 2 | Agency mortgage-backed commercial    
Assets    
Total available-for-sale securities 5,107 4,932
Fair value, measurements, recurring | Level 2 | Asset-backed    
Assets    
Total available-for-sale securities 2 12
Fair value, measurements, recurring | Level 2 | Corporate debt    
Assets    
Total available-for-sale securities 1,928 1,912
Fair value, measurements, recurring | Level 2 | Interest rate    
Assets    
Total assets, net amount 1  
Fair value, measurements, recurring | Level 2 | Foreign exchange    
Assets    
Total assets, net amount 2  
Fair value, measurements, recurring | Level 3    
Assets    
Total available-for-sale securities 34 34
Total assets, net amount 0  
Total assets 34 34
Liabilities    
Total derivative contracts in a payable position 1 0
Total liabilities 1 0
Fair value, measurements, recurring | Level 3 | Interest rate    
Liabilities    
Total derivative contracts in a payable position 0  
Fair value, measurements, recurring | Level 3 | Foreign exchange    
Liabilities    
Total derivative contracts in a payable position   0
Fair value, measurements, recurring | Level 3 | Credit    
Liabilities    
Total derivative contracts in a payable position 1  
Fair value, measurements, recurring | Level 3 | Equity    
Liabilities    
Total derivative contracts in a payable position 0  
Fair value, measurements, recurring | Level 3 | Equity securities    
Assets    
Equity securities 0 0
Fair value, measurements, recurring | Level 3 | U.S. Treasury and federal agencies    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 3 | U.S. States and political subdivisions    
Assets    
Total available-for-sale securities 34 34
Fair value, measurements, recurring | Level 3 | Foreign government    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 3 | Agency mortgage-backed residential    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 3 | Mortgage-backed residential    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 3 | Agency mortgage-backed commercial    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 3 | Asset-backed    
Assets    
Total available-for-sale securities 0 0
Fair value, measurements, recurring | Level 3 | Corporate debt    
Assets    
Total available-for-sale securities 0 $ 0
Fair value, measurements, recurring | Level 3 | Interest rate    
Assets    
Total assets, net amount 0  
Fair value, measurements, recurring | Level 3 | Foreign exchange    
Assets    
Total assets, net amount $ 0  
v3.26.1
Fair Value - Schedule of Fair Value Measurements - Reconciliation of Level 3 Assets And Liabilities (Details) - Fair value, measurements, recurring - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Derivative liabilities, net of derivative assets    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value at beginning of the period $ 0 $ 3
Net realized/unrealized losses (gains)    
Included in earnings 1 (1)
Included in OCI 0 0
Purchases and originations 0 0
Sales 0 0
Issuances 0 0
Settlements 0 0
Transfers into Level 3 0 0
Transfers out of Level 3 0 2
Fair value at ending of the period 1 4
Fair Value, Liability, Recurring Basis, Still Held [Abstract]    
Included in earnings 1 0
Included in OCI 0 0
Hedged available-for-sale securities    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value at beginning of the period 34 35
Net realized/unrealized gains    
Included in earnings 0 0
Included in OCI 0 0
Purchases and originations 0 0
Sales 0 0
Issuances 0 0
Settlements 0 0
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Fair value at ending of the period 34 35
Fair Value, Asset, Recurring Basis, Still Held [Abstract]    
Included in earnings 0 0
Included in OCI 0 0
Loans held-for-sale    
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value at beginning of the period 0 5
Net realized/unrealized gains    
Included in earnings 0 0
Included in OCI 0 0
Purchases and originations 0 8
Sales 0 (10)
Issuances 0 0
Settlements 0 0
Transfers into Level 3 0 0
Transfers out of Level 3 0 0
Fair value at ending of the period 0 3
Fair Value, Asset, Recurring Basis, Still Held [Abstract]    
Included in earnings 0 0
Included in OCI $ 0 $ 0
v3.26.1
Fair Value - Schedule of Fair Value Measurements - Nonrecurring Basis (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Loans held-for-sale, net $ 337 $ 549
Finance receivables and loans, net 136,350 133,964
Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Loans held-for-sale, net 336 545
Lower-of-cost-or-fair-value reserve, valuation reserve, or cumulative adjustments (15) (32)
Assets | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 358 589
Lower-of-cost-or-fair-value reserve, valuation reserve, or cumulative adjustments (113) (126)
Nonmarketable equity investments | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Other assets 2 10
Lower-of-cost-or-fair-value reserve, valuation reserve, or cumulative adjustments (1) 4
Repossessed and foreclosed assets | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Other assets 8 7
Lower-of-cost-or-fair-value reserve, valuation reserve, or cumulative adjustments (1) (1)
Level 1 | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Loans held-for-sale, net 0 0
Level 1 | Assets | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 0 0
Level 1 | Nonmarketable equity investments | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Other assets 0 0
Level 1 | Repossessed and foreclosed assets | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Other assets 0 0
Level 2 | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Loans held-for-sale, net 0 0
Level 2 | Assets | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 0 9
Level 2 | Nonmarketable equity investments | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Other assets 0 9
Level 2 | Repossessed and foreclosed assets | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Other assets 0 0
Level 3 | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Loans held-for-sale, net 336 545
Level 3 | Assets | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 358 580
Level 3 | Nonmarketable equity investments | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Other assets 2 1
Level 3 | Repossessed and foreclosed assets | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Other assets 8 7
Commercial | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Finance receivables and loans, net 12 27
Lower-of-cost-or-fair-value reserve, valuation reserve, or cumulative adjustments (96) (97)
Commercial | Level 1 | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Finance receivables and loans, net 0 0
Commercial | Level 2 | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Finance receivables and loans, net 0 0
Commercial | Level 3 | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Finance receivables and loans, net 12 27
Other | Commercial | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Finance receivables and loans, net 12 27
Lower-of-cost-or-fair-value reserve, valuation reserve, or cumulative adjustments (96) (97)
Other | Commercial | Level 1 | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Finance receivables and loans, net 0 0
Other | Commercial | Level 2 | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Finance receivables and loans, net 0 0
Other | Commercial | Level 3 | Fair Value, Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Finance receivables and loans, net $ 12 $ 27
v3.26.1
Fair Value - Schedule of Fair Value, by Balance Sheet Grouping (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Held-to-maturity securities $ 4,337 $ 4,371
Loans held-for-sale, net 337 549
Finance receivables and loans, net 136,350 133,964
Deposit liabilities 153,152 151,649
Short-term borrowings 4,126 4,695
Long-term debt 17,349 17,070
Carrying value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Held-to-maturity securities 4,337 4,371
Loans held-for-sale, net 337 549
Finance receivables and loans, net 136,350 133,964
FHLB/FRB stock 789 811
Deposit liabilities 40,215 42,310
Short-term borrowings 4,126 4,695
Long-term debt 17,349 17,070
Estimated fair value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Held-to-maturity securities 4,387 4,451
Loans held-for-sale, net 338 560
Finance receivables and loans, net 139,266 137,579
FHLB/FRB stock 789 811
Deposit liabilities 40,362 42,523
Short-term borrowings 4,123 4,706
Long-term debt 18,360 18,349
Estimated fair value | Level 1    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Held-to-maturity securities 0 0
Loans held-for-sale, net 0 0
Finance receivables and loans, net 0 0
FHLB/FRB stock 0 0
Deposit liabilities 0 0
Short-term borrowings 0 0
Long-term debt 0 0
Estimated fair value | Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Held-to-maturity securities 4,387 4,451
Loans held-for-sale, net 0 0
Finance receivables and loans, net 0 0
FHLB/FRB stock 789 811
Deposit liabilities 0 0
Short-term borrowings 0 0
Long-term debt 12,891 12,642
Estimated fair value | Level 3    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Held-to-maturity securities 0 0
Loans held-for-sale, net 338 560
Finance receivables and loans, net 139,266 137,579
FHLB/FRB stock 0 0
Deposit liabilities 40,362 42,523
Short-term borrowings 4,123 4,706
Long-term debt $ 5,469 $ 5,707
v3.26.1
Offsetting Assets and Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Offsetting [Abstract]    
Derivative assets, gross amounts of recognized assets/liabilities $ 3 $ 0
Derivative assets, gross amounts offset on the Condensed Consolidated Balance Sheet 0 0
Derivative assets, net amounts of assets/liabilities presented on the Condensed Consolidated Balance Sheet 3 0
Derivative assets, gross amounts not offset on the Condensed Consolidated Balance Sheet, financial instruments (1) 0
Derivative assets, gross amounts not offset on the Condensed Consolidated Balance Sheet, collateral (2) 0
Derivative assets, net amount 0 0
Total assets, gross amounts of recognized assets/liabilities 3 0
Total assets, gross amounts offset on the Condensed Consolidated Balance Sheet 0 0
Total assets, net amounts of assets/liabilities presented on the Condensed Consolidated Balance Sheet 3 0
Total assets, gross amounts not offset on the Condensed Consolidated Balance Sheet, financial instruments (1) 0
Total assets, gross amounts not offset on the Condensed Consolidated Balance Sheet, collateral (2) 0
Total assets, net amount 0 0
Derivative liabilities, gross amounts of recognized assets/liabilities 3 4
Derivative liabilities, gross amounts offset on the Condensed Consolidated Balance Sheet 0 0
Derivative liabilities, net amounts of assets/liabilities presented on the Condensed Consolidated Balance Sheet 3 4
Derivative liabilities, gross amounts not offset on the Condensed Consolidated Balance Sheet, financial instruments (1) 0
Derivative liabilities, gross amounts not offset on the Condensed Consolidated Balance Sheet, collateral (1) (4)
Derivative liabilities, net amount 1 0
Securities sold under agreement to repurchase, gross amounts of recognized assets/liabilities 526 545
Securities sold under agreements to repurchase, gross amounts offset on the Condensed Consolidated Balance Sheet - gross amounts offset on the consolidated balance sheet 0 0
Securities sold under agreements to repurchase, net amounts of assets/liabilities presented on the Condensed Consolidated Balance Sheet 526 545
Securities sold under agreement to repurchase, gross amounts not offset on the Condensed Consolidated Balance Sheet, financial instruments 0 0
Securities sold under agreement to repurchase, gross amounts not offset on the Condensed Consolidated Balance Sheet, collateral (526) (545)
Securities sold under agreements to repurchase, net amount 0 0
Total liabilities, gross amounts of recognized assets/liabilities 529 549
Total liabilities, gross amounts offset on the Condensed Consolidated Balance Sheet 0 0
Total liabilities, net amounts of assets/liabilities presented on the Condensed Consolidated Balance Sheet 529 549
Total liabilities, gross amounts not offset on the Condensed Consolidated Balance Sheet, financial instruments (1) 0
Total liabilities, gross amounts not offset on the Condensed Consolidated Balance Sheet, collateral (527) (549)
Total liabilities, net amount 1 $ 0
Derivative liabilities with no offsetting arrangements $ 1  
v3.26.1
Segment Information (Details)
$ in Millions
 3 Months Ended 12 Months Ended
Mar. 31, 2026
USD ($)
segment
subsegment
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
Segment Reporting [Abstract]      
Number of operating segments | segment 3    
Number of reportable segments | segment 3    
Number of operating subsegments | subsegment 2    
Segment Reporting Information [Line Items]      
Total financing revenue and other interest income $ 3,374 $ 3,393  
Total interest expense 1,517 1,675  
Net depreciation expense on operating lease assets 268 240  
Net financing revenue and other interest income 1,589 1,478  
Other revenue 513 63  
Total net revenue 2,102 1,541  
Provision for credit losses 467 191  
Compensation and benefits expense 491 505  
Insurance losses and loss adjustment expenses 121 161  
Goodwill impairment 0 305 $ 305
Other operating expenses      
Technology and communications 101 103  
Other 522 560  
Total other operating expenses 623 663  
Total noninterest expense 1,235 1,634  
Income (loss) from continuing operations before income tax expense (benefit) 400 (284)  
Total assets 197,269 193,331 196,002
Net financing revenue and other interest income after the provision for credit losses 1,100 1,300  
Operating Segments | Automotive Finance operations      
Segment Reporting Information [Line Items]      
Total financing revenue and other interest income 2,687 2,571  
Total interest expense 1,128 1,065  
Net depreciation expense on operating lease assets 268 240  
Net financing revenue and other interest income 1,291 1,266  
Other revenue 105 97  
Total net revenue 1,396 1,363  
Provision for credit losses 468 434  
Compensation and benefits expense 191 183  
Insurance losses and loss adjustment expenses 0 0  
Goodwill impairment 0 0 0
Other operating expenses      
Technology and communications 28 29  
Other 373 342  
Total other operating expenses 401 371  
Total noninterest expense 592 554  
Income (loss) from continuing operations before income tax expense (benefit) 336 375  
Total assets 117,612 111,672  
Operating Segments | Insurance operations      
Segment Reporting Information [Line Items]      
Total financing revenue and other interest income 49 44  
Total interest expense 13 14  
Net depreciation expense on operating lease assets 0 0  
Net financing revenue and other interest income 36 30  
Other revenue 342 364  
Total net revenue 378 394  
Provision for credit losses 0 0  
Compensation and benefits expense 32 30  
Insurance losses and loss adjustment expenses 121 161  
Goodwill impairment 0 0 0
Other operating expenses      
Technology and communications 4 5  
Other 193 196  
Total other operating expenses 197 201  
Total noninterest expense 350 392  
Income (loss) from continuing operations before income tax expense (benefit) 28 2  
Total assets 9,888 9,489  
Operating Segments | Corporate Finance operations      
Segment Reporting Information [Line Items]      
Total financing revenue and other interest income 243 221  
Total interest expense 130 117  
Net depreciation expense on operating lease assets 0 0  
Net financing revenue and other interest income 113 104  
Other revenue 35 29  
Total net revenue 148 133  
Provision for credit losses 8 14  
Compensation and benefits expense 26 25  
Insurance losses and loss adjustment expenses 0 0  
Goodwill impairment   0  
Other operating expenses      
Technology and communications 1 1  
Other 19 17  
Total other operating expenses 20 18  
Total noninterest expense 46 43  
Income (loss) from continuing operations before income tax expense (benefit) 94 76  
Total assets 13,803 11,002  
Corporate and Other      
Segment Reporting Information [Line Items]      
Total financing revenue and other interest income 395 557  
Total interest expense 246 479  
Net depreciation expense on operating lease assets 0 0  
Net financing revenue and other interest income 149 78  
Other revenue 31 (427)  
Total net revenue 180 (349)  
Provision for credit losses (9) (257)  
Compensation and benefits expense 242 267  
Insurance losses and loss adjustment expenses 0 0  
Goodwill impairment 0 305 $ 305
Other operating expenses      
Technology and communications 68 68  
Other (63) 5  
Total other operating expenses 5 73  
Total noninterest expense 247 645  
Income (loss) from continuing operations before income tax expense (benefit) (58) (737)  
Total assets $ 55,966 $ 61,168  
v3.26.1
Subsequent Events (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended
May 04, 2026
May 01, 2026
Apr. 14, 2026
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Subsequent Event [Line Items]            
Cash dividends declared per common share (in dollars per share) [1]       $ 0.30 $ 0.30  
Series B Preferred Stock            
Subsequent Event [Line Items]            
Par value (in dollars per share)       0.01   $ 0.01
Liquidation preference (in dollars per share)       $ 1,000   $ 1,000
Subsequent event            
Subsequent Event [Line Items]            
Cash dividends declared per common share (in dollars per share)     $ 0.30      
Subsequent event | Series D Preferred Stock            
Subsequent Event [Line Items]            
Stock issued during period (in shares)   1,000,000        
Dividend/coupon rate   7.10%        
Par value (in dollars per share)   $ 0.01        
Liquidation preference (in dollars per share)   $ 1,000        
Dividend rate, basis spread on variable rate   3.148%        
Subsequent event | Series B Preferred Stock            
Subsequent Event [Line Items]            
Dividend/coupon rate 4.70%          
Number of shares intended to be redeemed (in shares) 1,350,000          
Preferred stock, redemption price per share (in dollars per share) $ 1,000          
Shares intended to be redeemed as percentage of issued and outstanding shares 100.00%          
Aggregate liquidation preference $ 1,350          
[1] Figures in the table may not recalculate exactly due to rounding. Earnings per share is calculated based on unrounded numbers.